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Abstract
Insulin regulates glucose uptake in responsive cells by trafficking GLUcose 
Transporter 4 (GLUT4) molecules to the plasma membranes of these cells. This thesis 
focuses on events at the plasma membrane, including membrane fusion and activation 
of GLUT4. Wortmannin inhibition experiments in rat adipocytes did not show the 
trafficking-independent inhibition of insulin-stimulated glucose transport activity at 
low wortmannin concentrations seen in other cell types. The p38 MAP kinase 
inhibitor SB203580 inhibited labelling of cell surface GLUT4 as well as glucose 
transport activity.
Purified recombinant protein standards were used to quantify SyNaptosome- 
Associated Protein (SNAP) REceptor (SNARE) proteins in rat adipocytes. There were 
approximately 2,500,000 copies of syntaxin4, 8,900,000 copies of SNAP23,
1,900,000 copies of VAMP2 and 1,000,000 copies of Muncl8c in each adipose cell. 
Syntaxin4, SNAP23 and Muncl8 were predominantly localised to the plasma 
membrane. SNAP23 was in large excess compared to the other proteins in plasma 
membranes, suggesting that its availability was tightly regulated. VAMP2 was 
distributed between the plasma membrane and intracellular membranes. Insulin 
caused a two-fold increase in VAMP2 at the plasma membrane.
The small amounts of syntaxin4 in intracellular membranes were in large 
excess over Muncl8c in the same membranes. These results suggest that Muncl8c is 
unlikely to play a major role in trafficking syntaxin4 to the plasma membrane as has 
been suggested. A number of approaches were applied to expressing and purifying 
recombinant SNAREs. The purified proteins were reconstituted into liposomes. This 
system is intended to be the future basis for experiments on SNARE function and 
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IRAP Insulin responsive aminopeptidase
IRS Insulin receptor substrate
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Chapter 1 - Introduction and Review of the Literature
1.1. Glucose Homeostasis
Glucose is a major source of energy and an important source of carbon for the 
synthesis of organic molecules in eukaryotic cells. In vertebrates, glucose is 
transported throughout the body in the blood, and moves into and out of cells via a 
family of transporter proteins called GLUTs (GLUcose Transporters). Because 
GLUTs transport glucose down its concentration gradient, and cells require glucose as 
an energy source, it is vital that glucose homeostasis is maintained in the body. This is 
achieved by balancing the antagonistic effects of the hormones insulin and glucagon. 
Insulin is secreted by the pancreas in response to elevated blood glucose and promotes 
uptake and storage of glucose in responsive tissues. The pancreas secretes glucagon 
when blood glucose concentration is low. Glucagon stimulates the breaking down of 
glucose stored in responsive tissues and the release of this glucose into the blood.
1.1.1. Diabetes
A deficiency of insulin or a loss of response to insulin results in diabetes 
mellitus. The resulting elevated blood glucose causes the kidneys to excrete glucose 
and with it large volumes of water. Fat becomes the main source of energy for cellular 
respiration, and its breakdown causes the accumulation of acidic metabolites in the 
blood which can be life threatening as a result of the lowered pH. Type 1 diabetes is 
caused by an attack by the body’s own immune system on the pancreas, resulting in a 
deficiency in insulin secretion. Type 2 diabetic patients show normal insulin secretion 
but display insulin resistance, an inability to respond normally to insulin. This 
condition is associated with obesity. There is a great heterogeneity in the genetic
18
defects that cause type 2 diabetes (Jenkins and Campbell, 2004). The end result 
however is the same regardless of the cause -  elevated blood glucose.
The incidence of type 2 diabetes is growing rapidly in many populations 
(Diamond, 2003). This has led to an expansion of research into the biochemistry of 
glucose metabolism. The increase in type 2 diabetes is thought to be due to the 
tendency towards regular carbohydrate-rich meals in populations that are genetically 
adapted to periods of fluctuating food availability. The ability to rapidly convert 
dietary intake to fat at times of high food abundance would have been a selective 
advantage in populations where the food supply was intermittent. However, this 
ability could lead to obesity and type 2 diabetes when regular carbohydrate-rich meals 
and reduced exertion become the norm (Neel, 1962).
1.2. The glucose transporter family
The increase in the uptake of glucose from the blood in response to insulin by 
muscle, fat and liver cells is largely a result of the increase in the abundance of 
glucose transporter molecules on the surface of these cells that occurs in response to 
insulin. The glucose transporters, or GLUTs are members of the SLC2 family of 
glucose and polyol transporters. Thirteen members of this family have been identified 
in humans, either by purification or by sequence similarity. Twelve of the family 
members have been classified as GLUTs, and the remaining family member is the H+- 
myo-inositol cotransporter (HMIT1). The family is split into four main classes based 
on their genetic similarity. Class I GLUTs are the best characterised, and comprise of 
GLUT1, GLUT2, GLUT3 and GLUT4. Class II is made up of GLUT5, GLUT7, 
GLUT9 and GLUT11. Class III includes GLUT6, GLUT8, GLUT10 and GLUT 12, 
and HMIT1.
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The different GLUTs differ in their substrate specificities and tissue 
distribution. GLUTs 1-4 are specific transporters of glucose. GLUT1 is ubiquitously 
expressed, and is the predominant GLUT in erythrocytes and in the brain (Mueckler et 
al, 1985). GLUT2 is expressed in pancreatic p-cells, liver, kidney and the small 
intestine, and is able to transport fructose and glucosamine as well as glucose 
(Fukumoto et a l , 1988; Cheeseman, 1993; Uldry et al., 2002). GLUT2 plays a role in 
the mechanism that senses blood glucose levels and thereby controls secretion of 
insulin and glucagon (Thorens, 2001; Thorens, 2003). GLUT3 is expressed in the 
brain and most other tissues (Kayano et al., 1988), and GLUT4 is expressed only in 
the insulin-responsive tissues - heart, skeletal muscle and adipose tissue (Fukumoto et 
a l , 1989).
GLUT5 is a fructose transporter and is responsible for fructose uptake in the 
small intestine, testes and kidney (Kayano et a l , 1990). GLUT5 is also expressed in 
spermatozoa, where fructose is a major source of energy (Burant et al, 1992).
GLUT7 is able to transport both glucose and fructose, and is expressed in the small 
intestine, colon, testes and prostate (Li et al, 2004). GLUT9 is a glucose transporter 
and is expressed predominantly in the small intestine, placenta, lung and leukocytes, 
and may be important in early preimplantation development (Phay et al, 2000; 
Carayannopoulos et al, 2004). GLUT11 is thought to be predominantly a fructose 
transporter, but also shows some glucose transport activity. It is expressed in the 
pancreas, placenta, kidney, heart and skeletal muscle (Doege et a l, 2001).
Class III GLUTs are the most closely related to glucose transporters in 
prokaryotes and lower eukaryotes (Joost and Thorens, 2001). Class I and II GLUTs 
are thought to have evolved from class III GLUTs as a result of the complex 
requirements for glucose homeostasis in mammals. GLUT6 is specific for glucose and
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is expressed in brain, spleen and peripheral leukocytes (Doege et al., 2000a). GLUT8 
and GLUT 12 are thought to transport galactose and fructose as well as glucose 
(Doege et al., 2000b; Rogers et al., 2003). GLUT8 is predominantly expressed in 
testes, but is found at lower levels in most tissues (Ibberson et al., 2000; 
Carayannopoulos et al., 2000). GLUT 12 is expressed in heart and prostate (Macheda 
et al., 2002). GLUT 10, whose substrate specificity has not yet been characterised is 
predominantly expressed in the pancreas and liver (McVie-Wylie et a l,  2001). 
However, its substrate specificity. HMIT shows transport activity for myo-inositol 




Figure 1.1. Important features of GLUT4 structure. The major features shown 
include : the 12 amphipathic transmembrane helices with cytosolic amino and 
carboxy termini; the N-glycosylation site (N) on the extracellular loop between 
helices 1 and 2; the FQQI m otif (FQQI) in the amino terminal cytosolic domain, and 
the dileucine m otif (LL) in the carboxy terminal domain, both important for 
intracellular sorting and recruitment o f adaptor proteins.
The GLUTs are facilitative transporters o f their substrates. That is, their 
transport activities are not coupled to any energy or cargo exchange other than the
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movement of substrates down their concentration gradients (Baldwin et a l, 1981). All 
of these proteins share a characteristic topology with cytosolic amino and carboxy 
terminal ends flanking twelve transmembrane domains, with a glycosylation site on 
either the first (Class I and II) or the fifth (Class III) extracellular loop (Figure 1.1.). 
The seventh transmembrane domain is thought to be important in determining 
substrate specificities of the different family members (Arbuckle et al, 1996). Overall 
sequence homology between the members of the GLUT family is less than 40%.
There is however a much higher degree of sequence identity within the 
transmembrane domains.
Insulin results in a 20 to 40-fold increase in glucose uptake in responsive cells. 
GLUT1, which is only expressed at low levels in muscle and adipocytes is largely 
confined to the plasma membrane, and GLUT1 levels in the plasma membrane of 
adipocytes increase 2 to 3-fold in response to insulin. GLUT4, whose expression is 
confined to insulin-responsive tissues is expressed at far higher levels in muscle and 
adipocytes than GLUT1. In resting (or basal) cells, GLUT4 is largely confined to 
intracellular membranes. GLUT4 levels at the cell surface increase 20 fold in 
response to insulin stimulation. GLUT4 is therefore the dominant GLUT in the insulin 
response (Bryant et al, 2002). Tissues from patients with type 2 diabetes show 
defects in the trafficking and translocation of GLUT4 (Garvey et a l, 1998).
Therefore, understanding how GLUT4 trafficking is regulated should help in 
understanding and identifying the defects that underlie diabetes, and thereby aid the 
search for treatments directed towards specific molecular targets. The focus of this 
thesis is on the events at the plasma membrane that lead to the increased exposure of 
GLUT4 on the exterior surface of adipocytes in response to insulin.
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1.3. Intracellular GLUT4 compartments
GLUT4 is found in numerous intracellular compartments including the trans- 
Golgi nertwork (TGN) and the endosomal system. GLUT4 colocalises with different 
classes of vesicles including APl/clathrin coated vesicles that bud from the TGN or 
endosomes, AP2-coated vesicles that bud from the plasma membrane, and insulin- 
responsive vesicles that contain proteins such as the insulin-responsive 
aminopeptidase (TRAP) (Figure 1.2.) (James et a l , 1994; James and Piper, 1994; 
Keller et a l, 1995).
There is a general exocytic response to insulin, even in nonspecialised cells 
such as fibroblasts. However, the magnitude of the GLUT4 response is much larger 
than that of endosomal or trans-Golgi network (TGN) markers in insulin-sensitive 
cells (Hudson et a l , 1993; Ross et a l , 1998). This suggests that there is a separate 
insulin-sensitive compartment containing GLUT4 that is independent of the 
endosome and the TGN. The existence of the insulin-sensitive compartment is not 
dependent on the presence of GLUT4 itself, as IRAP trafficking responds normally to 
insulin in experiments where GLUT4 expression is downregulated or prior to GLUT4 
expression in 3T3-L1 pre-adipocytes (Ross et a l, 1998; Zhou et a l, 2000).
Biochemically blocking the recycling endosome compartment using a 
transferrin-horseradish peroxidase conjugate only partially inhibits the GLUT4 
response (Livingstone et a l, 1996), as does treatment with inhibitors of 
phospholipase D (Millar et al, 2000). These data suggest that the insulin-sensitive 
compartment is not dependent on the recycling endosome.
Separation of vesicles by size or density and electron microscopy studies 
identified insulin-responsive vesicles that contained GLUT4 and IRAP but no TGN or
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endosomal markers (Livingstone et a l , 1996; Wei et a l , 1998; Hashiramoto and 
James, 2000). The SNARE protein vesicle-associated membrane protein 2 (VAMP2) 
was also selectively localised to the insulin-responsive GLUT4 compartment (Sevilla 
et al., 1997). Cellugyrin was associated with GLUT4 vesicles found in the recycling 
endosome system, but not with insulin-sensitive GLUT4 vesicles (Kupriyanova and 
Kandror, 2000). The insulin-sensitive GLUT4 compartment is therefore 
biochemically distinct from the other GLUT4 compartments.
Morphological studies using electron microscopy in 3T3-L1 adipocytes and 
rat adipocytes showed that intracellular GLUT4 was distributed between vesicular and 
reticular membrane structures. A proportion of the vesicular structures and some of 
the reticular structures also contained VAMP2. The VAMP2-positive GLUT4 vesicles 
were separate from GLUT4 vesicles that also contain GLUT1 and transferrin 
receptors.
Insulin stimulation is thought to result in a rapid exocytosis of GLUT4 
originating from the vesicular VAMP2-containing pool, and a slower phase of 
exocytosis originating from stimulation of replenishment of this pool from the 
reticular VAMP2-positive GLUT4 compartment (Xu and Kandror, 2002). Disrupting 
VAMP2 function, or those of its SNARE partners syntaxin4 and SNAP23 selectively 
abolished insulin-stimulated GLUT4 traffic to the plasma membrane without affecting 
other GLUT4 trafficking events (Cheatham et a l , 1996; Tamori et ah, 1996; Tellam 
et al., 1997; Rea et a l , 1998). Insulin also appeared to stimulate the budding of 





•  Transferrin receptor
Figure 1.2. Insulin-responsive GLUT4 trafficking. GLUT4 is sorted through the 
trans-Golgi network (TGN) into a reticular storage compartment (RSC). GLUT4 
cycles between the RSC and an insulin responsive vesicular storage compartment 
(VSC). Budding o f vesicles from the RSC to the VSC may be increased on insulin 
stimulation. GLUT4 in the VSC is rapidly trafficked and fuses to the plasma 
membrane (PM) in response to insulin. The alternative route for GLUT4 from the 
RSC is to the endosomal system, comprising o f the early endosome (EE), late 
endosome (LE), and recycling endosome (RE), which constitutively shuttle GLUT4 
and other proteins like transferrin between the PM and the endosome. Exocytosed 
GLUT4 re-enters the cell via the endosomal system. Defective proteins are sorted to 
the degradative pathway (D) from the LE and the RSC. This figure is adapted from 
the review by (Holman and Sandoval, 2001).
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1.3.1. GLUT4 sorting motifs
A number of sorting signals are present on GLUT4. These include a FQQI 
motif at the amino terminus, and an acidic cluster at the carboxy terminus, which also 
contains a dileucine motif (Figure 1.1). The dileucine motif and the FQQI motif are 
thought to act in recruitment of the adaptor proteins, but the function of the acidic 
cluster is not known. The FQQI motif is important in sorting GLUT4 away from the 
endosome (Sandoval et al., 2000; Palacios et a l , 2001), and the dileucine motif has 
been shown to act in sorting GLUT4 between the TGN and GLUT4 storage vesicles 
(Jhun et al, 1992; Marsh et al., 1998; Holman and Sandoval, 2001).
1.3.2. IRAP
IRAP is completely colocalised with the insulin responsive GLUT4 
compartment, and co-trafficked with GLUT4 in response to insulin (Ross et al.,
1996). It is a type II membrane protein with a 109 residue cytoplasmic tail and a large 
894 amino acid lumenal domain. The lumenal domain is heavily glycosylated and 
contains an aminopeptidase catalytic domain (Keller et al., 1995). The catalytic 
domain has been shown to catalyse the cleavage of a number of vasoactive peptide 
hormones in vitro (Tsujimoto et al., 1992; Herbst et al., 1997; Matsumoto et al., 
2001). This suggests that IRAP may function in regulating blood circulation in 
response to insulin stimulation. However the in vivo substrates of IRAP have not been 
identified. The cytosolic tail of IRAP contains a dileucine motif and an acidic cluster, 
which may regulate its intracellular trafficking in a similar manner to those of GLUT4 
(Subtil et al., 2000; Johnson et al., 2001).
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1.3.3. Regulation of GLUT4 trafficking
Kinetic studies indicate that insulin both increases the rate of appearance of 
GLUT4 at the cell surface, and to a lesser degree decreases the re-endocytosis rate of 
GLUT4 (Jhun et al., 1992; Czech and Buxton, 1993; Satoh et a l , 1993; Yang and 
Holman, 1993). Four points at which insulin signals might regulate exocytosis of 
GLUT4 are: 1) the release of vesicles from the reticular storage pool to the insulin- 
sensitive vesicular storage pool, 2) trafficking of vesicles to the plasma membrane, 3) 
vesicle tethering or docking with the plasma membrane and 4) vesicle fusion with the 
plasma membrane. Insulin has been demonstrated to stimulate trafficking of GLUT4 
to the plasma membrane and budding of vesicles from the reticular GLUT4 pool (Xu 
and Kandror, 2002). On insulin stimulation, vesicles containing GFP-tagged GLUT4 
appeared to accumulate at a number of discrete points where they slowly fuse with the 
plasma membrane before GFP fluorescence rapidly disperses in the plane of the 
membrane (Fletcher et al., 2000). The speed of this membrane fusion step appears to 
be enhanced in insulin-treated cells, suggesting that this step may also be regulated by 
insulin.
1.4. Insulin signalling
There is a great diversity of responses that follow when insulin binds its 
receptor. These include increased glucose transport, cell division, and regulation of 
metabolic enzymes. A brief overview of the events linking insulin signalling to 
insulin-stimulated glucose transport in adipocytes is included here.
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1.4.1. The insulin receptor
The insulin receptor is a member of the receptor tyrosine kinase family. This 
family includes receptors for a number of other peptide hormones, and shares many 
downstream effectors with other members of the family (Patti and Kahn, 1998). The 
receptor consists of two a  and two transmembrane p subunits joined together by 
disulphide bonds to make up a ap heterodimer. Binding of insulin to the receptor 
causes a conformational change that activates the autocatalytic tyrosine kinase activity 
of one p subunit. This phosphorylates three tyrosine residues in the activation loop of 
the other p subunit, causing the activation loop to move away from the catalytic site 
so that ATP and substrates can bind.
1.4.2. Insulin receptor substrates
Members of the insulin receptor substrate (IRS) protein family bind the insulin 
receptor via phosphotyrosine binding domains, which recognise phosphorylated 
tyrosine residues on the receptor. IRS proteins are scaffolding proteins that do not 
have catalytic activity, but instead link downstream signaling molecules to the insulin 
receptor. Four IRS proteins have been characterised, of which IRS1 and IRS2 were 
ubiquitously expressed (Sun et al., 1991; Sun et al., 1995), IRS3 was restricted to 
adipose tissue (Lavan et al., 1997), and IRS-4 was expressed in the thymus, brain, 
kidney and possibly p-cells (Uchida et al., 2000).
IRS proteins contain a conserved series of protein interaction domains, 
including phosphotyrosine binding domains, through which they interact with the 
insulin receptor, and pleckstrin homology domains which are implicated in 
phosphoinositide binding and may also bind the insulin receptor. They also contain a 
number of tyrosine phosphorylation sites, which allow recruitment of downstream
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signalling proteins such as Grb-2, Nek and PI 3-kinase via their phosphotyrosine- 
binding sre homology-2 (SH2) domains (Giovannone et al, 2000).
Studies of IRS proteins have been hampered by the partially redundant 
functions of the proteins. In experiments with IRS-1 knockout mice, downstream 
targets of insulin were activated nearly to the same extent as they were in wild type 
mice in cells that expressed IRS-2, whereas cells with low IRS-2 levels showed little 
downstream activation, suggesting that IRS-2 was able to compensate for lack of IRS- 
1 (Araki et a l, 1994). IRS-3 also appeared to compensate for lack of IRS-1 in 
adipocytes from these knockout mice (Smith-Hall et al, 1997). Studies with IRS-1 
and IRS-2 knockout mice indicated that IRS-1 was the major insulin receptor 
substrate involved in regulation of glucose uptake by insulin in target tissues (Araki et 
al, 1994; Tamemoto et al, 1994), whereas IRS-2 was more important in regulating 
insulin secretion in beta cells (Withers et al, 1998; Higaki et al, 1999).
Tyrosine phosphorylation of IRS proteins by the insulin receptor enables 
binding of downstream proteins containing SH2 domains. The most important of 
these for insulin stimulated glucose transport is the p85 subunit of the Class 1A PI 3- 
kinase.
1.4.3. PI 3-kinases
PI 3-kinases are a family of enzymes that catalyse the phosphorylation of the 
3’ hydroxyl on the inositol ring on membrane lipid head groups. The 3’- 
phosphorylated lipid products that are produced by these enzymes act as targets for 
the recruitment of signalling molecules to membranes via specific lipid-binding 
domains, such as pleckstrin homology (PH), FYVE and Phox domains. PI 3-kinases 
are found in all eukaryotic cells and regulate many processes, including cell growth,
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division, differentiation, survival, motility and membrane trafficking (Katso et al.,
2001).
Although studies with inactive mutants of p85, microinjection of SH2 
domains, and inactivating antibodies to the pi 10 subunit have implicated the class la 
PI 3-kinases in insulin stimulation of glucose uptake, the existence of multiple 
isoforms complicates the picture (Kotani et al., 1995; Haruta et al., 1995; Sharma et 
al, 1998; Hausdorff et al., 1999). It is not known which of the five p85 isoforms and 
the three pi 10 isoforms form complexes in vivo, nor the differences between the 
functions downstream of the different isoforms (Vanhaesebroeck et al., 1997). The 
importance of the isoform specificity is illustrated by a study in which different p85 
isoforms directed PI 3-kinase activities either to the plasma membrane or to GLUT4 
vesicles in heart muscle (Kessler et al., 2001).
IRS function appears to be important for the specificity of downstream effects 
of PI 3-kinase activity. Growth factors other than insulin stimulated PI 3-kinase 
activity without increasing glucose uptake (Isakoff et al., 1995). This PI 3-kinase 
activity was recruited directly to the tyrosine kinase receptors and consequently 3’ 
phosphoinositide production was restricted to the immediate vicinity of the receptor. 
Recruitment by IRS molecules however, is unique to the insulin signalling pathway, 
and may enable remote activation of PI 3-kinase activity in specialised domains of the 
plasma membrane or on intracellular membranes. This may facilitate the activation of 
the specific downstream substrates required for recruitment of GLUT4 to the plasma 
membrane (Figure 1.3.A.).
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1.4.3.L Downstream targets of PI 3-kinase
Atypical protein kinase C (PKC<^  and PKCA-), a serine/threonine phosphatase, 
is recruited to sites of insulin signalling when its amino terminal domain interacts 
with the PI 3-kinase product PI(3,4,5)P3 (Standaert et al., 2001). Transfection of 
inactive mutants of PKCQ'A, resulted in attenuation of insulin stimulated glucose 
transport (Bandyopadhyay et al., 1997; Standaert et al., 1997; Bandyopadhyay et al., 
1999a). However, siRNA depletion of PKC£ or PKCA, or of both isoforms did not 
have any effect on insulin stimulated glucose transport (Zhou et al., 2004). Although 
the specific role played by PKC^A, in insulin stimulated glucose transport is still 
controversial, there is evidence that it mediates an interaction between Rab4 and the 
microtubule motor kinesin, which suggests that PKC /^A, may have a role in 
stimulating GLUT4 vesicle translocation to the plasma membrane (Imamura et al.,
2003). PKC£/X also phosphorylates serine residues that occur in the cytoplasmic 
domain of IRAP and it has been suggested that these phosphorylated residues play a 
role in IRAP and GLUT4 trafficking, although there is no evidence for this as yet 
(Ryu et al., 2002).
Akt, a serine/threonine kinase also known as protein kinase B (PKB) is 
recruited to sites of insulin signalling via interactions through its PH domain with 
PI(3,4,5)P3 on membrane lipid head groups. Akt represents a point of divergence on 
the insulin signalling cascade, as it mediates insulin regulation of glycogen synthesis 
and gene expression as well as glucose uptake (Cross et al., 1995; Nave et a l , 1999; 
Nakae et a l , 1999). Expression of constitutively active forms of Akt stimulated 
glucose transport in 3T3-L1 adipocytes and rat adipocytes (Kohn et a l , 1996; Tanti et 
al., 1997), and microinjection of antibodies against Akt inhibited insulin stimulated 
GLUT4 translocation (Hill et a l , 1999). Furthermore, glucose transport was
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attenuated in Akt2 knockout mice, but not in Aktl knockouts (Cho et a l , 2001a; Cho 
et al., 2001b), and reduction of Akt levels by siRNA inhibited insulin stimulated 
glucose transport (Jiang et al, 2003). However, there are also studies that argue 
against such a major role for Akt. Expression of inactive mutants of Aktl and Akt2 
did not inhibit insulin-stimulated glucose transport, but inhibited insulin stimulated 
protein synthesis in 3T3-L1 adipocytes (Kitamura et al, 1998). Furthermore, 
expression of inactive Akt2 only slightly inhibited insulin-stimulated glucose 
transport in another study in rat adipocytes (Cong et al, 1997).
Akt and PKC^/X are activated by phosphorylation of threonine residues in 
their regulatory domains by 3’-phosphoinositide-dependent protein kinase-1 (PDK-1) 
(Alessi et al, 1997; Chou et al., 1998; Le Good et a l, 1998; Bandyopadhyay et al, 
1999b; Alessi, 2001). SH2 domains on the adaptor protein Grbl4, which exists in a 
complex with PDK-1 are recruited by phosphorylated tyrosine residues in the insulin 
receptor that are phosphorylated following insulin binding (King and Newton, 2004). 
This brings PDK-1 into contact with its substrates.
Full Akt activation also requires phosphorylation on Ser473 by a second PDK, 
which has not been identified (Hresko et al, 2003). However, targeting Akt to 
GLUT4 vesicles resulted in basal levels of GLUT4 translocation similar to those seen 
with insulin in normal cells, indicating that the substrates of Akt may lie on or near 
GLUT4 vesicles (Ducluzeau et al, 2002; Chen et a l, 2003). The Rab GTPase- 
activating protein AS 160 was identified as an Akt substrate using an antibody directed 
against a consensus ATP substrate sequence. Mutation of the Akt phosphorylation site 
on AS 160 blocked insulin stimulated GLUT4 exocytosis at a step prior to docking 
with the plasma membrane (Sano et al, 2003; Zeigerer et al, 2004). The postulated 
Rab protein downstream of AS 160 has not been identified.
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Synip, a protein that regulates the docking of GLUT4 vesicles with the plasma 
membrane is also a substrate of Akt2 (Min et a l , 1999; Yamada et al., 2005). 
Phosphorylation of synip at its Akt substrate site appeared to regulate its binding to 
syntaxin4, a protein with an important role in the fusion of GLUT4 vesicles with the 
plasma membrane.
The effects of wortmannin inhibition of PI 3-kinase on insulin stimulated 
glucose uptake were alleviated by adding membrane permeable esters of 
PtdIns(3,4,5)P3 in the presence of insulin. However, these lipid analogs by themselves 
were not sufficient to stimulate glucose transport in the absence of insulin (Jiang et 
al., 1998). In addition, insulin-independent stimulation of IRS-1, PI 3-kinase and Akt 
via beta-integrin failed to elicit a glucose transport response (Guilherme and Czech, 
1998). These results suggest that insulin activates another pathway in addition to PI 3- 
kinase that is required for the stimulation of glucose uptake. Two pathways whose 
activation has been suggested to complement PI 3-kinase are those containing 
phospholipase Cy (PLCy) and the GTPase TC10 (Chiang et al., 2001; Lorenzo et al.,
2002).
1.4.4. Phospholipase C
Phospholipase C (PLC) catalyses the hydrolysis of PI(4,5)P2 to IP3 and DAG. 
PLC was implicated in insulin stimulated glucose transport when it was observed that 
lithium, a treatment for bipolar disorder and an inhibitor of enzymes that degrade 
inositol phosphates, enhanced insulin stimulated glucose transport when administered 
to animal and human subjects (Shah et al., 1986; Rossetti, 1989). Chemical inhibition 
of PLC or disruption of PLCy binding to the insulin receptor by microinjection of 
PLCy SH2 domains inhibited insulin stimulated glucose transport (Epps-Fung et al.,
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1997; Kayali et al., 1998). This inhibition was rescued by a cell permeable DAG 
analogue. A recent study showed that inhibition of PLCy abolished PKC£, activation 

















Figure 1.3. Insulin signalling leading to glucose uptake. A. The PI 3-kinase 
pathway. When insulin binds, the insulin receptor (IR) autophosphorylates, activating 
its tyrosine kinase activity, which phosphorylates IRS proteins, allowing recruitment 
and activation o f p85 and p i 10 subunits of PI 3-kinase. The resulting increase in 3 ’ 
phosphorylated lipids activates PDK1, which phosphorylates its substrates Akt and 
atypical PKC, leading to insulin-stimulated glucose uptake. B. The TC10 pathway. 
The IR phosphorylates Cbl, which recruits CAP. The complex then translocates to 
lipid rafts, where it associates with flotillin. TC10 is subsequently activated via the 
Crk/C3G complex, and promotes actin rearrangements and fusion of GLUT4 vesicles 
with the plasma membrane.
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only partly mediated through PKC^ (Lorenzo et a l, 2002). This same study also 
showed that PLCy activation by insulin was PI 3-kinase dependent. This suggests that 
PLCy is part of the PI 3-kinase dependent pathway that is required for activation of 
PKCC
1.4.5. The TC10 pathway
The second proposed PI 3-kinase independent insulin signalling pathway is the 
TC10 pathway (Figure I.3.B.). This pathway is activated through the tyrosine 
phosphorylation of c-Cbl by the insulin receptor, which is recruited to the insulin 
receptor through SH2 domains on the adaptor protein APS. Following 
phosphorylation of Cbl, a complex of Cbl with Cbl activating protein (CAP) is 
translocated to lipid rafts, where it binds flotillin, a raft associated protein. Cbl recruits 
a complex containing the adaptor protein Crkll and the GTPase exchange factor C3G. 
GTP exchange by this complex activates the TC10 GTPase (Watson et a l, 2001). 
Expression of a CAP mutant that is unable to bind Cbl resulted in partial inhibition of 
insulin stimulated glucose transport in 3T3-L1 adipocytes (Ribon et al, 1998; 
Baumann et a l, 2000). Expression of a dominant negative TC10 also partially 
inhibited insulin stimulated glucose transport (Chiang et a l, 2001). Conversely, 
(Thirone et a l, 2004) and (JeBailey et al, 2004) reported that there was no increase in 
Cbl phosphorylation in response to insulin in muscle tissue. Furthermore, wortmannin 
inhibited the proposed downstream effects of TCI 0 on actin remodelling without 
inhibiting TC10 activation and expression of a dominant negative mutant of TCI0 did 
not inhibit insulin stimulated actin remodelling in myoblasts (JeBailey et a l, 2004). In 
addition, supression of c-Cbl, Crkll and CAP proteins by siRNA had no effect on 
insulin stimulated glucose transport (Mitra et al, 2004). The conflicting data mean
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that the role of this pathway in insulin stimulated glucose transport remains 
controversial.
As well as the role in actin remodelling, TC10 has also been implicated in the 
assembly of the exocyst complex. The exocyst is involved in membrane tethering. 
Disruption of the exocyst complex disrupts insulin stimulated fusion of GLUT4 
vesicles with the plasma membrane (Inoue et a l, 2003). These data suggest that 
insulin stimulation of the TC10 pathway plays a role in stimulating membrane fusion. 
(Maffucci et a l, 2003) reported that PI3P was produced in response to insulin 
downstream of TCI 0 activation, and that this lipid head group stimulated GLUT4 
translocation in a PI 3-kinase independent manner in response to insulin.
To summarise, there is good evidence for a major role in insulin stimulated 
glucose uptake for IRS and PI 3-kinase dependent pathways, and for the requirement 
of at least one additional pathway. The identities of the additional pathways are 
unknown, and there are conflicting data in the literature both supporting and 
apparently ruling out roles for the PLCy and TC10 pathways. Although the relevance 
of these pathways is disputed, the insulin signalling field is approaching the point at 
which one can name an unbroken chain of molecules that connect the initial activation 
of the insulin receptor to the fusion of GLUT4 vesicles with the plasma membrane.
1.5. The role of the cytoskeleton in GLUT4 vesicle trafficking
Possible roles for the microtubule and actin cytoskeletons have already been 
mentioned in connection with the downstream targets of the PKC(^ /A. and TC10 
signalling pathways. Kinesin motors play important roles in transporting vesicles 
along microtubules in neurons and polarized epithelial cells (Fath et al, 1994; 
Goldstein and Philp, 1999). The intermediate filament protein vimentin and the
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microtubule protein a-tubulin were found in the perinuclear GLUT4 compartment in 
3T3-L1 adipocytes (Guilherme et al, 2000). Disruption of the motor proteins dynein 
and kinesin inhibited insulin stimulated GLUT4 translocation (Guilherme et al., 2000; 
Emoto et al, 2001). However, chemical depolymerisation of the microtubule 
cytoskeleton resulted in the accumulation of GLUT4 vesicles beneath the plasma 
membrane, possibly because the GLUT4 vesicles could not be retained in the 
perinuclear compartment or because GLUT4 recycling from the plasma membrane to 
the endosome was disrupted. These GLUT4 vesicles were able to fuse with the 
plasma membrane on insulin stimulation and were reintemalised following removal of 
insulin, but remained in the vicinity of the plasma membrane (Molero et a l, 2001; 
Shigematsu et al, 2002). This implies that the intact microtubule cytoskeleton and 
kinesin and dynein activity are required for maintaining intracellular 
compartmentalization of GLUT4, but not for insulin stimulated GLUT4 
extemalization. It is possible that the geometry of adipose cells, with their relatively 
small cytosolic volume obviates the need for the long distance vesicle transport 
mediated by the microtubule cytoskeleton.
Insulin stimulates actin rearrangements in many cell types (Ridley and Hall, 
1992; Tsakiridis et al, 1994; Nobes et a l, 1995; Berfield et al, 1996). Insulin 
stimulated GLUT4 exocytosis was blocked by the actin depolymerizing agents 
latrunculins A and B (Wang et a l, 1998; Omata et a l, 2000). Insulin treatment also 
caused recruitment of PI 3-kinase to GLUT4 vesicles, and this process was also 
dependent on actin depolymerisation and reassembly (Wang et al, 1998). Insulin- 
induced actin polymerisation was mediated by the actin-regulatory neural Wiskott- 
Aldrich syndrome protein (N-WASP), which was localised to the plasma membrane 
in response to insulin. A dominant negative TC10 mutant inhibited plasma membrane
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localisation of N-WASP and actin rearrangements in response to insulin (Jiang et al., 
2002). The actin motor Myolc was also localised to GLUT4 vesicles in response to 
insulin and was required, along with an intact actin network for the accumulation of 
GLUT4 vesicles at the plasma membrane. This insulin-induced localisation of Myolc 
to GLUT4 vesicles was insensitive to wortmannin, and appeared to promote fusion of 
GLUT4 vesicles with the plasma membrane by driving membrane remodelling (Bose 
et al., 2002). Wortmannin-independent actin rearrangements are therefore required 
upstream of insulin-induced fusion of GLUT4 vesicles with the plasma membrane. 
The process of fusion itself was inhibited by inhibitors of PI 3-kinase (Bose et al,
2004), and may be dependent on the recruitment of PI 3-kinase to GLUT4 vesicles 
(Wang et al., 1998). However, this inhibition of GLUT4 vesicle fusion with the 
plasma membrane by PI 3-kinase inhibitors was overcome by overexpression of 
Myolc (Bose et al, 2004). This suggests that the various insulin signalling pathways, 
as well as interacting with each other, may have overlapping functions. This may be a 
reason for the conflicting experimental data on the various pathways.
Cortical actin rearrangements therefore occur in response to insulin signalling 
and are required for fusion of GLUT4 vesicles with the plasma membrane, whereas 
the microtubule cytoskeleton appears to be involved in intracellular GLUT4 retention, 
but not in the exocytic response.
1.6. Regulation of GLUT4 transporter activity
As well as regulating GLUT4 vesicle trafficking and fusion with the plasma 
membrane, there is evidence that insulin also directly regulates the glucose transport 
activity of GLUT4. There is a delay following insulin stimulated GLUT4 exocytosis 
before glucose uptake is detected, suggesting that the transporters are inactive when
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first inserted into the plasma membrane (Kamieli et al, 1981; Yang et al., 1992;
Satoh et a l, 1993). Treatments of 3T3-L1 adipocytes with cell permeable analogues 
of the lipid products of PI 3-kinase activity were able to mimic insulin-induced 
GLUT4 exocytosis, but not glucose transport in the presence of wortmannin. Cells 
treated with wortmannin regained full glucose transport activity when both insulin 
and the lipid products of the PI 3-kinase reaction were added to them (Jiang et al, 
1998; Sweeney et a l, 2004). These data suggest the existence of a further PI 3-kinase 
independent insulin signal that regulates the transporter activity of GLUT4 following 
insertion into the plasma membrane. Results from the Klip laboratory have implicated 
the p38 MAP kinase pathway in this process (Somwar et a l, 2001b; Somwar et al, 
2002), and are discussed in detail in Section 3.1.
1.7. Membrane fusion
Insulin signalling results in the movement of GLUT4 vesicles towards the 
plasma membrane. Glucose uptake through GLUT4 requires the simultaneous 
exposure of the GLUT4 molecule to the outside and inside of the cell. This is 
achieved by fusion of GLUT4 containing vesicles with the plasma membrane. The 
cellular machinery involved in eukaryotic membrane fusion has been intensively 
studied in many endocytic and secretory pathways. These pathways have many 
features in common that have prompted unifying hypotheses regarding the conserved 
mechanism of membrane fusion.
Fusion of membranes requires that opposing membranes be brought together. 
The transition from long range transport to docking of membranes is termed tethering, 
and is mediated by the Rab family of GTPase proteins. The identities of the tethering 
factors involved in GLUT4 exocytosis are not known, though Rab4 and Rabl 1 have
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been found on insulin responsive GLUT4 vesicles (Kessler et al., 2000). The 
interaction of Rab4 with the motor protein KIF3 was stimulated by insulin via the PI 
3-kinase and PKCA, signalling pathways, and disruption of this interaction inhibited 
insulin stimulated glucose transport (Imamura et al., 2003). Rab4 was also found to 
interact with the SNARE protein syntaxin4 in an insulin dependent manner (Li et al., 
2000). Syntaxin4 is involved in the later stages of GLUT4 vesicle fusion with the 
plasma membrane. This suggests that Rab4 may link long and short range transport of 
GLUT4 vesicles in the exocytic pathway, although Rab-mediated tethering typically 
occurs via an intermediate tethering complex, rather than directly to SNARE proteins 
(Zerial and McBride, 2001).
1.7.1. Docking and SNARE proteins
The SNARE proteins are thought to act following the tethering of transport 
vesicle and target membrane. SNAREs were originally identified in synaptic vesicles 
(Sollner et al., 1993), and are a large family with 24 known members in yeast, and at 
least 35 in mammals (Bock et al., 2001). They can be functionally classified as 
vesicular (v-SNARE) and target (t-SNARE) SNAREs according to the membrane on 
which they are present. The best characterised SNARE proteins are those involved in 
synaptic transmission. They are syntaxinl and SNAP25, which reside on the plasma 
membrane and act as the t-SNARE, and VAMP, which is present on synaptic vesicles 
and is the v-SNARE. SNARE proteins vary greatly in structure, but share a common 
SNARE motif. This is a stretch of 60-70 amino acids that include eight heptad 
repeats, typical of coiled coil motifs. Most SNAREs include a membrane anchor at 
their carboxy terminus adjacent to the SNARE motif, although some are soluble and
40
others, like SNAP25 contain post-translational lipid additions that act as the 
membrane anchor.
SNARE motifs are relatively unstructured in solution. However, SNARE 
motifs from cognate SNARE proteins spontaneously assemble into four-helical 
bundles in a parallel configuration, called the core complex (Hanson et al., 1997; Lin 
and Scheller, 1997). Syntaxinl and VAMP2 each contribute one SNARE motif to the 
core complex, and SNAP25 contributes two SNARE motifs. The core complex is an 
extremely stable structure, able to withstand denaturation by SDS and temperatures of 
up to 95°C (Fasshauer et a l , 2002).
1.7.2. The role of SNARE proteins in membrane fusion
SNARE-specific clostridial neurotoxins have been useful tools in studying 
SNARE function. VAMP is cleaved by tetanus toxin and botulinum toxins (BoNT) B, 
D, F and G. SNAP-25 is cleaved by BoNT A, C and E. Syntaxin is cleaved by BoNT 
C (Pellizzari et al., 1999). SNARE proteins on opposing membranes form the core 
complex prior to membrane fusion in vivo. Prevention of the formation of this 
complex by cleaving SNAREs with clostridial neurotoxins blocked neurotransmitter 
release and led to an accumulation of docked synaptic vesicles (Hunt et al., 1994).
The assembly of the trans-SNARE complex brings the opposing membranes 
into close proximity, and the energy released by the assembly of this stable complex 
is thought to provide sufficient energy to overcome the repulsion between 
membranes, and thereby catalyse fusion (Hanson et al., 1997; Skehel and Wiley,
1998). Following fusion, all three proteins in the SNARE complex reside in the target 
membrane as a cis-complex (Figure 1.4.). Recycling of the SNAREs for further 
rounds of fusion requires ATP-dependent disassembly of the cis-complex by NSF and
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aSNAP (Whiteheart and Matveeva, 2004). The case for SNARE proteins as the 
machinery for membrane fusion was strengthened further by experiments in which 
purified SNARE proteins were able to catalyse fusion between artificial lipid bilayers 
(Weber et a l, 1998).
In vitro interactions between SNAREs are relatively unspecific, meaning t- 
SNAREs bind v-SNAREs promiscuously (Fasshauer et a l , 1999). However, 
according to the SNARE hypothesis, interactions between cognate SNAREs are 
responsible for maintaining the specificity of fusion events between membrane 
compartments (Sollner et al, 1993). This is supported by results from in vitro fusion 
experiments with combinations of yeast SNAREs. With just one exception out of 147 
combinations, only combinations of SNAREs that had been shown to function 
together in vivo were able to catalyse in vitro membrane fusion, despite the ability of 
their cytosolic domains to bind promiscuously (Parlati et al, 2002). This specificity 
adds support to the suggestion that SNAREs catalyse fusion in vivo. However, studies 
of complex formation in vivo have so far failed to provide a direct demonstration that 
SNAREs provide the machinery that catalyses fusion. Studies on both sea urchin 
cortical granules and yeast vacuoles showed that SNARE complex formation 
preceded membrane fusion, but that subsequent disassembly of the complexes did not 
prevent completion of the fusion reaction (Coorssen et al, 1998; Tahara et al, 1998; 
Ungermann et a l, 1998). Furthermore, synaptic transmission still occured in VAMP 





















Figure 1.4. The SNARE hypothesis and SNARE-mediated membrane fusion.
Specific v- and t-SNAREs in opposing membranes form trans-SNARE complexes 
that bridge the vesicle and target membranes, bringing them into close proximity. The 
SNARE complex may cause dehydration o f the membranes, bringing them closer 
together, and exerts a force on membrane lipids, causing deformation o f the lipid 
bilayer. These actions lower the energy barrier to full fusion. Following fusion, the 
SNAREs are bound in a cis-complex that is disassembled by NSF and aSNAP, after 
which they can partake in further rounds o f fusion.
One alternative mechanism for membrane fusion involves the v-type ATPases. 
In the yeast vacuole system, SNAREs act upstream o f the v-ATPase by bringing 
opposing membranes together. v-ATPase complexes (whose previously characterised 
function was in active pumping o f protons into the vacuole) form a bridge between 
the membranes, and may drive membrane fusion by forming a proteinaceous 
discontinuity in the lipid bilayer, which opens up to form an aqueous pore, thereby
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achieving membrane fusion (Peters et al, 2001). This type of fusion has only been 
observed in the yeast vacuole system, although v-ATPases are present in many types 
of vesicle, including GLUT4 vesicles (Malikova et a l, 2004).
Apart from catalyzing membrane fusion, it has been suggested that SNAREs 
may act as a link between membrane fusion and other events in the cell, such as 
signalling. For example, SNARE proteins may be involved in regulating membrane 
fusion sensitivity to calcium ion concentration (Stewart et al, 2000). SNAP25 and 
SNAP23 have been shown to differentially regulate fusion with respect to calcium ion 
concentration by interacting with diverse members of the synaptotagmin family 
(Chieregatti et al, 2004). SNAREs have also been shown to interact directly with and 
regulate the activities of calcium channels (Jarvis et al, 2002; Ji et a l, 2003; Merz 
and Wickner, 2004; Verderio et al, 2004). SNARE proteins may thus regulate both 
the availability of calcium ions and the sensitivity of the fusion apparatus to calcium. 
GLUT4 vesicle fusion with the plasma membrane is one of many membrane fusion 
events that have been shown to require increased calcium ion concentration 
(Whitehead et a l, 2001). Other proteins that interact with SNAREs, such as proteins 
of the Secl/Muncl8 (SM) family may link membrane fusion to regulation by 
signalling pathways (Barclay et al, 2003).
The SNARE proteins therefore have a function in bringing lipid membranes 
together upstream of the fusion reaction, and may themselves catalyse the fusion 
reaction. There is a lack of direct evidence for SNARE-catalysed membrane fusion in 
vivo, and the exact role played by SNAREs is still controversial.
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1.7.3. SNAREs in GLUT4 exocytosis
The adipocyte homologs of syntaxinl, SNAP25 and VAMP that are involved 
in GLUT4 exoytosis are syntaxin4, SNAP23, and VAMP2. They are thought to be 
structurally analogous in the SNARE complex, that is syntaxin4 and VAMP2 are both 
single transmembrane domain proteins that contribute one SNARE domain each to 
the SNARE complex, and SNAP23 is attached to the membrane via palmitoylated 
cysteine residues and contributes two SNARE domains to the core complex 
(Thurmond and Pessin, 2001).
Interference with syntaxin4 function by introduction of anti-syntaxin4 
antibodies, or soluble domains of syntaxin4 into cells inhibited insulin stimulated 
GLUT4 exocytosis and glucose uptake (Cheatham et al, 1996; Volchuk et al., 1996). 
Insulin stimulation also increased co-immunoprecipitation of GLUT4 vesicles with 
syntaxin4 (Olson et a l, 1997), suggesting that insulin signalling regulates interactions 
of GLUT4 vesicles with syntaxin4.
Treatment of 3T3-L1 adipocytes with BoNT B or BoNT D inihibited insulin 
stimulated glucose uptake (Tamori et al, 1996), suggesting a role for VAMP2 or 
VAMP3 (cellubrevin) in this process. Inhibition of insulin stimulated glucose uptake 
by cleavage of VAMP2 and VAMP3 with tetanus toxin could be reversed by addition 
of toxin resistant VAMP2 in muscle cells (Randhawa et a l, 2004). Several studies 
have also indicated that VAMP2 is associated with the insulin responsive GLUT4 
compartment, whereas VAMP3 colocalises with GLUT4 in non insulin responsive 
compartments (Martin et a l, 1996; Sevilla et a l, 1997; Millar et al, 1999).
Proteolytic cleavage by BoNT A of SNAP25, which is present in adipocytes 
did not affect insulin stimulated glucose transport (Chen et al, 1997; Macaulay et al,
1997). However, addition of the toxin insensitive homolog SNAP23 to permeabilised
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3T3-L1 adipocytes inhibited insulin stimulated GLUT4 translocation (Rea et al.,
1998). SNAP23 participated in complexes with syntaxin4 and VAMP2 both in 
adipocytes and in vitro (Tamori et al., 1998; St Denis et al., 1999). These data 
implicate syntaxin4, SNAP23 and VAMP2 as the SNAREs involved in insulin- 



















♦  Insulin 5ym a,,i"4 f
Insulin receptor ^  SN A P-23 Munc18c
GLUT4 |  VAMP 2
Figure 1.5. Membrane fusion in insulin stimulated glucose uptake. Insulin 
signalling stimulates translocation o f GLUT4 vesicles to the plasma membrane, and 
induces dissociation o f M uncl8c from syntaxin4. This allows a t-SNARE complex to 
form, which then form a ternary SNARE complex, perhaps with the help o f M uncl8c, 
leading to fusion with the plasma membrane. Similarly, insulin signalling dissociates 
the syntaxin4/synip complex, allowing SNARE complex assembly and subsequent 
fusion.
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1.7.4. SNARE-interacting proteins in GLUT4 exocytosis
I.7.4.I. Synip and Muncl8c
Synip and the Secl/Muncl8c family (SM family) protein Muncl8c are 
associated with syntaxin4 in the basal state, but dissociate from syntaxin4 on insulin 
stimulation (Araki et al., 1997; Tamori et al., 1998; Min et al., 1999). Synip has also 
been identified as a substrate of Akt2, and phosphorylation on a serine residue by 
Akt2 appears to regulate its interaction with syntaxin4 in response to insulin (Yamada 
et ah, 2005). This was the first interaction to be identified that directly linked insulin 
signalling to the vesicle fusion machinery.
Both synip and Muncl8c appear to block SNARE complex formation when 
associated with syntaxin4, so are thought to be possible negative regulators of 
SNARE complex assembly. PI 3-kinase inhibition did not block insulin stimulated 
GLUT4 exocytosis in adipocytes derived from Muncl8c -/- mouse embryos, implying 
that Muncl8c also plays a critical role in the PI 3-kinase mediated regulation of the 
vesicle fusion machinery (Kanda et al., 2005). Disruption of the Muncl 8c/syntaxin4 
complex by injection of complex inhibiting peptides caused accumulation of unfused 
GLUT4 vesicles at the plasma membrane, suggesting that Muncl8c may also have a 
positive role to play in the fusion reaction (Thurmond et al., 2000).
This apparent dual inhibitory and stimulatory role of Muncl 8c is not 
uncommon in SM family proteins. The SM family proteins are unusual in that 
although they show a high degree of sequence homology and they all bind to 
syntaxins, they also show great diversity in their modes of binding to syntaxins. For 
example, neuronal Muncl8a binds to a closed conformation of syntaxin that is 
incompatible with SNARE complex formation (Dulubova et al., 1999). The yeast SM 
protein, Seclp binds to an assembled ternary SNARE core complex (Carr et al.,
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1999). SM proteins present in the ER, the Golgi apparatus, and the TGN bind to a 
conserved amino-terminal domain in their syntaxin partners (Dulubova et a l , 2002; 
Yamaguchi et a l , 2002). Finally, the yeast SM protein Vps33p interacts with the 
syntaxin Vam3p indirectly via a multi-protein complex (Sato et a l , 2000). SM 
proteins have been associated with either negative or positive regulation of SNARE 
complex assembly in these systems, or both negative and positive regulation in the 
case of Muncl 8a (Pevsner et a l , 1994; Voets et a l, 2001).
Muncl8c is thought to bind to syntaxin4 in the closed conformation, as it 
prevents SNARE complex formation when in this binary complex (Araki et al, 1997; 
Tamori et a l , 1998). However, it can also bind a ternary syntaxin4/SNAP23/VAMP2 
complex in vitro (Widberg et al, 2003). These multiple modes of binding may 
indicate that Muncl8c/SNARE interactions have more than one function upstream of 
membrane fusion.
1.7.4.2. Tomosyn
Tomosyn is a ubiquitously expressed protein that has been shown to bind to 
syntaxin4, the syntaxin4/SNAP23 dimer and the syntaxin4/Muncl8c dimer in vitro 
via a VAMP2-like domain. Overexpression of tomosyn in 3T3-L1 adipocytes 
inhibited insulin stimulated GLUT4 vesicle translocation to the plasma membrane. 
Because of these interactions, and the similarity of the domain structure of tomosyn to 
that of the Golgi tethering factor pi 15, it has been suggested that tomosyn may 
function as a tethering factor for GLUT4 vesicles with the plasma membrane 
(Widberg et a l, 2003).
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1.7.4.3. VAP-33
VAMP-associated protein of 33 kDa (VAP-33) binds to VAMP2 in vitro, and 
was found to colocalise with VAMP2 and GLUT4 in L6 myoblasts and 3T3-L1 
adipocytes. Overexpression of VAP-33 or introduction of anti-VAP-33 antibodies into 
cells inhibited insulin-stimulated GLUT4 translocation (Weir et al., 1998; Foster et 
al., 2000). VAP-33 may therefore regulate VAMP2 availability and thereby GLUT4 
vesicle fusion in insulin responsive tissues.
1.7.4.4. Cysteine string protein
Cysteine string protein (csp) is associated with synaptic vesicles and 
chaperone proteins and is thought to be involved in targeting chaperone proteins to 
the exocytic machinery where they can regulate assembly of protein complexes 
(Evans et al., 2003). Csp was also detected in plasma membranes from 3T3-L1 
adipocytes. Csp interacted with syntaxin4 in these cells, and may play a role in the 
assembly of complexes with syntaxin4 (Chamberlain et al., 2001).
1.7.4.5. Pantophysin
Synaptophysin is a VAMP2-interacting protein that is expressed in 
neuroendocrine cells, and may have a role in regulating interactions with other 
SNARE proteins (Edelmann et al., 1995). The related protein pantophysin was 
detected in 3T3-L1 adipocytes and in mouse adipose tissue. Pantophysin co- 
immunoprecipitated with VAMP2 and was postulated to regulate SNARE assembly in 
insulin-responsive cells, although there was no evidence of any insulin-induced 
changes to the protein (Brooks et al., 2000).
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Of these SNARE-interacting proteins, synip and Muncl8c appear to be the 
best candidates for potential targets for insulin regulation of GLUT4 vesicle fusion 
with the plasma membrane. Both appear to negatively regulate trans-SNARE complex 
assembly in the basal state, and Muncl8c may also be required at a late stage of 
insulin-stimulated membrane fusion. The distribution and quantitation of Muncl8c 
and SNAREs is examined in this thesis.
1.8. Aims of the work described in this thesis
The work described in this thesis was undertaken with the overall aim of 
clarifying the relationships between insulin signalling pathways and docking and 
fusion of GLUT4 vesicles with the plasma membrane in the adipocyte. Chapter 3 
addresses the question of whether insulin stimulates the transport activity of GLUT4 
in addition to the fusion of GLUT4 vesicles with the plasma membrane, and examines 
the potential involvement of a p38 MAP kinase dependent pathway in this process. In 
Chapter 4, proteins involved in the membrane fusion reaction in adipocytes are 
quantified, with the aim of providing an improved basis for the interpretation of 
results of experiments involving these proteins. Chapter 5 describes the development 
of an in vitro assay for membrane fusion mediated by syntaxin4, SNAP23 and 
VAMP2. The rationale for devising this assay was that it would facilitate the 
interpretation of molecular and cellular events underlying in vivo responses to insulin.
50
Chapter 2 - Materials and Methods
2.1. Chemical reagents
All laboratory chemicals and reagents were of analytical grade and were 
purchased from Sigma-Aldrich unless otherwise stated.
Enhanced chemiluminescent reagent (ECL), 3-0-[14C]methyl-D-glucose, glutathione- 
sepharose 4B, NHS-sepharose-FF were obtained from Amersham Pharmacia Biotech. 
Monocomponent porcine insulin was a generous gift of Dr. G. Daniellson (Novo 
Nordisk).
BioWest extended duration chemiluminescent substrate was obtained from UVP. 
Optiphase Safe scintillation fluid was obtained from LKB.
Collagenase Type I was obtained from Worthington Biochemical.
Bovine Serum Albumin (BSA) (Bovine Cohn Fraction V) was from Intergen 
Company.
Protein molecular weight markers were obtained from Sigma and NEB.
Lipids were obtained from Avanti Polar Lipids.
Kanamycin sulphate and n-octylglucoside was obtained from Melford Laboratories. 
Ni-NTA agarose was obtained from Novagen.
Acrylamide stock (30% acrylamide, 0.8% bis-acrylamide) was obtained from 
Flowgen.
Molecular biology grade agarose and DNA molecular weight markers were obtained 
from Invitrogen.
The plasmids pGEX-SNAP23 and pGEX-Muncl8c were generous gifts from Dr. H. 
Tamori (Kobe University, Japan) and Prof. J. Pessin (University of Iowa, USA).
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pSNiR3 was a generous gift from Prof. Dr. D. Langosch, Technische Universitat 
Munchen, Germany.
2.1.1. Oligonucleotide primers
DNA primers were made to order through EasyOligo (Helena Biosciences). 
Primer sequences are shown below:
Primer name Sequence
stx4nt a t g c g c g a c a g g a c c c a t g a g t t g a g g c
stx4ct t c c a a c g g t t a t g g t g a t g c c a a t g a t g
NcoIstx4 c c g c c g c c a t g g g c c g a c a g g a c c c a t g a g t
stx4XhoI c g g c c t c g a g t g c t c c a a c g g t t a t g g t g a
EcoRI-stx4-5P c g c c g a a t t c a t g c g c g a c a g g a c c c a t g a
Stx4-STOP-XhoI-3P c g c t c g a g t t a t c c a a c g g t t a t g g t g a t g
T7 promoter primer t a a t a c g a c t c a c t a t a g g g
pSNiR3-HA c g a t c g g a a t t c g c c a c c a c g c g g a a c c a g
pET-Aval-rbs t c c c t c g a g g a c c c t c t a g a a a t a a t t t t g
T7 terminator primer g c t a g t t a t t g c t c a g c g g
vamp2nt a t g t c g g c t a c c g c t g c c a c c g t c c c g a
vamp23p g g c c c t t c t t a g g c a g g g c a g a c t c c t c a g
NcoI-VAMP2 g g c c a g c c a t g g c g g c t a c c g c t g c c a c c g
VAMP2-XhoI c g g t c g c t c g a g a g t g c t g a a g t a a c g a t
EcoRI-VAMP2 g t a t a g g a a t t c a t g t c g g c t a c c g c t g c c
VAMP2-STOP-BamHI c g g c g g a t c c t t a a g t g c t g a a g t a a a c g
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2.1.2. Buffers
Generally used buffers were made up as shown below and stored for up to one month
at 4°C.
Electrophoresis Running buffer 0.025 M Tris-HCL, pH 6.3, 0.1% (w/v) SDS and 
0.2 M glycine
HES buffer (Hepes/EDTA) 10 mM Hepes, pH 7.2, 1 mM EDTA and 250 mM 
Sucrose
Krebs-Ringer-Hepes, (KRH) 10 mM Hepes, pH 7.4, 140 mM NaCl, 4.7 mM 




154 mM NaCl, 12.5 mM Na2HP04.12H20, pH 7.2
Stacking Gel buffer (4x) 0.5 M Tris-HCL, pH 6.8 and 0.4% (w/v) SDS
Resolving Gel buffer (4x) 1.5 M Tris-HCL, pH 8.8 and 0.4% (w/v) SDS
The following solutions were stored at room temperature.
Ponceau stain 0.1% Ponceau S (w/v) in 3% trichloroacetic acid 
(v/v)
SDS Sample buffer 10% SDS (w/v), 0.5M Tris-HCl, pH 6.8,0.05% 
(w/v) bromophenol blue and 10% (v/v) glycerol
Low-SDS Sample buffer 1% SDS (w/v), 0.5M Tris-HCl, pH 6.8, 0.05% 
(w/v) bromophenol blue and 10% (v/v) glycerol
Tris-buffered Saline (TBS) 10 mM Tris, pH 7.4, and 154 mM NaCl
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TBS-Tween 10 mM Tris, pH 7.4,154 mM NaCl and 0.1% (v/v) 
Tween-20
Transfer buffer 39 mM glycine, 48 mM Tris, pH 8.8, 0.0375% 
(w/v) SDS and 20% (v/v) methanol
Tris-acetate EDTA buffer 40 mM Tris-acetate, 1 mM EDTA, pH 8.
Protease inhibitor cocktail was made up as two separate lOOOx stocks, the first 
containing 1 mg/ml leupeptin, 1 mg/ml aprotonin, 1 mg/ml pepstatin A, 1 mg/ml 
antipain. The second stock consisted of 100 mM 4-(2-aminoethyl) benzenesulphonyl 
fluoride (AEBSF).
LB media was made up with 10 g of Bacto-tryptone, 5 g of yeast extract and 10 g of 
NaCl per litre in water, pH was adjusted to 7.5 with NaOH, and the LB was sterilized 
by autoclaving.
2.1.3. Bovine Serum Albumin for adipocyte cultures
10 g of BSA (Fraction V) was dissolved in double distilled water overnight at 
4°C. The solution was filtered through a Millipore type A 0.8 pm membrane filter 
under vacuum and the pH was adjusted to 7.6 with 10 M NaOH. Final BSA 
concentration was adjusted to 10% with double distilled water, and stored at -20°C.
2.1.4. Insulin
1 mg of porcine insulin was dissolved in 1 ml of 30 mM HC1 and made up to 3 
ml with double distilled water. 1 ml of this solution was diluted to 50 ml with 10 mM
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Hepes buffer pH 7.6, 1% BSA. This solution, containing 1 pM insulin was stored in 
small aliquots at -20°C, and was not refrozen once thawed.
2.1.5. Antibodies
Primary antibodies used in this report are listed below. Working dilutions are 
of 1 mg/ml stocks and are given for western blotting and immunofluorescence (IF).
Antibody Type Source Working
dilution





p38 MAP kinase Purified rabbit 
polyclonal
















Cell Signaling Technology 1:1000













Cell Signaling Technology 1:1000
SNAP23 Purified rabbit 
polyclonal
Synaptic Systems 1:1000
SNAP23 Purified rabbit 
polyclonal
As described in Section 2.6. 1:1000
Syntaxin4 Purified rabbit 
polyclonal





Synaptic Systems 1:1000 
1:100 (IF)
VAMP2 Purified rabbit 
polyclonal
As described in Section 2.6. 1:1000
Muncl8c Purified rabbit 
polyclonal
As described in Section 2.6. 1:1000
GLUT4 Purified rabbit 
polyclonal




Secondary antibodies used are listed below. Working dilutions are given for 
western blotting (wb) and immunofluorescence (IF).
Antibody Source Working dilution













Molecular Probes 1:200 (IF)
AlexaFluor568-conjugated 
goat anti-mouse IgG
Molecular Probes 1:200 (IF)
2.2. Protein Biochemistry Techniques
2.2.1. SDS-Polyacrylamide gel electrophoresis
Proteins were analysed by electrophoresis using a modification of the method 
of Kato, using the discontinuous buffer system of Laemmli (Laemmli, 1970; Kato et 
al., 1983). Stacking gels were made from stock stacking gel buffer, acrylamide and 
double distilled water to give final concentrations of 125 mM Tris-HCl, pH 6.8 and 
0.1% (w/v) SDS, 6% acrylamide and polymerised with addition of 0.005% (w/v) 
ammonium persulphate (APS) and 0.05% (w/v) N,N,N,N’- 
tetramethylethylenediamine (TEMED). Resolving gels were made at acrylamide 
concentrations of 10%, 12% and 14%, depending on the experiment in a buffered 
solution of 0.375 M Tris-HCl, pH 8.8 and 0.1% (w/v) SDS and polymerised by 
adding 0.005% (w/v) ammonium persulphate (APS) and 0.05% (w/v) N,N,N,N’- 
tetramethylethylenediamine (TEMED). Unless otherwise stated, protein samples were 
solubilised in SDS sample buffer and heated for 5 min at 95°C in SDS sample buffer 
containing 100 mM dithiothreitol (DTT). Samples were loaded onto gels and run in 
either the Protean II, Mini Protean II, or Mini Protean III gel systems (BioRad). Gels 
were run in 25 mM Tris-HCl, pH 8.3, 192 mM glycine, 0.1% (w/v) SDS at a constant
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current of 25 mA per gel in the Protean II system, and at constant voltage of 180 V in 
the Mini Protean systems until the blue dye front had run out of the gel. Samples were 
run alongside Broad Range Molecular Weight Markers (NewEnglandBiolabs) or High 
Molecular Weight Markers (Sigma).
2.2.2. Coomassie Blue Staining
Gels were stained with coomassie brilliant blue reagent (0.2% (w/v)
Coomassie blue R-250 in 30% (v/v) methanol, 10% (v/v) glacial acetic acid, 60%
(v/v) water) overnight at room temperature, followed by destaining in 30% (v/v) 
methanol, 10% (v/v) glacial acetic acid, 60% (v/v) water.
2.2.3. Copper Staining
For quick visualisation of proteins, gel strips were stained for 5 min with 300 
mM CuCh and washed with water (Lee et al., 1987).
2.2.4. Electrophoretic Transfer of Proteins to Nitrocellulose
Proteins were transferred by the semi-dry transfer method (Towbin et al.,
1979) using a Multiphor II NovaBlot electrophoretic transfer unit (Amersham 
Pharmacia Biotech). Nine pieces of Whatman 3 mm paper, cut to the size of the 
resolving gel were soaked in transfer buffer (39 mM glycine, 48 mM Tris base, 
0.0375% (w/v) SDS and 20% (v/v) methanol, pH 8.8) and placed on the anode. A 
sheet of nitrocellulose (45 pM pore size, Gelman Sciences) was soaked in transfer 
buffer and placed on the paper. The resolving gel was soaked in transfer buffer and 
placed on the nitrocellulose sheet, followed by another nine pieces of Whatman paper 
that had been soaked in transfer buffer. The cathode was replaced on top of this and
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the system was run at a fixed current of 0.8 mA per cm2 of gel surface for 1 h 50 min. 
At the end of the run, the nitrocellulose sheet was rinsed in water and proteins were 
visualised with Ponceau stain. Positions of molecular weight markers were marked 
with a soft pencil, and stain was washed off with TBS-Tween.
2.2.5. Western blotting
Nonspecific protein binding sites were blocked by incubating the 
nitrocellulose membrane in 5% (w/v) Marvel dried skimmed milk in TBS-Tween for 
30 min with gentle rocking. Excess milk was rinsed off with TBS-Tween and the 
membrane was incubated with the required dilution of primary antibody in TBS- 
Tween, 1% BSA for 1 h. The membrane was washed five times with TBS-Tween 
with vigorous rocking, with each wash lasting 10 min. The membrane was then 
incubated with the appropriate secondary antibody diluted in TBS-Tween, 5% (w/v) 
Marvel dried skimmed milk for 1 h with gentle rocking, and washed extensively as 
before.
Specific protein bands were visualised using ECL reagent or Bio West 
extended duration chemiluminescent substrate according to the respective 
manufacturers’ instructions. Bands were detected using an EpiChemill darkroom and 
digital camera system (UVP). Bands were quantified using Labworks software 
(UVP).
2.2.6. Competition western blot assay
2pg of purified Muncl8c serum was incubated for 1 h at room temperature in 200pl 
of TBS with or without 0.2 mg of recombinant GST-Muncl8c. Solutions were 
centrifuged at lOOOOg for 10 minutes at 4°C, made up to 2 ml with TBS-T and were
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PCR products and digested plasmid DNA fragments were run on 1% agarose 
Tris-acetate EDTA gels run at a constant 160 V for 20 -  40 min and visualised by 
ethidium bromide staining under uv transillumination. Where required bands were 
excised from gels and purified using the GenElute agarose gel slice purification kit 
(Sigma). DNA sequencing was carried out using a PE Biosystems ABI 377 DNA 
Sequencer.
2.3.2. Polymerase chain reaction
DNA was amplified by PCR with 2 U of PfuTurbo DNA polymerase 
(Stratagene) in 50 pi reactions using the following program in MiniCycler (MJ 
Research): 94°C for 50 s, 55°C for 1 min, 72°C for 1 min. This cycle was repeated 34 
times, followed by a final extension at 72°C for 6 min.
2.3.3. Plasmid manipulations
Plasmid DNA was purified from cultures of transformed XL 1 Blue strain E. 
coli in 5 ml of LB media using the Wizard Plus SV minipreps DNA purification 
system (Promega) according to the protocol provided by the manufacturer. Restriction 
enzymes were purchased from Promega or Sigma-Aldrich. Digests were carried out at 
37°C according to the instructions of the manufacturer. Ligations were done using the 




2.4.1.1. Cloning of syntaxin4 from rat adipocytes
Total RNA was extracted from epididymal fat pads of male Wistar rats using 
Trizol (Invitrogen, UK) according to the manufacturer’s instructions. Messenger RNA 
was isolated from the total RNA population using the PolyATtract IV system 
(Promega), and was reverse transcribed to produce a single stranded adipocyte cDNA 
library using Superscript II reverse transcriptase (GibcoBRL). The coding region of 
syntaxin4 was amplified by PCR using the first strand cDNA mixture as a template, 
with the primers stx4nt and stx4ct. The PCR product was blunt cloned directly into 
pT7Blue to yield the plasmid pT7Blue-stx4. This was repeated with the product from 
a second identical RT-PCR reaction, and the syntaxin4 inserts from both RT-PCR 
reactions were sequenced.
2.4.1.2. Construction of pET28a-stx4, a syntaxin4-his expression vector
The syntaxin4 coding region from pT7Blue-stx4 was amplified by PCR with 
the primers NcoIstx4 and stx4XhoI. The product, containing the syntaxin4 coding 
region flanked by Ncol and Xhol restriction sites, was blunt cloned into pT7Blue to 
produce pT7Blue-NcoIstx4XhoI. The syntaxin4 coding region was excised from this 
plasmid with the restriction enzymes Ncol and Xhol and ligated into pET28a that had 
been cut with the same enzymes.
The resulting plasmid, pET28a-stx4 therefore contained an insert coding for 
syntaxin4 with a carboxy-terminal his-tag under transcriptional control of the T7 
promoter.
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2.4.I.3. Construction of pDRSNl-stx4, a NucA-syntaxin4 expression vector
The NucA-syntaxin4 expressing plasmid was derived from pSNiR3. pSNiR3 
is a pET21 derived plasmid designed to express a his-tagged NucA moiety at the 
amino terminus of the fusion protein, with a thrombin cleavage site between the NucA 
moiety and the multiple cloning site. There is also a hemaglutinin epitope tag (HA- 
tag) that remains on the target protein following thrombin cleavage. Following 
insertion of the syntaxin4 sequence, the plasmid was modified to remove the HA-tag 
from the target protein and to reduce the six-glycine residue spacer that remains on 
the fusion protein following thrombin digestion to two glycine residues.
EcoRI and Xhol sites were added to syntaxin4 coding DNA by PCR of 
pT7Blue-stx4 with the adaptor primers EcoRI-stx4-5P and Stx4-STOP-XhoI-3P. The 
PCR product was blunt cloned into pT7Blue to yield pT7Blue-EcoRIstx4-STOP- 
Xhol. The syntaxin4 coding fragment was excised from this plasmid using the 
restriction enzymes EcoRI and Xhol and ligated into the corresponding sites on 
pSNiR3 to produce pSNiR3-stx4. In order to modify this plasmid as described above, 
the NucA encoding region of pSNiR3 was amplified by PCR with the T7 promoter 
primer and pSNiR3-HA and the product was blunt cloned into pT7Blue to yield 
pT7Blue-NucAl. The NucA coding region was cut out from this plasmid with the 
enzymes Xbal and EcoRI and ligated into the corresponding sites on pSNiR3-stx4 to 
yield the modified NucA-syntaxin4 expressing plasmid pDRSNl-stx4.
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2.4.1.4. Construction of pGEX-tSNAREs and pGEX-tSNAREs(NucA), t-SNARE 
co-expression vectors
The syntaxin coding region from pT7Blue-stx4-STOP was cut out with EcoRI 
and Xhol and ligated into pET28a cut with the same enzymes, making pET28a-stx4- 
STOP. The syntaxin coding sequence, together with the ribosome binding site was 
amplified from pET28a-stx4-STOP by PCR with the primers pET-Aval-rbs and the 
T7 terminator primer. The purified PCR product was blunt cloned into pT7Blue. The 
insert was then cut out of this plasmid with Xhol, and was ligated into the Xhol site in 
pGEX-SNAP23, resulting in the plasmid pGEX-tSNAREs. This plasmid codes for 
bacterial expression of GST-SNAP23 and unmodified syntaxin4, both under control 
of the same tac promoter.
pGEX-tSNAREs(NucA) was made by amplifying the NucA-syntaxin4 coding 
region from pDRSNl-stx4 by PCR with the primers pET-Aval-rbs and the T7 
terminator primer. The PCR product was cloned into pT7Blue then cut out with Xhol 
and ligated into the Xhol site in pGEX-SNAP23. The resulting plasmid codes for 
bacterial expression of GST-SNAP23 and NucA-syntaxin4 under the control of a 
single tac promoter.
2.4.2. VAMP2
2.4.2.1. Cloning of VAMP2 from rat adipocyte cDNA
The coding sequence of VAMP2 was cloned from a Marathon (Clontech) rat 
adipocyte cDNA library, constructed according to the manufacturer’s instructions by 
Dr. Paul Whitley (Whitley et al., 2003). The coding region of VAMP2 was amplified 
from this library by PCR using the primers vamp2nt and vamp23p. The purified 
product was reamplified by PCR with the primers NcoI-VAMP2 and VAMP2-XhoI
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to produce a PCR product containing the VAMP2 cloning region flanked by Ncol and 
Xhol restriction sites. This product was blunt cloned into pT7Blue to yield the 
plasmid pT7Blue-NcoIVAMPXhoL
2.4.2.2. Construction of a pET28a-VAMP2, a VAMP2-his expression vector
The VAMP2 coding region was cut out from pT7Blue- NcoIVAMPXhoI with 
Ncol and Xhol and ligated into the Ncol and Xhol sites of pET28a. The resulting 
plasmid encoded the expression of full length VAMP2 with a carboxy-terminal his- 
tag.
2.4.2.3. Construction of pDRSNl-VAMP2, a NucA-VAMP2 expression vector
The VAMP2 coding region was amplified from pET28a-VAMP2 by PCR with 
the primers EcoRI-VAMP2 and VAMP2-STOP-BamHI. This fragment was blunt 
cloned into pT7Blue and cut out with EcoRI and BamHI, and ligated into pSNiR3 cut 
with the same enzymes to produce pSNiR3-VAMP2. The NucA coding region from 
pT7Blue-NucAl was cut out with Xbal and EcoRI and ligated into PSNiR3-VAMP 
that had been cut with the same enzymes, resulting in pDRSNl-VAMP2.
2.4.2.4. Construction of pDRSNl-VAMPcyt, a NucA-VAMPcyt expression plasmid
NucA-VAMPcyt, a Nuclease A fusion protein with the cytosolic domain of 
VAMP2, was expressed from the plasmid pDRSNl-VAMPcyt. This plasmid was 
constructed by restriction digest of pDRSNl-VAMP2 with Bell and BamHI, and re- 
ligating the remainder of the plasmid to itself. These enzymes cut VAMP2 either side 
of the transmembrane domain coding sequence and leave compatible sticky ends,
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which when ligated together, leave a plasmid that codes for a Nuclease A fusion 
protein with the cytosolic domain of VAMP2.
2.4.3. SNAP23
2.4.3.I. Construction of pDRSNl-SNAP23, a NucA-SNAP23 expression vector
The SNAP23 coding region of pGEX-SNAP23 was cut out by restriction 
digest with EcoRI and Xhol and ligated into the EcoRI and Xhol sites in pSNiR3, 
producing pSNiR3-SNAP23. The NucA coding region from pT7Blue-NucAl was cut 
out with Xbal and EcoRI and ligated into pSNiR3-SNAP that had been cut with the 
same enzymes, resulting in pDRSNl-SNAP23. This plasmid codes for the expression 
of SNAP23 with an amino terminal NucA tag.
2.5. Recombinant protein expression
In general, for a 1 1 expression culture, a single colony of Rosetta(DE3)pLysS 
transformed with the appropriate expression plasmid was incubated for 16 h in 5 ml of 
LB supplemented with the appropriate antibiotics at 37°C with shaking at 200 rpm. 
The entire culture was then transferred to 1 1 or 2 1 of sterile LB which were incubated 
with shaking at 37°C until the optical density of the culture at 600 nm had reached 
0.5. Expression was induced at this point by adding 0.5 mM IPTG for pGEX-based 
plasmids and 1 mM IPTG for pET-based plasmids. The culture was incubated for a 
further three hours, after which cells were harvested by centrifugation at 5000 g for 5 
min. Cell pellets were stored at -70°C until required.
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2.5.1. Expression and purification of syntaxin4-his
pET28a-stx4 was transformed into the Rosetta(DE3)pLysS strain and the cells 
were propagated in 2 1 of LB supplemented with 50 mg/1 kanamycin and 34 mg/1 
chloramphenicol. Following harvesting and freezing, the bacterial pellet was thawed 
and resuspended in 40 ml 25 mM sodium phosphate buffer pH 8, 1 M NaCl 
containing protease inhibitors and sonicated on ice with four pulses of 30 s with 30 s 
pauses between pulses. Triton X-100 was then added to a final concentration of 4% 
v/v. Following solubilisation for 1 hour at 4°C, the lysate was cleared by 
centrifugation at 20000g for 30 min at 4°C. Cleared lysate was bound to 0.5 ml Ni- 
NTA agarose for 2 h at 4°C under slow rotation. The Ni-NTA resin was then loaded 
onto a 2 ml gravity column and washed five times with 10 ml 25 mM phosphate 
buffer pH 7, 0.5 M NaCl, 1 % TritonX-100. Proteins were eluted from the resin with 
imidazole or on a pH gradient.
2.5.2. Expression and purification of NucA-syntaxin4
Rosetta(DE3)pLysS cells containing pDRSNl-stx4 were grown in 2 1 of LB 
supplemented with 200 mg/1 ampicillin and 34 mg/1 chloramphenicol. Following 
harvesting and freezing, the cell pellet was allowed to thaw on ice and resuspended in 
50 ml of 50 mM sodium phosphate buffer pH 8, 10 mM CaCl2 containing protease 
inhibitors, then incubated on ice for 15 min to allow digestion of genomic DNA by 
Nuclease A. Crude inclusion bodies were pelleted by centrifugation at lOOOOg for 10 
min at 4°C. At this point inclusion bodies were either solubilised in 50 ml of IB buffer 
(25 mM sodium phosphate buffer pH 8, 1.5 M NaCl, 1% (w/v) n-octylglucoside) for 1 
hour at 4°C for binding to Ni-NTA, or washed three times with 50 ml of 50 mM
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sodium phosphate buffer pH 7.5, 1 mM EDTA, 1% n-octylglucoside and then 
solubilised in 5 ml of IB buffer for 1 hour at 4°C.
Solubilised inclusion bodies from a 2 1 culture were incubated with 0.75 ml of 
Ni-NTA agarose for 2 h at 4°C. The resin was loaded onto a gravity column and 
washed with 20 ml 25 mM sodium phosphate buffer pH 7, 1.5 M NaCl, 1% n- 
octyiglucoside. Proteins were eluted in this same buffer containing an additional 500 
mM imidazole. Alternatively, thrombin was used to digest the syntaxin4 moiety away 
from the resin. 2 units of thrombin (Novagen) were added to the Ni-NTA resin with 
bound syntaxin4 in a volume of 1.5 ml of IB buffer and digested for 16 h at 4°C. 
Cleaved syntaxin4 was recovered by loading the resin onto a gravity column and 
eluting the protein with 25 mM sodium phosphate buffer pH 7, 250 mM NaCl, 1% n- 
octylglucoside with additional varying concentrations of KC1.
2.5.3. Expression and purification of GST-SNAP23
Rosetta(DE3)pLysS cells transformed with pGEX-SNAP23 were grown in 2 1 
of LB media supplemented with 200 mg/1 Ampicillin and 34 mg/1 chloramphenicol. 
Following harvesting and freezing, the cell pellet was thawed on ice and resuspended 
in 50 ml of 50 mM Tris buffer pH 8 containing 500 mM NaCl, 10 mM DTT and 
protease inhibitors. The suspension was sonicated on ice at the maximum intensity 
that did not cause frothing for four 30 s pulses with pauses of 30 s. Insoluble material 
was pelleted by centrifugation at 20000g for 30 min. The supernatant was incubated 
with 1.5 ml of glutathione-sepharose for 2 hours with rotation at 4°C. The resin was 
washed in a 2 ml gravity column and bound proteins were eluted in the same buffer 
containing 20 mM glutathione.
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2.5.4. Expression and purification of coexpressed t-SNAREs
Rosetta(DE3)pLysS cells transformed with pGEX-tSNAREs were grown in 2 
1 of LB media supplemented with 200 mg/1 Ampicillin and 34 mg/1 chloramphenicol. 
Following harvesting and freezing, the cell pellet was thawed on ice and resuspended 
in 50 ml of ice cold 50 mM Tris buffer pH 7.5, 1 mM EDTA, 1% n-octylglucoside 
containing protease inhibitors. DNA was sheared by sonication at the maximum 
intensity that did not produce frothing, with two 45 s pulses with a 45 s pause between 
pulses. The suspension was centrifuged at 16000g for 10 minutes. The pellet was 
washed three times with 50 ml of ice cold 50 mM Tris buffer pH 7.5, 1 mM EDTA, 
1% n-octylglucoside.
Inclusion bodies were isolated from Rosetta(DE3)pLysS cells transformed 
with pGEX-tSNAREs and pGEX-tSNAREs(NucA) and washed in the same way as 
described for NucA-syntaxin4 purification (Section 2.5.2.). Both sets of washed 
inclusion bodies were solubilised in 5 ml of 6 M guanidine HC1, 10 mM DTT, 1% n- 
octylglucoside for 20 min at room temperature. Insoluble material was removed by 
centrifugation at 20000g for 30 min at 4°C.
2.5.5. Expression and purification of VAMP2-his
Rosetta(DE3)pLysS containing pET28a-VAMP2 were grown up in 2 1 of LB 
media containing 50 mg/1 kanamycin and 34 mg/1 chloramphenicol. Following 
harvesting and freezing, cells were harvested and the cell pellet was stored at -70°C 
overnight.
The cell pellet was resuspended in 40 ml of 50 mM sodium phosphate buffer 
containing 500 mM NaCl and protease inhibitors. The cell suspension was sonicated 
on ice at the highest possible intensity that did not produce frothing for four 30 s
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pulses with 30 s pauses in between. Triton X-100 was added to a final concentration 
of 4% (w/v) and the lysate was solubilised with rotation for 1 hour at 4°C. The lysate 
was cleared by centrifugation at 20000g for 30 min. 500 pi of Ni-NTA resin was 
added to the cleared lysates and incubated with slow rotation for 1 h at 4 °C. 
Following binding, the resin was loaded onto a 2 ml gravity column and washed with 
20 ml 25 mM sodium phosphate buffer pH 7 containing 500 mM NaCl and 1% Triton 
X-100 (w/v), followed by washing with 20 ml of 25 mM sodium phosphate buffer pH 
7, 500 mM NaCl, 1% n-octylglucoside. Proteins were eluted either by washing the 
column with a gradient of imidazole in the final wash buffer, or by a pH gradient of 
50 mM phosphate and 50 mM phosphate-citrate buffers containing 300 mM KC1 and 
1% n-octylglucoside.
2.5.6. Expression and purification of NucA-VAMP2
Rosetta(DE3)pLysS cells containing pDRSNl-VAMP2 were grown in 1 1 of 
LB supplemented with 200 mg/1 ampicillin and 34 mg/1 chloramphenicol. Crude 
inclusion bodies containing NucA-VAMP2 were prepared from these cells as 
described for NucA-syntaxin4, solubilised in 50 ml IB buffer and bound to 1.5 ml Ni- 
NTA agarose for 2 h at 4°C. The resin was washed with 20 ml IB buffer in a 2 ml 
gravity column. Proteins were eluted from the resin by a gradient of imidazole or by 
digestion with 10 u of thrombin in 2.5 ml IB buffer for 16 h at room temperature.
2.5.7. Expression and purification of NucA-VAMPcyt
NucA-VAMPcyt was expressed and purified by binding to Ni-NTA agarose 
and eluted with imidazole as described for NucA-VAMP2 in Section 2.5.6.
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2.5.8. Expression and purification of NucA-SNAP23
NucA-SNAP23 was expressed and purified by binding to Ni-NTA agarose and 
eluted with imidazole, as described for NucA-VAMP2 Section 2.5.6.
2.5.9. Expression and purification of GST-Muncl8c
GST-Muncl8c for quantitation experiments was purified from 
Rosetta(DE3)pLysS cells containing pGEX-Muncl8c (a kind gift from Professor 
Jeffrey Pessin, University Of Iowa, USA) that were grown in 2 1 of LB supplemented 
with 200 mg/1 ampicillin and 34 mg/1 chloramphenicol. Protein was purified from the 
harvested and frozen cell pellet as described for the coexpressed t-SNAREs (Section 
2.5.4).
2.6. Preparation of novel rabbit antibodies against SNAP23, Muncl8c and 
VAMP2
2.6.1. Immunisations
One rabbit was immunised per antigen. GST-SNAP23 and GST-Muncl8c 
were purified by binding lysates of bacteria transformed with pGEX-SNAP23 or 
pGEX-Muncl8c to glutathione sepharose and eluting with glutathione solution, as 
described for GST-SNAP23 in Section 2.5.3. VAMP2 was purified by thrombin 
digestion of NucA-VAMP2 as described in Section 2.5.6. Six 200 pg aliquots of each 
protein were desiccated in a rotary evaporator. Animal work was carried out by 
Harlan Sera-Lab (Leicestershire, UK). For each immunisation, one aliquot was 
resuspended in equal volumes of sterile PBS and adjuvant (Freund’s complete 
adjuvant for initial immunisations, and incomplete Freund’s adjuvant for subsequent 
booster immunisations) and injected subcutaneously into the rabbit. Five booster
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immunisations were carried out at fortnightly intervals. Terminal bleeds were carried 
out one week after the final immunisation.
2.6.2. Affinity purification of antibodies
NucA-SNAP23 and NucA-VAMPcyt were extensively dialysed against PBS 
and concentrated with a Centricon Plus-20 centrifugal filter unit to around 0.5 ml 
containing -10 mg/ml of protein as measured by absorbance at 280 nm, and bound to 
0.5 ml of NHS-conjugated sepharose (Amersham Pharmacia Biotech) for 2 h at room 
temperature with rotation. The resin was loaded onto a 2 ml gravity column and was 
washed extensively with 50 mM Tris pH 7.5, followed by washes with 10 ml of 0.2 M 
glycine, pH 2.8, and 10 ml of 0.1 M NaHCCb, pH 8.5, 0.5 M NaCl. These two washes 
were repeated twice and the column was equilibrated with TBS-Tween containing 0.5 
M NaCl. 1.25 ml of lOx TBS-Tween and 1.25 ml of 5 M NaCl were added to 10 ml of 
immunised rabbit serum, and the buffered rabbit serum was adsorbed by slowly 
passing through the column three times batchwise using a peristaltic pump. The 
column was then washed with 20 ml TBS-Tween containing 0.5 M NaCl, and then 
with 20 ml TBS containing 0.5 M NaCl. Antibodies were eluted using 0.2 M glycine, 
pH 2.8 and collected in 1 ml fractions in tubes containing 50 ml 1 M Tris pH 8.5. 
Absorbance of eluted fractions was measured at 280 nm, and protein-containing 
fractions were pooled, dialysed against PBS containing 0.02% (w/v) NaN3 overnight 
and concentrated in a Centricon Plus-20 centrifugal concentrator. Protein 
concentration was adjusted to 1 mg/ml and the purified sera were stored in 1% BSA at 
-20°C. Columns were washed extensively with 0.2 M glycine, pH 2.8 and stored in 
TBS-Tween containing 0.02% (w/v) NaN3 .
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Because of the difficulty in obtaining sufficient amounts of soluble protein, 
serum against GST-Muncl8c was affinity purified by binding to GST-Muncl8c on a 
nitrocellulose membrane. 2 ml of solubilised inclusion bodies containing GST- 
Muncl 8c (Section 2.5.9.) were separated by SDS-PAGE in the Proteanll gel system, 
and electrophoretically transferred to nitrocellulose. The nitrocellulose was stained 
with Ponceau stain and the band at -97 kDa, corresponding to the migration of GST- 
Muncl8c was cut out. A 4 cm length of the nitrocellulose membrane was rinsed 
briefly in TBS-Tween and blocked for 1 h with 5% dried milk in TBS-Tween with 
gentle rocking. The membrane was washed three times for five min each with TBS- 
Tween. 0.1 ml of lOx TBS-Tween was added to 1 ml of serum and this was incubated 
together with the strip of membrane for 1 hour at room temperature in a 1.5 ml tube. 
The membrane was washed five times for five min each with TBS-Tween. Specific 
antibodies were eluted by incubating the membrane strip with 1 ml of 0.1 M glycine- 
HC1 pH 2.8 for 3 min. The supernatant was neutralised immediately following elution 
by transferring it to a 1.5 ml tube containing 0.1 ml 2M Tris pH 8 on ice. The eluate 
was then dialysed overnight against PBS containing 0.02% (w/v) NaN3 . Dialysate was 
concentrated, and protein concentration was adjusted to 1 mg/ml. The purified serum 
was stored in 1% (w/v) BSA at -20°C.
2.7. Isolation of rat adipocytes
Isolated adipocytes were prepared from the whole epididymal fat pads of male 
Wistar rats weighing 175-190 g as described (Taylor and Holman, 1981). Rats were 
killed by cervical dislocation. Immediately afterwards, epididymal fat pads were 
removed to KRH buffer, 1% BSA at 37°C for transportation. The washed tissue was 
placed in KRH buffer, 3.5% BSA, 5 mM glucose, 0.7 mg/ml collagenase (4 pads for
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every 5 ml of buffer) and chopped finely with scissors. The tissue was then digested 
in a 37°C water bath with continuous agitation at ~140 rpm until most of the clumps 
of cells had dispersed. The cell suspension was then filtered through a 250 pm nylon 
mesh (Lockertex), returned to a still water bath, and cells were allowed to float.
Buffer below the cells was removed using a blunt needle and syringe, and the cells 
were washed four to five times in 20 ml KRH buffer, 1% BSA to remove collagenase, 
allowing the cells to float and removing buffer with the needle and syringe each time. 
The cell suspension was adjusted to 40% packed cell volume. Cell density was 
estimated by resuspending the cells and taking up a sample into a capillary tube. The 
tube was then sealed at one end with plasticine and centrifuged briefly at lOOOg. 
Packed cell volume was the fraction of the length of packed cells to total suspension 
in the tube.
2.8 .3-O-Methyl-D-Glucose Uptake Assay
3-O-methyl-D-glucose (3-OMG) uptake was measured by the method 
described by (Whitesell and Gliemann, 1979). Adipocytes were prepared by the 
standard method and made up to 40% packed volume in KRH buffer containing 1% 
(w/v) BSA and treated as required. 50 pi of this cell suspension were added to 10 pi 
of 200 pM 3-O-methyl-D-glucose in BSA-free KRH buffer also containing 0.15 pCi 
of 3-0-[14C]methyl-D-glucose in a 4 ml polypropylene tube (Nunc). Uptake was 
terminated by addition of phloretin. Phloretin was dissolved to 60 mM in ethanol 
before adding BSA-free KRH to give a final concentration of 0.3 mM. 3 ml of this 
phloretin solution was added to the cells to terminate the experiment. Uptake (cpmt) 
was measured over 3 seconds in insulin treated cells, timed with a metronome set to 
120 beats per min. Uptake in basal cells was measured over a 2 min period, and the
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equilibrium distribution of radioactivity (cpma) was determined by measuring the 
uptake by insulin treated cells over a 15 minute period. The background value (b), 
which measures extracellular trapped radioactivity, was determined by adding the cell 
suspension to the reaction after addition of phloretin. Following termination, 1 ml of 
200/100 cs silicon oil (BDH) was overlaid onto the buffer containing the terminated 
uptake experiment, and the tubes were centrifuged at 2500 rpm in the swing-out rotor 
of a MSE benchtop centrifuge for 45 s. Following centrifugation, the cells appeared in 
aggregates in the oil layer. These cells were collected by adsorption to a short length 
of pipe-cleaner, with care being taken not to penetrate into the aqueous layer. The 
pipe-cleaner with adhered cells was then placed into a scintillation vial, to which was 
added 8 ml of scintillation fluid (Optiphase Safe™). 14C activity was measured in a 
Packard 1500 TRI-CARB or 1600 TR liquid scintillation counter. The rate constant of 
sugar uptake (V/S) was calculated from the fractional filling (F) using the following 
equatiors, which assume that the rate of filling (approaching equilibrium) is a single 
exponertial function of time:
F = cpmt-b
cpma-b




2.9.1. Labelling of cell surface GLUT4
Cells were labeled as described by (Holman et al, 1990; Ryder et al, 2000). 1 
ml of treated adipocytes at 40% packed volume in KRH buffer containing 0.1% BSA 
were transferred to 35 mm polystyrene dishes at 18°C. 300 pM Bio-LC-ATB-BGPA 
photolabel was added to the cells, which were irradiated for 1 min in a Rayonet RPR- 
100 photochemical reactor with 300 and 350 nm lamps. Cells were then transferred to 
polystyrene tubes and washed three times with 25 ml KRH buffer containing 1% 
(w/v) BSA at 18°C, and once with PBS containing protease inhibitors.
2.9.2. Precipitation of labelled GLUT4
Cells were lysed in PBS containing 2% (w/v) Thesit (Roche) and protease 
inhibitors, and centrifuged at 20000g for 20 min at 4°C. Biotinylated transporters in 
the supernatant were precipitated with 40 pi of a 50% slurry of streptavidin-agarose 
beads (Pierce) overnight at 4°C with rotation. The beads were then washed four times 
with 1 ml PBS containing 1% (w/v) Thesit, four time with 1 ml PBS containing 0.1% 
(w/v) Thesit, and four times with 1 ml PBS. Bound proteins were eluted in 30 pi 
SDS-PAGE sample buffer at 95°C for 30 min. The eluate was collected, and the 
elution was repeated. Eluates pooled from these two elutions were analysed by SDS- 
PAGE and western blotting.
2.9.3. Measurement of exocytosis
Exocytosis was measured as described by (Yang et al, 2002). 5 ml of 
adipocytes at 40% packed volume were treated with 5 nM insulin for 20 min at 37 °C 
and were labeled as described above, except that the GP15 photolabel was used
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instead of Bio-LC-ATB-BGPA. Cells were transferred to polypropylene tubes and 
washed twice with 50 ml KRH buffer pH 6.0 and twice with 50 ml KRH buffer 
containing 1% (w/v) BSA and 2 mM D-glucose. Cells were incubated for 40 min at 
37°C so that GLUT4 trafficking returned to the basal condition.
0.5 ml aliquots of cells were treated with 20 nM insulin and wortmannin as required. 
40 jig/ml neutravidin was added at the same time as insulin, and exocytosis was 
allowed to proceed for 20 min. Reactions were terminated by adding 1 ml of 2 mM 
KCN in KRH buffer containing 0.1% BSA (w/v) at 18°C, and the cells were washed a 
further three times in the same buffer. The cells were lysed and unquenched labelled 
GLUT4 was precipitated on streptavidin-agarose beads as described above.
2.10. Plasma Membrane Lawn Assay
2.10.1. Coverslip preparation
22 mm square glass coverslips were cleaned by immersion in 70% (v/v) 
ethanol for 5 min, followed by brief immersion in absolute ethanol. They were 
allowed to dry on Whatman 3 mm paper in a drying cabinet set to 37°C. 1 mg/ml 
poly-L-lysine in water was diluted to a final concentration of 0.1 mg/ml in 100 mM 
sodium phosphate buffer pH 7.2. The poly-L-lysine solution was pipetted onto one 
surface of the coverslip, ensuring that the whole of the desired adhesive surface was 
covered, and was incubated at room temperature for 10 min. Coverslips were rinsed 
five times with 1 ml water and dried in the drying cabinet.
2.10.2. Lawn preparation
Treated cells were washed with KHME buffer in order to remove BSA. Cells 
were allowed to settle to the top of the tube and excess buffer was removed, leaving
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densely packed cells. 100 pi of the cell suspension was pipetted onto a strip of 
parafilm. A poly-L-lysine coated coverslip was held with the adhesive side down in 
contact with the drop of cell suspension for 5 seconds. Unattached cells were washed 
off by gently pipetting 1 ml of KHME buffer over the coverslip. Attached cells were 
lysed by gently pipetting 1 ml of l/3x KHME buffer over the coverslip. This was 
repeated a further three times. The coverslip was then placed with the adhesive side 
up in a 3 cm Petri dish containing 3 ml of KHME buffer. Loose material was washed 
off by up and down pipetting of the buffer over the cells on the coverslip. The buffer 
in each dish was replaced twice more to remove unattached material. The coverslip at 
this stage has a coating of plasma membranes with the cytosolic face up.
The coverslip was washed briefly with 3 ml PBS, and lawns were then fixed 
with 3 ml of 2% (w/v) paraformaldehyde in PBS for 30 min at room temperature.
2.10.3. Lawn labelling
Lawns were washed three times with PBS and blocked with 0.1% (w/v) 
saponin in PBS containing 1% (w/v) BSA and 3% (w/v) goat serum for 45 min at 
room temperature. Lawns were labeled by incubation with 5 pg/ml affinity purified 
rabbit anti-GLUT4 serum and 10 pg/ml monoclonal anti-VAMP2 antibody (Synaptic 
Systems) in the same buffer for 1 h at room temperature. Lawns were washed three 
times, each for 20 min in PBS containing 0.1% (w/v) saponin, and then incubated 
with AlexaFluor488-conjugated goat anti-rabbit IgG antibody and AlexaFluor568- 
conjugated goat anti-mouse IgG antibody, both diluted at 1:200 in PBS containing 1% 
(w/v) BSA for 1 h at room temperature. Lawns were washed three times with PBS for 
20 min each at room temperature, embedded in Vectashield mounting medium 
(Vector Laboratories, Burlingame, CA), and mounted onto glass slides.
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2.10.4. Fluorescence microscopy
Lawns were analysed using a Zeiss LSM-510 inverted laser-scanning confocal 
microscope with a 63x/NA1.4 plan-apochromatic oil-immersion objective. 
Fluorophores were excited at 488 nm and 568 nm with an argon and a helium-neon 
laser respectively. Fluorescence data was collected at a resolution of 1024 x 1024 
pixels using the 505-550 nm band pass filter and the 560 nm high pass filter in 
multitrack mode and was analysed using the Zeiss LSM Software Version 2.5. Mean 
pixel fluorescence intensity was measured in a circle of area 298.56 pm2 in three 
membrane patches per frame. Four frames were sampled per slide.
2.11. Detection of signalling proteins
1 ml of adipocytes at 40% packed volume in KRH containing 1% (w/v) BSA 
were treated with insulin as described in the figure legends with or without 20 min 
pre-treatment with 10 pM SB203580. For inhibition experiments SB203580 was 
dissolved to 10 mM in DMSO. SB203580 was replaced with 0.1% (v/v) DMSO in 
control cells.
Following insulin treatment, cells were washed briefly in 20 ml of KRH buffer 
containing 20 nM insulin where appropriate, but without BSA. Excess buffer was 
removed and cells were transferred to a 1.5 ml microfuge tube. Cells were allowed to 
float for ~15s, and 200 pi of packed cells from the top of the tube were removed with 
a pipette and lysed directly in 200 pi of 2 x SDS sample buffer containing 1 mM 
DTT, 1 mM Na3VC>4 , 20 mM NaF, 2 mM sodium molybdate, 100 nM okadaic acid, 
7.5% (v/v) p-mercaptoethanol and protease inhibitors and heated for 15 min at 65 °C. 
Lysates were centrifuged at lOOOg for 1 min and supernatants were analysed by SDS-
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PAGE and transferred to nitrocellulose for western blotting. The amounts loaded on 
the gels were checked by blotting with antibodies against either p38 MAP kinase or 
the p-subunit of the insulin receptor.
2.12. Quantitation of membrane fusion proteins in rat adipocytes
2.12.1. Generation of protein standards for quantitative experiments
GST-syntaxin4, NucA-SNAP23, NucA-VAMPcyt and GST-Muncl8c were 
expressed and purified according as described in Section 2.5. The proteins were 
further purified by preparatory SDS-PAGE in large format Proteanll format gels. 
When the dye front had run out of each gel, a thin strip was cut out parallel to the 
direction of the running of the gel and copper-stained to locate the protein band. A 
strp corresponding to the position of the protein band was cut out from the remaining 
gel and electroeluted in a model 422 electroeluter (BioRad) according to the 
manufacturer’s instructions. Concentrations of recovered proteins were estimated by 
measuring absorbance at 280 nm against a blank consisting of the electroeluate from a 
gel strip of equivalent size from a gel run with only SDS sample buffer loaded. Molar 
extinction coefficients were calculated from the amino acid sequence (Gill and von 
Hifpel, 1989).
The accuracy of routine estimation of protein purity is limited by the detection 
raige of coomassie blue or silver staining on SDS-PAGE gels. The amount of protein 
reqiired for detection of trace contaminants often saturates the standard protein bands, 
anc when the standard protein band lies in the linear range the contaminant bands are 
ofhn below the linear detection threshold. The method described below was used in a 
stuly by (Coorssen et al., 2003) to eliminate this problem. The estimation of NucA- 
VAMPcyt purity is shown below as an example (Figure 2.1.). Following SDS-PAGE
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of a series of increasing total concentrations of NucA-VAMPcyt protein standards, the 
gel was stained with coomassie blue. A digital image was taken of the backlit gel 
using the EpiChemill darkroom and digital camera system (UVP) and analysed using 
Labworks software (UVP). From this image, measurements were taken in each lane of 
the integrated staining intensity (OD) of the specific NucA-VAMPcyt band and of the 
total staining intensity in the entire length and width of the lane above the background 
intensity.
The OD of specific bands and the OD of total staining in each lane were 
plotted against the loaded protein concentrations (Figure 2.1.). The linear range of the 
OD of the specific NucA-VAMPcyt bands was determined from this curve and 
extrapolated to the maximum protein loaded value for the purity calculation. The 
difference between the total lane OD the uncorrected NucA-VAMPcyt band OD at the 
maximum protein loaded value was taken as a measure of the contaminating proteins. 
This allowed estimation of low-abundance contaminating proteins even though the 
NucA-SNAP23 band was saturating. The purity was then calculated as a ratio of the 
extrapolated linear specific band OD to the sum of this value and the contaminating 
protein OD.
Concentration of specific proteins was calculated from the total protein 
concentration and the purity estimation. For quantification experiments, serial 
dilutions of the proteins were made with electrophoresis running buffer down to 10'12 
molecules of specific protein/pl. These serial dilutions were stored at -80°C for later 
use.
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Figure 2.1. Estimation of NucA-VAMPcyt purity for quantification experiments.
A. Purified recom binant NucA-VAM Pcyt was analysed by SDS-PAGE and stained 
with coomnassie blue. B. Staining intensities (OD) were quantified from  a digital 
image o f  the gel in A and specific band OD and total lane OD were plotted against the 
total protein loaded. Contaminating proteins were estimated by subtraction o f  the 
uncorrected specific protein band OD from the total staining in the 15 pg  lane. Purity 
was calculated as the proportion o f the extrapolated nonsaturating VAM P2 band 
density (VAM P2 linear, dashed line) over the sum  o f this value and the estimated 
contaminants. The estim ated purity o f  N ucA -V AM Pcyt by this m ethod was 88%.
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2.12.2. Quantitation of SNAP23, syntaxin4, VAMP2 and Muncl8c in rat 
adipocytes
Isolated adipocytes were washed twice in KRH buffer to remove BSA. Cell 
density was estimated by counting the average number of cells in 16 squares of a 
Neubauer Haemocytometer in triplicate. 0.5 ml of the cell suspension was lysed by 
adding an equal volume of 2 x SDS sample buffer containing 100 mM DTT and 
protease inhibitors. Lysates were heated at 95 °C for 10 minutes and allowed to cool 
to room temperature. The lysate below the fat layer was collected and the volume was 
made up to 1 ml with SDS sample buffer. Lysates were then standardised by adding 
SDS sample buffer so that each microlitre of lysate contained the equivalent of 103 
cells, determined from the cell density counts.
For quantitation, 10 pi aliquots of standardised lysate were heated to 95°C for 
10 minutes and were run in triplicate on SDS-PAGE alongside a dilution series of 
recombinant protein standards.
2.12.3. Distribution of SNAREs and Muncl8c in rat adipocyte fractions
Following treatment, cells were washed three times with HES buffer 
containing protease inhibitors at 18°C. The subfractionation protocol was based on 
that described by (Weber, 1988). For subfractionation, adipocytes were homogenised 
by 10 strokes in a 55 ml Potter Elvehjem homogeniser, and the homogenate was 
centrifuged for 2 min at lOOOg at room temperature. The homogenate was incubated 
on ice for five minutes, and the infranatant below the solidified fat layer was collected 
and centrifuged at 18000 rpm for 20 minutes in a Beckman TLA 100.3 rotor at 4°C. 
The pellet, which contained crude plasma membranes, mitochondria and nuclei was 
retained for further purification. The supernatant containing the cytosol and
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microsomal fractions was centrifuged at 30000 rpm in the TLA 100.3 rotor for 9 
minutes at 4°C. The pellet from this spin, which contained the high density 
microsomal fraction was resuspended in 200 pi of HES buffer containing protease 
inhibitors. The supernatant was centrifuged at 100000 rpm in the TLA 100.3 rotor for 
17 minutes at 4°C to pellet the low density microsomal fraction. This was 
resuspended in 400 pi HES buffer containing protease inhibitors. The supernatant 
from this spin was the cytosol. The crude plasma membrane pellet was resuspended in 
300 pi of HES buffer containing protease inhibitors and carefully overlaid onto a 600 
pi cushion of 1.12 M sucrose in 20 mM HEPES buffer pH 7.2, 1 mM EDTA. The 
sucrose cushion was centrifuged in a Beckman TLS55 rotor at 35000 rpm for 20 
minutes at 4°C. The pellet from this spin, which contained mitochondria and nuclei 
was carefully washed with HES buffer and resuspended in 400 pi of HES buffer 
containing protease inhibitors. The sucrose cushion containing the plasma membranes 
was made up to 3 ml with HES buffer and centrifuged at 37000 rpm in the TLA 100.3 
rotor for 9 min at 4°C. The pellet containing the plasma membrane fraction was 
resuspended in 3 ml of HES buffer and the spin was repeated. The pellet was then 
resuspended in 400 pi HES buffer containing protease inhibitors. Protein content in 
each fraction was estimated using the BCA protein assay kit (Pierce) according to the 
manufacturer’s instructions.
2.12.4. Detection of SDS-resistant complexes
In order to detect SNAREs in SDS-resistant complexes, freshly purified 
plasma membranes from basal or insulin-treated adipocytes were diluted to 0.2 mg/ml 
of protein in HES buffer. 50 pi of 3 x low-SDS sample buffer were added to 100 pi 
aliquots of the purified plasma membranes and mixed thoroughly. Two identical 45 pi
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aliquots were taken from each of these samples, and one was heated at 95°C for 5 
minutes, while the other was maintained at room temperature. Tubes were spun 
briefly at 1000 rpm to collect condensation and the entire contents of each tube were 
analysed by SDS-PAGE, transferred to nitrocellulose and western blotted with rabbit 
SNAP23 antibody, VAMP2 monoclonal antibody (both from Synaptic Systems, 
Gottingen, Germany) and anti-syntaxin4 rabbit serum.
2.13. Liposome reconstitution experiments
2.13.1. Reconstitution of t-SNAREs into liposomes
Lipids were purchased from Avanti Lipids. Reconstitution of syntaxin4 
followed the method described by Weber et al. (1998). Specifically, 100 pi of a 15 
mM mixture of POPC (1-palmitoyl, 2-oleoyl phosphatidylcholine):DOPS (1,2- 
dioleoyl phosphatidylserine) at a ratio of 85:15 in chloroform was evaporated under a 
gentle stream of nitrogen and remaining chloroform was removed by exposure to 
vacuum for 30 min. The lipids were then resuspended in 500 pi of inclusion body 
preparation containing 3.6 mg/ml of NucA-syntaxin4 (Section 2.5.2.) and incubated at 
room temperature for 30 min on a slowly rocking platform.
The vial containing the solubilised lipids and protein was vortexed vigorously 
while 1 ml of IB buffer was rapidly added to it. The vial was vortexed for a further 30 
s and dialysed overnight at 4°C against 2 litres of 25 mM sodium phosphate buffer pH
7.4, 250 mM NaCl, 2 mM DTT (reconstitution buffer) containing 4 g Biobeads SM2 
beads (BioRad) to remove traces of detergent.
Liposomes were recovered by flotation in an Optiprep density gradient. This 
was set up by mixing 500 pi of dialysate with 1 ml of 60% (w/v) Optiprep density
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gradient medium and loading this into a 2.2 ml centrifuge tube (Beckman). This was 
overlaid with 300 pi of 30% (w/v) Optiprep in reconstitution buffer followed by 200 
pi of 20% (w/v) Optiprep in reconstitution buffer and 100 pi of reconstitution buffer. 
The sample was centrifuged in a TLS-55 rotor (Beckman) at 55000 rpm for 3 h 50 
min at 4°C.
In order to form the t-SNARE complex on syntaxin4-containing liposomes, 
1.5 ml of 2 mg/ml GST-SNAP23 equilibrated against 25 mM sodium phosphate 
buffer, 1.5 M NaCl, 5 mM DTT was added to the liposome preparation immediately 
following dilution of detergent and vortexing. This was then dialysed against 2 1 of 
reconstitution buffer overnight at 4°C. Liposomes were recovered on an Optiprep 
gradient as described for NucA-syntaxin4.
2.13.2. Formation of t-SNARE complex on glutathione-sepharose
4 mg of GST-SNAP23 bound to 0.5 ml glutathione-sepharose was incubated 
with 3.6 mg of NucA-syntaxin4 inclusion body preparation in a total volume of 2 ml 
of IB buffer. The proteins were incubated with rotation for 2 h at 4°C, loaded onto a 
gravity column, and washed with 10 ml 50 mM borate buffer pH 8.5, 500 mM NaCl, 
10 mM DTT, 1% n-octylglucoside, then eluted with the same buffer containing 20 
mM glutathione.
2.13.3. Reconstitution of coexpressed t-SNAREs into liposomes
For reconstitution into liposomes, 500 pi of the solubilised inclusion body 
preparation expressed from cells containing the plasmid pGEX-tSNAREs was used 
(Section 2.5.4.). The buffer was exchanged for 25 mM sodium phosphate buffer pH
7.4, 750 mM NaCl, 1 mM DTT, 1% n-octylglucoside using a Bio-Spin 6 buffer
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exchange column (Bio-Rad). There was noticeable precipitation of protein at this step. 
The protein solution was centrifuged at 20000g for 10 min to remove insoluble 
material and the supernatant was incubated at room temperature for 1 h to allow 
complexes to form and then reconstituted into liposomes exactly as described for 
NucA-syntaxin4 (Section 2.13.1).
2.13.4. Reconstitution of VAMP2 into liposomes
All lipids were from Avanti Polar Lipids. A lOOpl mixture of 3 mM 
POPC:DOPS:NBD-DPPE:rhodamine-DPPE (82:15:1.5:1.5) in chloroform was dried 
under a gentle stream of nitrogen, followed by 30 min under vacuum. The lipids were 
resuspended in 100 pi of 4 mg/ml VAMP2 (purified as described in section 2.5.6.) 
and incubated for 30 minutes at room temperature on a rocking platform. Protein-free 
liposomes were made by substituting the protein solution with IB buffer. The vial 
containing the lipid-protein mixture was vortexed vigorously and 200 pi of 
reconstitution buffer were added to the vial while vortexing for a further 30 seconds. 
Liposomes were dialysed against 2 litres of reconstitution buffer containing 4 g of 
Biobeads SM2 beads (Bio-Rad).
Liposomes were recovered by flotation in a step gradient of Optiprep, set up in 
a 2.2 ml tube as follows: 300 pi of liposome dialysate was mixed with 600pl of 60% 
(w/v) Optiprep. This was overlaid with 600 pi of 30% Optiprep in reconstitution 
buffer followed by 200 pi of 20% Optiprep in reconstitution buffer, and 200 pi 
reconstitution buffer. The gradient was centrifuged at 55000 rpm for 3 h 50 min at 
4°C in the TLS-55 rotor. Liposomes collected as a single bright pink band near the 




Nonfluorescent liposomes made with coexpressed t-SNAREs and fluorescent 
liposomes containing VAMP2 were used in the subsequent fusion assays. Assays 
were carried out in 96-well white FluoroNunc plates (Nunc). Relative concentrations 
of VAMP2 liposomes and protein-free fluorescent liposomes were measured by NBD 
fluorescence with the excitation filter set to 485 nm and emission measured at 535 nm 
in a FarCyte fluorescent plate reader (Amersham Biosciences).
For the fusion experiments, duplicate wells were loaded with 45 pi of t- 
SNARE liposome preparation, and VAMP2 liposomes were added so that syntaxin4 
and VAMP2 were present at equimolar levels, in order to maximise the signal to noise 
ratio. Each well therefore contained approximately 30 pmoles of syntaxin4 and 
VAMP2. These were about Vio the amounts used in the original assay on which this 
one is based, but still higher than the density in synaptic vesicle membranes (Walch- 
Solimena et al., 1995b; Weber et a l , 1998). The final volume in each well was made 
up to 50 pi with reconstitution buffer. An equivalent amount of protein-free 
fluorescent liposomes was substituted for VAMP2 liposomes in some wells to act as a 
negative control. Liposome mixtures were incubated for 16 h at 4°C to allow 
liposomes to dock prior to measurements being taken. Fluorescence was measured in 
the FarCyte set to 37°C with the excitation filter set to 485 nm and emission measured 
at 535 nm, with 10 flashes and the integration time set to 40 ps. Measurements were 
taken at two minute intervals. After three hours of measurements, 10 pi of 2.5 %
(w/v) TritonX-100 was added to dissolve lipids and therefore maximally disperse 




Numerical data were plotted using GraphPad Prism version 4.0 (GraphPad 
Software, Inc.). Prism 4.0 was also used for all statistical analyses. Inhibition profiles 
in Chapter 2 were fitted to the Hill equation, from which IC50 values were calculated. 
Other quantitative data were analysed by two tailed paired or unpaired t tests.
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Chapter 3 - The role of p38 MAP kinase in the regulation of glucose uptake by 
insulin
3.1. Introduction
Insulin increases the number of GLUT4 molecules at the surface of responsive 
cells by both increasing the rate of translocation of GLUT4 vesicles to the plasma 
membrane and decreasing the rate of GLUT4 internalisation (Jhun et a l , 1992; Czech 
and Buxton, 1993; Satoh et al., 1993; Yang and Holman, 1993). It is thought that the 
net increase in GLUT4 at the plasma membrane underlies the increase in glucose 
uptake following insulin stimulation. There is some evidence, introduced in Section
1.6., that as well as regulating the availability of GLUT4 at the cell surface, insulin 
also regulates the catalytic activity of GLUT4.
Time course studies have shown that the appearance of GLUT4 at the plasma 
membrane of adipocytes precedes insulin stimulated glucose uptake, suggesting that 
the transporters are inactive when first inserted into the plasma membrane (Kamieli et 
al., 1981; Yang et a l , 1992; Satoh et a l , 1993). This effect was magnified when the 
temperature was reduced to 22°C (Somwar et a l , 2001a), though this may be because 
fusion of GLUT4 vesicles with the plasma membrane was slower at temperatures 
below 23°C (Elmendorf et a l , 1999).
It is important to define the sequence of the events leading to insulin 
stimulated glucose transport. These are GLUT4 vesicle translocation, where GLUT4 
vesicles are translocated to the vicinity of the plasma membrane, followed by GLUT4 
exocytosis, which results in exposure of GLUT4 to the outside of the cell and finally 
GLUT4-mediated glucose transport. Insulin stimulated glucose uptake and GLUT4 
translocation are sensitive to the PI 3-kinase inhibitors wortmannin and LY294002
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(Clarke et al, 1994; Sanchez-Margalet et al, 1994; Okada et a l, 1994; Cheatham et 
al, 1994). Furthermore, transfections of inactivating truncated mutants of p85, the 
regulatory subunit of class 1A PI 3-kinase, or of one of its SH2 domains also blocked 
insulin stimulated GLUT4 translocation (Kotani et a l, 1995; Haruta et al, 1995; 
Sharma et al, 1998). Insulin stimulated glucose uptake and GLUT4 translocation 
were also inhibited by microinjection of antibody specific to the pi 10 catalytic 
subunit of the class 1A PI 3-kinase (Hausdorff et al, 1999). This evidence indicates 
that the class 1A PI 3-kinase function upstream of GLUT4 translocation in insulin 
stimulated glucose transport (Section 1.4.).
Wortmannin irreversibly inhibits the catalytic activity of class 1 and class 3 PI 
3-kinases with IC50s in the range 1 to 10 nM (Fruman et a l, 1998). Two recent 
studies on 3T3-L1 adipocytes and L6 myotubes suggested that there is a higher 
affinity target for wortmannin that can lead to reversible inhibition of glucose 
transport activity without affecting the insulin stimulated exposure of GLUT4 at the 
cell surface (Hausdorff et al, 1999; Somwar et al, 2001b). Wortmannin has been 
reported to inhibit glucose uptake and GLUT4 exocytosis with IC50s of 6 nM and 80 
nM, respectively, in 3T3-L1 adipocytes. Expression of a constitutively active Akt 
abolished the sensitivity of glucose uptake of these cells to low concentrations of 
wortmannin, indicating that wortmannin did not inhibit glucose transport activity by 
direct interaction with GLUT4. This result also suggests that Akt interacts with the 
high affinity wortmannin pathway downstream of the low affinity target (Hausdorff et 
al, 1999). Wortmannin inhibited insulin stimulated glucose uptake with an IC50 of 3 
nM and GLUT4 exocytosis with an IC50 of 43 nM in L6 myotubes. In addition, the 
increase in p38 MAP kinase activity in response to insulin in L6 myotubes was 
inhibited at low wortmannin concentrations similar to those that inhibited glucose
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transport but not GLUT4 exocytosis (Somwar et a l , 2001b). The authors suggested 
that there was a link between the effects of wortmannin on the p38 MAP kinase 
pathway and the inhibition of insulin stimulated glucose uptake, as previous studies 
had indicated that p38 MAP kinase played a role in the stimulation of glucose uptake 
by insulin.
There is also evidence that a PI 3-kinase independent insulin signalling 
pathway is required to stimulate GLUT4 transporter activity at the cell surface. 
Addition of cell-permeable analogs of the lipid products of PI 3-kinase activity mimic 
the action of insulin in translocating GLUT4 to the surface of responsive cells (Jiang 
et a l, 1998; Maffixcci et al, 2003; Sweeney et a l, 2004). However, these lipids do 
not increase glucose uptake above the basal rate, despite the increased presence of 
transporters on the cell surface. These lipids do however restore insulin-like glucose 
transport rates to wortmannin or LY294002-treated cells in combination with insulin, 
but have no effect on the transport rate in the absence of insulin (Jiang et a l, 1998; 
Maffiicci et a l, 2003; Sweeney et al, 2004). This indicates that there is an insulin 
signalling pathway that regulates glucose transporter activity at the cell surface 
independently of the lipid products of PI 3-kinase activity.
The pyridinyl imidazole p38 MAP kinase inhibitors SB203580 and SB202190 
and the unrelated azaazulene p38 MAP kinase inhibitors A291077 and A304000 
inhibit insulin stimulated glucose uptake (Sweeney et al, 1999; Somwar et al, 2002). 
The dual phosphorylation of p38a MAP kinase and p38p MAP kinase at their 
regulatory sites and their activities increased following insulin treatment in L6 
myotubes and 3T3-L1 adipocytes. Both phosphorylation and the activity of p38 MAP 
kinase were inhibited by wortmannin in a manner consistent with this pathway being 
the high affinity target for wortmannin. Also, expression of a dominant negative p38
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MAP kinase inhibited insulin stimulated glucose uptake without inhibiting GLUT4 
exocytosis (Somwar et al., 2001b; Somwar et al., 2002). These results have led to a 
model, represented in Figure 3.1, in which the catalytic activity o f GLUT4 is 
regulated by insulin in a p38 MAP kinase dependent pathway, independently o f class 
1A PI 3-kinase and GLUT4 exocytosis.
Insulin
w
-  ^  p38 "
Translocation
PI-3-Kinase
Figure 3.1. The model for p38 MAP kinase regulation of GLUT4 activity. Insulin, 
via the insulin receptor (IR), activates the class 1A PI 3-kinase pathway which 
stimulates translocation o f GLUT4 vesicles to the plasma membrane. Insulin 
stimulates GLUT4 activity following insertion in the plasma membrane via a p38 
MAP kinase (p38) dependent pathway. Both pathways are inhibited by wortmannin 
and can be bypassed by expressing a constitutively active Akt (Hausdorff et al., 1999; 
Somwar et al., 2001a; Somwar et al., 2001b; Somwar et al., 2002).
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The conclusions drawn from this series of studies on p38 MAP kinase have 
been disputed by a number of other groups. Expression of dominant negative mutants 
of either p38 MAP kinase or of the p38 MAP kinase activator MKK6 in 3T3-L1 
adipocytes did not inhibit insulin stimulated glucose transport, whereas a 
constitutively active MKK6 construct increased glucose transport independently of 
insulin in a wortmannin independent manner. This appeared to be a long term effect, 
mediated by increased expression of GLUT1, rather than increased exocytosis of 
GLUT4 (Fujishiro et al., 2001). Furthermore, Kayali et al (2000) reported that 
activity of dual phosphorylated p38 MAP kinase in 3T3-L1 adipocytes was not 
stimulated by insulin, and that insulin stimulated glucose transport was not 
significantly inhibited by the p38 MAP kinase inhibitors SB203580, SB202190, and 
PD169316 at concentrations that blocked p38 MAP kinase activity. Moreover, 
Carlson et al. (2003) did not detect any increase in p38 MAP kinase activity in 
isolated human adipocytes following insulin treatment.
The experiments described in this chapter examined the extent to which 
wortmannin was able to uncouple insulin-stimulated glucose transport from GLUT4 
exocytosis. The effects of insulin and the p38 MAP kinase inhibitor SB203580 on the 
activation of the Akt and MAP kinase pathways were also examined. These results 




3.2.1. Wortmannin inhibition of insulin stimulated GLUT4 translocation to the 
plasma membrane
The plasma membrane lawn assay described in Section 2.10 was used to 
determine the effect of wortmannin on insulin stimulated GLUT4 vesicle 
translocation. Lawn preparation was rapid, around 20 seconds from cell lysis to 
fixation, increasing the chances of capturing a representative snapshot of events on 
the intracellular face of the plasma membrane. Vesicles on the plasma membrane 
remain attached in this assay, meaning that it cannot distinguish between translocation 
and exocytosis (Robinson et al., 1992; Avery et al., 2000; Yang et al., 2002). Unlike 
many other cell types, the small volume of cytosol in adipocytes relative to the fat 
droplet makes it difficult to distinguish between events inside the cell and those at or 
near the plasma membrane in intact cells under the microscope. The plasma 
membrane lawn assay increases the ability to resolve events at the plasma membrane.
In the following series of experiments, cells were treated with wortmannin for 
20 min, followed by a further 20 min with insulin before being immobilised for the 
assay. In order to quantify GLUT4 vesicle translocation, the plasma membrane lawns 
were subjected to immunofluorescence analysis with antibodies to GLUT4 and 
VAMP2. VAMP2 is a component of GLUT4 vesicles (Cain et al, 1992), and 
provided an additional measure of GLUT4 vesicle translocation.
The immunofluorescence (IF) (shown in Figure 3.2) was quantified on three 
membrane patches in each of four viewing fields per condition. The mean IF value for 
basal cells was subtracted from the IF value for each treatment. These were then
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Figure 3.2. Wortmannin inhibition of GLUT4 vesicle translocation. Rat adipocytes were pre-treated with wortmannin for 20 min. 20 nM 
insulin was added for a further 20 min. The adipocytes were then processed for the plasma membrane lawn assay. The micrographs are 
representative o f GLUT4 and VAMP immunofluorescence from three independent experiments.
expressed as a percentage of the difference in IF between non-wortmannin treated 
insulin stimulated and basal cells. This gave a measure of the inhibition of insulin 
stimulation by wortmannin. Wortmannin inhibited the insulin stimulated appearance 
of GLUT4 and on the plasma membrane with an IC50 of 14.1 nM (95% confidence 
interval (C.I.) 9.5 to 20.8 nM). VAMP2 appearance on the plasma membrane was 
inhibited with an IC50 of 12.5 nM (95% C.I. 9.0 to 17.4 nM) (Figure 3.4).
3.2.2. Wortmannin inhibition of insulin stimulated GLUT4 exocytosis
GLUT4 exocytosis in rat adipocytes was quantified by labelling molecules 
exposed to the exterior surface of the cell with GP15, a trifunctional photolabel. A 
hexose moiety on GP15 allows it to bind to the glucose binding site on the GLUT4 
molecule. A photoactivateable diazirine group covalently links the label to any 
adjacent proteins when subjected to ultraviolet illumination. Thirdly, a biotin affinity 
tag allows the experimenter to purify labelled molecules. Labelled molecules can then 
be analysed by SDS-PAGE and Western blotting. GLUT4 that is exposed to the 
outside of the cell can be labelled in this way. However, direct labelling may exclude 
GLUT4 molecules whose glucose binding sites are altered, by allosteric regulation for 
example. This prompted a refinement in the technique, whereby cells were first 
stimulated with insulin and exocytosed GLUT4 was labelled as described above, 
insulin was then removed and cells were allowed to recover and re-intemalise GLUT4 
(Yang et al., 2002). In order to measure exocytosed GLUT4, cells were treated in the 
presence of avidin in order to quench the biotin moiety photolabelled GLUT4 
molecules on the cell surface. Unbound avidin was then washed away, and the cells 
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Figure 3.3. Wortmannin inhibition of GLUT4 exocytosis. Glucose transporters on 
the cell surface o f  rat adipocytes were labelled with GP15 photolabel (A) in the 
presence o f 20 nM insulin for 40 min. Insulin and unbound photolabel were removed 
by extensive washing. For the inhibition experiments the cells were treated with 
wortmannin for 20 min, avidin and 20 nM insulin were added for a further 20 min. 
Cells were then solubilised, and biotinylated GLUT4 was precipitated with 
strepatividin-agarose and analysed by SDS-PAGE and W estern blotting with GLUT4 
antiserum. The blot shown in (B) is representative o f  three experiments carried out 
with Dr Jing Yang.
ability to be isolated by streptavidin precipitation, and m ust therefore have been inside 
the cell during treatment. W hen analysed by W estern blot, this m ethod provided a 
direct m easure o f translocation and exposure o f  the exofacial binding site at the cell 
surface. The assay was not dependent on any changes in the affinity o f  GLUT4 for 
glucose.
This indirect exocytosis assay was used as described in Section 2.9.3. to 
determine the effect o f wortmannin on insulin-stim ulated GLUT4 exocytosis in
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adipocytes. The mean amount of exocytosed GLUT4 for basal cells was subtracted 
from the value for the other treatments. These values were then expressed as a 
percentage of the difference between non-wortmannin treated insulin stimulated and 
basal cells. This gave a measure of the inhibition of insulin stimulation of GLUT4 
exocytosis by wortmannin. The results, shown in Figure 3.3 and plotted in Figure 3.4 
show that insulin stimulated GLUT4 exocytosis was inhibited by wortmannin with an 
IC50 of 8.2 nM (95% C.I. 4.6 to 14.8 nM).
3.2.3. Wortmannin inhibition of insulin stimulated 3-O-Methyl-D-glucose uptake
Glucose transport activity was measured by the 3-O-methyl glucose uptake 
assay (Section 2.8.). The results were normalised with basal and insulin values in the 
absence of wortmannin set at 0% and 100% respectively. The normalised results were 
plotted together with those for GLUT4 vesicle translocation and GLUT4 exocytosis 
on the same axes (Figure 3.4). Wortmannin was found to inhibit insulin stimulated 
glucose uptake with an IC50 of 8.5 nM (95% C.I. 6.4 to 11.3 nM). This value was the 
same as the value obtained by measuring the rate of exposure of biotinylated GLUT4 
and both these values were slightly smaller than those obtained for GLUT4 vesicle 
translocation, although the differences were not found to be statistically significant. 
However, the curves for inhibition of exocytosis and uptake were less sigmoidal in 
character than the translocation curves. The difference between the curves is most 
pronounced in the 5 nM wortmannin treatments, where there is a significantly smaller 
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Figure 3.4. Wortmannin inhibition of insulin-stimulated glucose transport.
Glucose transport activity was estimated in rat adipocytes that had been treated with 
wortm annin for 40 min in the presence o f  20 nM insulin for the last 20 min, using the 
3-OM G uptake assay. 3-OM G uptake m easurem ents from five independent 
experiments are plotted in black alongside GLUT4 exocytosis, GLUT4 vesicle 
translocation and VAM P2 translocation. All data points are normalised against basal 
and insulin values in the absence o f wortmannin.
3.2.4. Effect of insulin on activation of MAP kinase pathways
As the IC50 value for wortmannin inhibition o f  glucose uptake was similar to 
those for GLUT4 exocytosis, the activation o f  M AP kinase pathways following 
insulin stimulation was examined in order to see whether there was a link between 
glucose uptake and p38 M AP kinase activation. M AP kinases are activated by dual 
phosphorylation at their regulatory ‘core signalling m odule’, a Thr-X-Tyr m otif in the 
activation loop within the kinase domain (Boulton et al., 1990; Derijard et al., 1994; 
Raingeaud et al., 1995). Activation o f MAP kinases was detected by western blotting 
o f  adipocyte extracts with antibodies raised against peptides containing the 
phosphorylated ‘core signalling m odules’ as described in Section 2.11.
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1.00±0.00 2.60±0.32* 1.49+0.19* 1.2810.12 1.2010.09 0.7210.09
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1.00+0.00 2.80+0.42* 1.9810.13* 1.4710.26 1.3810.24 1.1210.44
Figure 3.5. Insulin stimulated MAP kinase activation in rat adipocytes. A. Rat
adipocytes were stimulated with 20 nM insulin for the times indicated. Lysates were 
analysed by SDS-PAGE and western blotting with phospho-specific M APK 
antibodies and a p38 M AP kinase antibody as a loading control. The blots shown are 
representative o f  at least three independent experiments. B. M ean band inensities 
from the experiments represented in A, corrected for loading differences and 
normalised to basal values, ±  standard error o f  means (S.E.M.). * indicates that the 
value differs significantly from the value in the absence o f  insulin (i.e. p<0.05, paired, 
two-tailed t test).
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Figure 3.6. Phosphorylation of CREB, a downstream effector of p38 MAP kinase 
in response to insulin. A. Rat adipocytes were stim ulated with 20 nM  insulin for the 
times indicated. Lysates were analysed by SDS-PAGE and W estern blotting with 
phospho-specific p38 M AP kinase and CREB antibodies, and antibodies to the P- 
subunit o f the insulin receptor (IRp) as a loading control. This blot is representative o f 
three independent experiments. B. M ean band intensities from the experim ents 
represented by A, corrected for differences in loading and norm alised to basal values, 
± S.E.M.
Following insulin treatm ent there was a rapid rise in p44/42 Erk M AP kinase 
phosphorylation that peaked at 2.60 ± 0.32 times the basal value. This returned to 
basal levels within 15 min after insulin treatm ent began. Phosphorylation o f  
SAPK/JNK also peaked at 5 m in following insulin treatm ent at 2.80 ± 0.42 tim es 
basal levels and returned to basal levels 20 min after insulin treatm ent began. 
Phospho-p38 M AP kinase levels peaked after 15 m in o f  insulin treatm ent at 1.35 ±
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0.14 times basal levels and had returned to basal levels after 20 min of insulin 
treatment (Figure 3.5).
There was no detectable change in phosphorylation of the p38 MAP kinase 
substrate CREB in response to insulin (Figure 3.6).
3.2.5. Effect of glucose in buffers used for isolation of rat adipocytes
Through indirect comparisons of western blots from different experiments 
carried out in this laboratory (not shown), it was observed that in the absence of 
insulin, levels of phosphorylated p38 MAP kinase in rat adipocytes appeared to be at 
least an order of magnitude higher those observed in an equivalent amount of protein 
extracted from 3T3-L1 adipocytes. The possibility that the elevated basal p38 MAP 
kinase phosphorylation in rat adipocytes compared to 3T3-L1 adipocytes was a result 
of the isolation procedure was considered.
In a report by (Ruan et al., 2003), a number of signaling pathways were 
observed to be activated during the isolation of mouse adipocytes, including by 
implication MAP kinase pathways. Direct comparison is difficult however, because 
the protocol described was much longer than that used to isolate rat adipocytes in the 
experiments described in this thesis. Nevertheless, the possibility of unintended 
activation of signalling pathways was considered. AMPK is activated in response to 
the change in [AMP]/[ATP] under conditions of low glucose in muscle cells. It has 
also been reported that AMPK activation can stimulate GLUT 1-mediated glucose 
uptake in clone9 cells (Barnes et al., 2002). However, (Xi et a l , 2001) showed that 
there was no link between AMPK activation and that of p38 MAP kinase in rat 
adipocytes. Nevertheless, the possibility that basal p38 MAP kinase phosphorylation
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Figure 3.7. Effect of the presence of glucose during preparation of rat adipocytes 
on MAP kinase phosphorylation. A. Rat adipocytes were prepared either with the 
usual buffers or with 0.1% glucose in the wash buffer. Cells were stim ulated with 20 
nM insulin for the times indicated, lysed and analysed by SDS-PAGE and W estern 
blotting with phospho-specific antibodies for p38 M AP kinase, CREB, p44/42 
M APK, and antibodies to the p-subunit o f the insulin receptor (IRP) as a loading 
control. This blot is representative o f  three different experiments. B. M ean band 
intensities at the 10-minute timepoints o f  the experiments represented in A. Intensities 
were corrected for loading differences and normalised against the basal values, ± 
S.E.M.
may be elevated as a result o f  the absence o f glucose in the buffers used to wash and 
m aintain the adipocytes following isolation was considered. However, the presence or
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absence o f  glucose in these buffers had no effect on either basal p38 M AP kinase 
phosphorylation or its response to insulin (Figure 3.7).
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Figure 3.8. p38 MAP kinase response to varying concentrations of insulin. Rat
adipocytes were stim ulated with different concentrations o f  insulin for 10 min, lysed, 
and analysed by SDS-PAGE and W estern blotting with antibodies to the p subunit o f  
the insulin receptor (IRB) as a loading control, and phospho-specific antibodies to 
Akt(Thr308), p38 M AP kinase and CREB. This blot is representative o f  two different 
experiments.
3.2.6. Effect of insulin concentration on p38 MAP kinase activation
The effect on the phosphorylation o f p38 M AP kinase o f  treating adipocytes 
with different concentrations o f  insulin was examined. As well as stim ulating the 
insulin receptor, high concentrations o f  insulin such as those used to stimulate 3T3-L1 
adipocytes may also stimulate related receptors, such as the IGF1 receptor, whose 
ligand is reported to stimulate p38 MAP kinase. There was no apparent increase in 
p38 M AP kinase phosphorylation between cells treated with 20 nM  and 200 nM 
insulin (Figure 3.8).
3.2.7. Effect of SB203580 on glucose uptake and GLUT4 exocytosis
Treatment o f  adipocytes with 10 pM  SB203580 inhibited insulin-stim ulated 3- 
OM G uptake by 35.24%  ± 0.05%  (Figure 3.9). This is slightly smaller than the -5 0 %
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inhibition reported in 3T3-L1 adipocytes by Sweeney et al. (1999). However, in 
contrast to the lack o f  inhibition o f  GLUT4 exocytosis reported by Sweeney et al. 
(1999), labelling o f transporters at the cell surface with Bio-LC-ATB-BGPA 
photolabel (Section 2.9.1.) was also inhibited by 29.6%  ± 4.1%  following treatm ent 




Figure 3.9. Inhibition of insulin stimulated glucose uptake by SB203580. Rat
adipocytes were treated with 10 pM  SB203580 for 20 m in followed by 20 nM  insulin
for a further 20 min. Uptake was measured by the 3-OM G uptake assay. The chart
shows means from four experiments. SB203580 had a statistically significant effect (p
< 0.05) on insulin stimulated uptake, as measured by paired, two-tailed t test. Error













Figure 3.10. Inhibition of GLUT4 photolabelling by SB203580. Rat adipocytes
were trerated with 10 pM  SB203580 for 20 min, followed by a further 20 min with 20
nM  insulin. Cell surface GLUT4 was labelled with Bio-LC-ATB-BGPA photolabel as
described in General M ethods and Streptavidin agarose precipitates were analysed by
SDS-PAGE and western blot with anti-GLUT4 rabbit serum. GLUT4 bands from six
experiments were quantified. SB203580 had a statistically significant effect (p < 0.05)
on uptake, as measured by paired, two-tailed t test.
3.2.8. Effect of SB203580 on activation of p38 MAP kinase and Akt
Extracts from rat adipocytes treated with 10 pM  SB203580 with and w ithout 
insulin treatment were analysed for activation o f  p38 M AP kinase and Akt by western 
blotting. Akt is activated by phosphorylation on Thr308 and Ser473 (Alessi et al., 
1996), and phosphorylation on these residues can be detected with specific antibodies. 
Treatment with 10 pM  SB203580 reduced basal and insulin-stim ulated p38 M AP 
kinase phosphorylation by 35%  and 42% respectively. There was no change in either 
CREB phosphorylation or phosphorylation o f Akt on Thr308. Both basal and insulin 
stim ulated phosphorylation o f  Akt on Ser473 were consistently reduced following
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treatm ent with 10 pM  SB203580, although this was not found to be statistically 
significant (Figure 3.11).
Insulin +  -  +
SB203580 +  +A.
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Basal Insulin Basal Insulin
P-p38 MAPK 1.00±0.00 1.13±0.03 0.6510.06* 0.6510.02*
P-CREB 1.00±0.00 1.00±0.00 1.0710.03 0.9710.03
P-Akt (Ser473) 1.00±0.00 6.80±0.76 0.9410.04 6.3710.90
P-Akt (Thr308) 1.00±0.00 11.6711.20 1.0010.00 11.6710.67
Figure 3.11. Effect of SB203580 on insulin stimulated phosphorylation of Akt at 
Thr308 and Ser473. A. Isolated rat adipocytes were stimulated for 10 min with 20 
nM  insulin with or w ithout 20 m in prior treatm ent with 10 pM  SB203580. Cell 
lysates were analysed by SDS-PAGE and W estern blotting with phospho-specific 
antibodies to p38 M AP kinase, CREB, Akt(Thr308), Akt(Ser473), and the p subunit 
o f the insulin receptor (IRB). Blots shown are representative o f three different 
experiments. B. M ean band intensities from the experiments represented in A, 
adjusted for loading differences and normalised to basal values, ± S.E.M. * indicates 
that treatment with SB has a significant effect (p<0.05, paired, two-tailed t test).
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3.3. Discussion
Low nanomolar concentrations of wortmannin have previously been shown to 
differentially inhibit insulin stimulated glucose transport and GLUT4 exocytosis in 
3T3-L1 adipocytes (Hausdorff et al., 1999; Somwar et al., 2001b). However, similar 
experiments carried out in our laboratory failed to detect any differences in the 
inhibition of these two processes by wortmannin in the same cell type (Clarke et al, 
1994). A possible explanation for the different results between the groups is in the 
methods used to measure GLUT4 exocytosis. Somwar et al (2001) and Hausdorff et 
al (1999) detected GLUT4 tagged with Myc on the extracellular domain. Clarke et al 
(1994) however, used a biotinylated affinity label containing a glucose moiety 
designed to bind to GLUT4 at the cell surface. (Ferrara and Cushman, 1999) showed 
that this photolabel was unable to bind external GLUT4 in adipocytes that had been 
treated with the adrenergic agent isoproterenol. GLUT4 at the surface of cells treated 
with wortmannin or isoproterenol may be altered in some way and therefore have a 
lower affinity for the glucose moiety of the photolabel, thereby making the inhibited 
GLUT4 effectively invisible to the photolabelling assay.
The wortmannin inhibition experiments reported here included a modified 
exocytosis assay designed to ensure that all GLUT4 molecules on the cell surface 
were quantifiable (Section 2.9.3., Figure 3.3). Measurement of insulin-stimulated 3- 
OMG uptake, GLUT4 vesicle translocation (Figure 3.2) and exocytosis (using the 
modified photolabelling protocol, Figure 3.3) in rat adipocytes showed that 
wortmannin inhibited these three processes with similar IC50s of ~8 nM (Figure 3.4). 
A single target may therefore be responsible for the inhibition of all three processes 
by wortmannin. By implication, this target must therefore be upstream of GLUT4 
translocation. These results do not necessarily imply that insulin does not regulate the
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catalytic activity of GLUT4, only that GLUT4 exocytosis and glucose uptake cannot 
be separated at low concentrations of wortmannin, unlike in previous reports of 
experiments in cultured muscle and fat cells (Hausdorff et al., 1999; Somwar et al., 
2001b).
There was less inhibition of insulin stimulated GLUT4 vesicle translocation 
than of glucose transport or GLUT4 exocytosis at wortmannin concentrations of 5 nM 
or less. The slope of the glucose uptake and GLUT4 exocytosis inhibition curves was 
also gentler and less sigmoidal in character than the GLUT4 translocation curve 
(Figure 3.4). This implies that exocytosis and glucose uptake are being inhibited at 
multiple steps, consistent with the existence an additional wortmannin-sensitive step 
after translocation but prior to fusion of GLUT4 vesicles with the plasma membrane. 
These results contradict the reported high affinity wortmannin target regulating 
transporter activity, but are consistent with more recent reports of a late pre-fusion 
step that is inhibited by the PI 3-kinase inhibitor LY294002 (Bose et al., 2004) and is 
dependent on Akt activity (van Dam et a l , 2005).
The IC50 values for wortmannin inhibition of insulin stimulated glucose 
uptake, GLUT exocytosis and GLUT4 vesicle translocation in these experiments lies 
in between the values for the high and low affinity wortmannin targets reported by 
(Somwar et a l , 2001b) and (Hausdorff et a l , 1999). Some of these differences may 
be dependent on cell type. It is thought that wortmannin competes with ATP for its 
binding site on PI 3-kinase. Differences in sensitivities of different cell types to 
wortmannin may therefore be a result of differences in local ATP concentrations.
Such differences in sensitivity may also be because different PI 3-kinase isoforms are 
responsible for the effects being measured. Wortmannin inhibits class I, class II, C20 
and C2y PI 3-kinase isoforms with IC50s in the narrow range between 1 and 10 nM,
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and therefore cannot be used to distinguish between effects of different PI 3-kinase 
isoforms. In order to attribute functions to specific PI 3-kinase isoforms, other 
approaches such as dominant negative mutants, knockouts, and RNA interference are 
required.
It has also been suggested that the postulated high affinity target of 
wortmannin may not be a PI 3-kinase. This proposed high affinity wortmannin target 
has not been identified, but a series of papers from Amira Klip’s laboratory has put 
forward evidence that the p38 MAP kinase pathway is involved in upregulating the 
catalytic activity of GLUT4 in response to insulin in muscle cells and in 3T3-L1 
adipocytes and that this step is wortmannin-sensitive (Sweeney et a l , 1999; Somwar 
et al., 2000; Konrad et a l, 2001; Somwar et a l, 2001a; Somwar et a l, 2001b;
Somwar et a l, 2002).
The activation of the p38 MAP kinase pathway was examined in order to 
determine its possible involvement in insulin stimulated glucose transport. Insulin 
treatment of adipocytes resulted in a small transient increase in dual-phosphorylated 
p38 MAP kinase that peaked at an additional 35% over the basal value after 15 min of 
treatment and returned to basal levels after 20 min of insulin treatment (Figure 3.5). 
These changes are relatively small compared to the ~2.5-fold increases in p38 
phosphorylation in muscle cells and 3T3-L1 adipocytes previously reported (Konrad 
et a l, 2001). No change was seen in phosphorylation of the p38 MAP kinase substrate 
CREB following insulin treatment (Figure 3.6). Adding glucose to the buffers used to 
wash and store our cells or increasing the insulin concentration had no effect on the 
magnitude of the insulin effect on p38 MAP kinase activation (Figure 3.7). However, 
changes in p38 MAP kinase activation following insulin treatment also appear to vary 
according to cell type and species, as primary human adipocytes show no increase at
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all in p38 MAP kinase phosphorylation following insulin treatment (Carlson et al, 
2003).
The link between insulin stimulated glucose transport and p38 MAP kinase 
activation was examined in a series of experiments with the p38 MAP kinase inhibitor 
SB203580. 10 pM SB203580 inhibited insulin-stimulated 3-OMG uptake by 35% 
(Figure 3.9). SB203580 reduced p38 MAP kinase phosphorylation by 35% in the 
basal state and by 41% following insulin treatment (Figure 3.11). However, surface 
GLUT4 photolabelling was also reduced by 30% in insulin-treated rat adipocytes that 
had been preincubated with 10 pM SB203580 (Figure 3.10), contradicting the reports 
that SB203580 inhibits insulin-stimulated glucose transport independently of GLUT4 
exocytosis. Again, it might be argued that the photolabelling assay only measures 
GLUT4 at the cell surface that is able to bind the glucose moiety of the label, and that 
a GLUT4 molecule that is being negatively regulated (by allosteric alteration of the 
glucose binding site, for example) may not be able to bind the label efficiently.
Following the completion of this work, a direct comparison of several 
different methods of measuring cell surface GLUT4 in 3T3-L1 adipocytes was 
reported. These studies showed that the mannose photolabelling method 
underestimated cell surface GLUT4 in cells treated with insulin and SB203580 when 
compared to direct cell surface protein biotinylation or detection of ectopically 
expressed GLUT4 containing a tag on the first extracellular loop (Bazuine et a l, 
2005). Further work carried out in our laboratory following completion of the 
experiments described here also showed that SB203580 acted as a non-competitive 
inhibitor to glucose transport into the cell and as a competitive inhibitor to glucose 
transport out of the cell (Ribe et al, 2005). Taken together, these studies strongly
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suggest that the presence of SB203580 in cells reduces the ability of the extracellular 
domain of GLUT4 to bind glucose.
When lysates from insulin and SB203580 treated rat adipocytes were blotted 
for activated Akt, Thr308 phosphorylation was found to be unaffected by the 
inhibitor. Ser473 phosphorylation however, was consistently lower in SB treated cells 
than in control cells (Figure 3.11). As Akt activity requires phosphorylation on 
Thr308 and Ser473 mediated by PDK1 and PDK2 respectively (Alessi et al., 1997; 
Anderson et al, 1998), the fact that phosphorylation of Akt at one of these sites may 
be reduced in the presence of SB203580 makes it impossible to attribute the effects of 
the inhibitor on glucose uptake to inhibition of p38 MAP kinase. Akt was inhibited by 
38% in the presence of 10 pM SB203580 in an in vitro phosphorylation assay (Davies 
et al, 2000). Additionally, (Lali et al, 2000) have shown that SB203580 inhibits 
phosphorylation of Akt on Ser473 by directly inhibiting PDK1 at micromolar 
concentrations in T cells. Furthermore, (Rane et al, 2001) found that PDK2 activity 
in human neutrophils - and therefore phosphorylation of Akt on Thr308 - was also 
inhibited by SB203580 at concentrations similar to the IC50 for p38 MAP kinase. The 
target for SB203580 inhibition of PDK2 activity was identified as MAPKAPK-2, 
itself a p38 MAP kinase substrate. Also, the p38 MAP kinase inhibitor PD169316 
reportedly has no effect on insulin stimulated glucose uptake in 3T3-L1 adipocytes 
even when applied at 50 times the IC50 for p38 MAP kinase inhibition (Kayali et al, 
2000). Together, these results suggest that the effects on insulin stimulated glucose 
uptake previously attributed to inhibition of p38 MAP kinase may in fact be due to 
inhibition of Akt.
The specificity of SB203580 is reported to improve when it is used at the 
lower concentration of 1 pM, but the data presented by Somwar et al (1999)
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supporting p38 MAP kinase involvement shows no inhibition of insulin stimulated 
glucose transport at this concentration of SB203580 (over double the IC50 value). 
(Somwar et al., 2002) addressed the question of specificity of SB203580 by 
substituting two novel azaazulene p38 MAP kinase inhibitors for SB203580, 
producing similar inhibition of glucose uptake without inhibition of GLUT4 
exocytosis. These novel inhibitors are otherwise uncharacterized in the literature, and 
given the evidence against p38 MAP kinase involvement in insulin stimulated glucose 
transport (Kayali et al, 2000; Fujishiro et al., 2001; Carlson et al., 2003), doubts 
about their specificities must persist until their effects on other known components of 
the insulin signaling pathway have been demonstrated.
It is difficult to reconcile the apparently contradictory accounts of the role of 
p38 MAP kinase in insulin stimulated glucose uptake in 3T3-L1 adipocytes offered by 
(Somwar et al., 2002) and (Fujishiro et al., 2001). Insulin produced only a two-fold 
increase in exocytosis of Myc-GLUT4 in the study by the Klip laboratory (Somwar et 
al., 2002). This response is unusually small for this type of cell, and is similar in 
magnitude to that seen when CHO cells, which lack a specialized GLUT4 
compartment, express Myc-GLUT4 (Kanai et al., 1993). These results may be 
affected by the increased GLUT4 expression levels, as changes in GLUT4 expression 
levels in adipocytes reportedly alter trafficking of GLUT4 and expression levels of 
proteins involved in GLUT4 trafficking (Carvalho et al., 2004). Moreover, studies in 
which expression or activity of p38 MAP kinase are altered may also be misleading, 
as p38 MAP kinase has been shown to be a strong inducer of GLUT4 expression 
(Montessuit et al., 2004).
In summary, the results presented in this chapter show that, unlike in recent 
reports of similar experiments in 3T3-L1 cells, wortmannin is unable to differentially
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inhibit insulin stimulated glucose transport and GLUT4 exocytosis. The results of the 
wortmannin inhibition experiments on GLUT4 vesicle translocation, GLUT4 
exocytosis and glucose uptake do not support the concept of a wortmannin sensitive 
step that leads to a change in the catalytic activity of GLUT4. The results suggest the 
existence of a wortmannin sensitive step between GLUT4 vesicle translocation and 
GLUT4 exocytosis. A small increase in p38 MAP kinase phosphorylation was 
observed following stimulation with insulin, but no detectable change in 
phosphorylation of CREB, a substrate of p38 MAP kinase was detected. Both insulin 
stimulated glucose uptake and cell surface GLUT4 labelling were inhibited by 10 pM 
SB203580, as was p38 MAP kinase phosphorylation. Insulin stimulated 
phosphorylation of Akt at Ser473 was also inhibited by 10 pM SB203580. The direct 
and indirect effects of SB203580 on Akt activity may therefore contribute to the 
reduction in insulin stimulated glucose transport, although more recent work has 
indicated that SB203580 is likely to inhibit GLUT4 transporter activity directly.
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Chapter 4 -  Quantitation and distribution of syntaxin4, SNAP23, VAMP2 and 
Muncl8c in rat adipocytes
4.1. Introduction
The fusion of GLUT4 vesicles with the plasma membrane is the final step in 
insulin-stimulated translocation of GLUT4 to the plasma membrane. The cellular 
machinery controlling intracellular membrane fusion, introduced in Section 1.7., is 
common to all eukaryotes and includes NSF, the SNAP proteins, SNAP receptors 
(SNAREs) and Secl/Muncl8 homologs (SM proteins) (Mayer, 2002). Syntaxin4 and 
SNAP23 are present on adipocyte plasma membranes and act as t-SNAREs when 
GLUT4 vesicles fuse with the plasma membrane in response to insulin (Timmers et 
a l , 1996; Olson et al, 1997; Rea et al, 1998; St Denis et al, 1999). VAMP2 is 
present on the insulin-responsive intracellular GLUT4 compartment and is thought to 
be the v-SNARE in the fusion reaction with the plasma membrane (Sevilla et al, 
1997; Millar et a l, 1999). These three SNAREs form a ternary complex in vitro and 
are present together in complexes isolated from adipocytes, which also include NSF 
and aSNAP (Timmers et al, 1996; Olson et al, 1997; Rea et al, 1998).
The recruitment of insulin-responsive GLUT4 vesicles to the plasma 
membrane is regulated not only by availability of GLUT4 vesicles near the plasma 
membrane (by translocation) but also on the respective membranes. For instance, 
VAMP2 from GLUT4 vesicles formed SNARE complexes more readily on plasma 
membranes from insulin-treated adipocytes than on plasma membranes isolated from 
basal cells (Timmers et a l, 1996; Inoue et al, 1999). Also, association of plasma 
membranes and GLUT4 vesicles from 3T3-L1 adipocytes in vitro increased when 
either was isolated from insulin-treated cells (Inoue et al, 1999). Furthermore, insulin
115
treatment increased co-immunoprecipitation of GLUT4 vesicle proteins with the 
cytosolic domain of syntaxin4 in 3T3-L1 adipocytes (Olson et a l, 1997). These 
results suggest that SNARE complex formation may be a point of regulation by 
insulin, and that this regulation may take place on both the plasma membrane and the 
GLUT4 vesicle.
Muncl8c is a potential mediator of this regulation by insulin. Muncl8c is 
associated with syntaxin4 in 3T3-L1 adipocytes and blocked fusion of GLUT4 
vesicles with the plasma membrane when overexpressed (Araki et al, 1997; 
Thurmond et al, 1998; Tamori et al, 1998; Macaulay et a l, 2002), but paradoxically 
may also be required for the fusion reaction, as fusion was inhibited when its binding 
to syntaxin4 is disrupted by mutation or microinjection of inhibitory peptides 
(Thurmond et al, 2000; Thurmond and Pessin, 2000). Unlike the neuronal Muncl8a 
Muncl8c could bind to a ternary SNARE complex (Widberg et a l, 2003). Insulin 
treatment disrupted the Muncl8c/syntaxin4 complex in 3T3-L1 adipocytes 
(Thurmond et a l, 1998). This suggests that Muncl8c may regulate the ability of 
syntaxin4 to form complexes with the other SNAREs. A recent report of experiments 
with adipocytes derived from Muncl8c deficient mouse embryos indicated that 
Muncl8c blocked GLUT4 exocytosis in a wortmannin sensitive manner. In the 
absence of Muncl8c, insulin stimulated GLUT4 exocytosis was not wortmannin 
sensitive (Kanda et al, 2005). This is an important development that directly links 
Muncl8c and the membrane fusion machinery to the insulin signalling pathway.
Levels of syntaxin4, SNAP23, VAMP2 and Muncl8c have previously been 
quantified in 3T3-L1 adipocytes (Hickson et a l, 2000). As the binary binding 
properties of these proteins are well characterised (Foster et al, 1998), quantitating 
these proteins may be useful in identifying interactions that are likely to be under
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regulation. For example, overexpression of SNAP23 stimulated GLUT4 exocytosis. 
This implies that the availability of SNAP23 limits the extent of fusion of GLUT4 
vesicles with the plasma membrane (Foster et al., 1999). However, the quantitative 
data showed that there were three times as many SNAP23 molecules as there were of 
its binding partner syntaxin4 (Table 4.1) (Hickson et al., 2000). This suggests that the 
availability of SNAP23 may be tighly regulated and is potentially important in the 
regulation of insulin stimulated glucose transport.
Protein Number of copies per cell
Syntaxin4 0.374 x 106
SNAP23 1.15 x 106
VAMP2 0.495 x 106
Muncl8c 0.452 x 106
Table 4.1. Estimated numbers of syntaxin4, SNAP23, VAMP2 and Muncl8c 
molecules in 3T3-L1 adipocytes. These estimates are based on the quantitative 
western blot analyses in the study by (Hickson et a l , 2000).
This study did not provide any information about the spatial distribution of the 
proteins in 3T3-L1 cells. Knowing how proteins are distributed within cells is 
important when considering the functional implications relative protein levels, as 
proteins that do not interact spatially are unlikely to interact functionally. The 
experiments in this chapter describe the quantification of syntaxin4, SNAP23, 
VAMP2 and Muncl8c levels in rat adipocytes, in subcellular fractions and in SDS 
resistant complexes and the functional implications of the results are discussed.
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4.2. Results
4.2.1. Characterisation of novel antibodies on western blots
Novel rabbit antibodies were raised against SNAP23, VAMP2 and Muncl8c 
and prepared as described in Section 2.6. for use in the experiments described below. 
Adipocyte total lysates were run on SDS-PAGE and western blotted with the purified 
rabbit antibodies alongside commercial antibodies for the same proteins (Figure 4.1).
The major bands in the SNAP23 (at 27 kDa) and VAMP2 (16 kDa) blots were 
in the same positions as those detected by commercial antibodies directed against the 
same proteins. The SNAP23 antibody also detected an additional band at 36 kDa.
This 36 kDa band was detected in the cytosol (Figure 4.5), and was not detected by 
the commercial antibody and is therefore unlikely to contain any SNAP23. The 
Muncl8c antibody detected major bands at 59 and 65 kDa (Figure 4.1C). A western 
blot competition assay was performed to determine the specific band corresponding to 
Muncl8c, as described in Section 2.2.6. Blots carried out in the absence of competing 
Muncl8c showed the presence of the two bands at 59 and 65 kDa. In the presence of 
competing GST-Muncl8c, the 65 kDa band disappeared, showing that this was the 
band corresponding to Muncl8c (Figure 4.1C). This agreed with the molecular weight 
of the protein predicted from the amino acid sequence.
4.2.2. Quantification of syntaxin4, SNAP23, VAMP2 and Muncl8c in rat 
adipocytes
GST-syntaxin4, NucA-SNAP23, NucA-VAMPcyt and GST-Muncl8c were 
expressed and purified as described in Section 2.12. for use as protein standards for 
quantification of these proteins in adipocytes. Purities of the purified proteins were 
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Figure 4.1. Specificities of affinity purified rabbit antibodies. Adipocyte lysates 
were western blotted w ith affinity purified rabbit antibodies from this laboratory 
(rabbit) and commercial equivalents for A. SNAP23 and B. VAM P2, both purchased 
from Synaptic Systems (SySy). C. Adipocyte lysates were western blotted with 
purified anti-M uncl8c rabbit serum or with anti-M uncl8c serum that had been 
preincubated with excess G ST-M uncl8. Arrowheads indicate expected positions o f 
specific bands.
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Band densities on the gels and total staining in each lane were m easured from digital 
images o f  the backlit gels and used to provide an estimate o f  the purities o f  the protein 
standards using the m ethod described in Section 2.12.1. and Figure 2.1. Purities o f the 
protein standards were estimated at 74% (GST-syntaxin4), 81% (NucA-SNAP23,
88% (NucA-VAMPcyt) and 95% (G ST-M uncl8c). The absolute concentration o f 
specific protein in each standard was calculated from these estimates and the 
m easurem ents o f  total protein concentrations.
kDa 0.1 0 .2  0 .5  1 .0  2 .0  5 .0  10 1 5  fig  p ro te in
2 1 2 —
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NucA-VAMP2 GST-Munc18c
Figure 4.2. SDS-PAGE analysis of recombinant protein standards used for 
quantitation of adipocyte SNAREs. A range o f  amounts o f each recom binant 
protein was analysed by SDS-PAGE and subjected to staining with coomassie blue. 
Protein purity was estimated from the band densities and the total staining in each 
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Figure 4.3. Quantification of SNAREs and Muncl8c. Lysates from 10 cells, 
estimated from cell suspensions using a haem ocytom eter were run on SDS-PAGE in 
triplicate alongside known quantities o f  recom binant protein standards. Proteins were 
transferred to nitrocellulose and western blotted using purified rabbit sera against the 
respective proteins. Band densities were estimated and protein concentrations were 
calculated from calibration curves drawn from the standards. Representative blots 
from one o f three separate experiments are shown here.
Lysates were m ade from adipocyte suspensions o f  known cell densities so that 
the recom binant protein standards could be compared to lysates from known numbers 
o f  cells. The lysate equivalent o f 104 adipocytes was run in triplicate on SDS-PAGE 
alongside dilutions containing known numbers o f  the recom binant protein standard 
molecules (Section 2.12.2.). Proteins were then transferred to nitrocellulose and 
analysed by western blotting with the respective rabbit antibodies (Figure 4.3). Band 
intensities o f the protein standards were quantified and used to construct a calibration
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curve that was used to quantify the proteins in the lysate samples. The average 
number of copies of the proteins per adipocyte was determined from three separate 
experiments (Table 4.2).
Protein Number of copies per cell 
(n=3)
Syntaxin4 (2.5 ± 0.3) x 106
SNAP23 (8.9 ± 1.7) x 106
VAMP2 (1.9 +0.3) x 106
Muncl8c (1.0 ± 0.2) x 106
Table 4.2. Estimated numbers of syntaxin4, SNAP23, VAMP2 and Muncl8c 
molecules in rat adipocytes. Estimates of the numbers of protein molecules per 
adipocyte ± S.E.M. were calculated from band intensities of the blots represented in 
Figure 4.3.
4.2.3. Insulin induced redistribution of SNAREs and Muncl8c on intracellular 
membranes
In order to select a suitable timepoint to track insulin induced changes in the 
distribution of syntaxin4, SNAP23, VAMP2 and Muncl8c, the appearance of GLUT4 
and VAMP2 on plasma membranes following insulin treatment was monitored by the 
plasma membrane lawn assay (Section 2.10.). Isolated adipocytes were treated with 
20 nM insulin and processed for the plasma membrane lawn assay and labelled with 
rabbit anti-GLUT4 and mouse anti-VAMP2 antibodies. Immunofluorescence from 
fluorescent secondary antibodies was quantified as described in Section 2.10.4. The
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tim e-course o f  trafficking o f both proteins followed the same curve (Figure 4.4), as 
was to be expected if  they trafficked in the same vesicles. There was a 1 m in delay 
following insulin treatm ent followed by the rapid appearance o f GLUT4 and VAMP2 
on the membrane patches. The amount o f  the proteins on the lawns continued to 
increase for 20 min. By 40 min o f  insulin treatm ent, levels o f both proteins on the 
plasm a membrane patches had dropped to 70% o f the m aximum  level.
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Figure 4.4. GLUT4 and VAMP2 appearance on plasma membrane lawns 
following insulin treatment. Adipocytes were treated with 20 mM insulin for the 
times indicated, adhered to coverslips and processed for the plasm a membrane lawn 
assay. Lawns were probed with antibodies against GLUT4 and VAMP2. 
Im m unofluorescence was quantified and plotted as a percentage o f  the maximum 
increase in intensity following insulin treatment. Results are means from three 
separate experiments except at t=40 min, where n=2.
Subsequent experiments were carried out with 20 m in o f  insulin treatment so 
that cells were m axim ally stim ulated as far as appearance o f  GLUT4 vesicles on the 
plasm a m embranes was concerned. In other words the cells had reached a steady state 
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Figure 4.5. Distribution of SNAREs and Muncl8c in rat adipocytes. Fractions 
prepared from adipocytes treated with and without 20 nM insulin were analysed by 
SDS-PAGE and western blotting with rabbit antibodies to SNAP23, syntaxin4, 
VAM P2 and M uncl8c. The arrowheads show bands corresponding to these proteins 
in the cytosol, high density m icrosomes (HDM ), low density microsom es (LDM ), and 
plasm a membranes (PM). Blots are representative o f  three separate experiments.
In order to m onitor the distribution o f the proteins in rat adipocytes, 20 pg o f  
subcellular fractions from adipocytes that had been treated with insulin for 20 min 
were analysed by SDS-PAGE and western blotting alongside samples from non 
insulin-treated cells as described in Section 2.12.3. (Figure 4.5). Relative levels o f  the 
proteins in each fraction were calculated from the band intensities and the total 
protein content o f  the subcellular fractions.
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Syntaxin4 SNAP23 VAMP2 Muncl8c
BASAL
PM 1940000±190000 84500001280000 4100001110000 7700001140000
LDM 172000124000 79000159000 919000196000 74000124000
HDM 36300018000 2510001177000 531000116000 5800011000
INSULIN
PM 18700001130000 841000140000 8900001200000 7300001160000
LDM 13800016000 112000166000 696000162000 85000138000
HDM 469000111000 283000118000 2770001118000 76000123000
Table 4.3. Distribution of SNAREs and Muncl8c in rat adipocytes. The table 
shows the estimated number of molecules of each protein ± S.E.M. in membrane 
fractions from adipocytes from three separate experiments, based on the band 
intensities from the blots represented in Figure 4.5 and the estimates of total numbers 
of molecules of each protein (Table 4.2).
All the proteins tested were concentrated in the HDM, LDM and PM fractions, 
with < 2% of the total detectable in cytosol and mitochondria/nuclei fractions (Table 
4.3). SNAP23, syntaxin4 and Muncl8c were predominantly localised to the plasma 
membrane with 95%, 78% and 75% of the respective cellular totals of these proteins 
in the plasma membrane. There was no change in Muncl8c distribution following 
insulin treatment (Figure 4.6). There were small shifts of around 4% of the total 
syntaxin4 to the HDM following insulin treatment and of around 0.4% of the total 
SNAP23 to the LDM. VAMP2 was more evenly distributed, with 48% in the basal 
LDM, and the rest evenly split between HDM and PM fractions. Following insulin 
treatment, there was a redistribution of VAMP2 from the LDM to the PM, resulting in 
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treatment. Asterisks indicate where insulin causes a significant effect, determined by 
paired two-tailed t tests, where p<0.05.
4.2.4. SDS-resistant complexes
The presence of SNAREs in SDS-resistant complexes was inferred by the 
increase in detection of SNARE monomers following heat treatment of plasma 
membrane samples as described in Section 2.12.4. (Figure 4.7). Insulin treatment had 
no significant effect on the difference between heated and unheated samples (p>0.05 
by paired, two-tailed t test). Detection of syntaxin4 and VAMP2 monomers increased 
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Figure 4.7. Effect of heat treatment on detection of SNAREs. (A) Plasma 
membranes from rat adipocytes were solubilised in sample buffer containing 0.1% 
SDS. They were then analysed by SDS-PAGE and western blotting with rabbit anti- 
syntaxin4 serum and SNAP23 and VAMP2 monoclonal antibodies, with or without 
10 m in prior heating o f  samples at 95°C. (B) Bands on blots o f  heat-treated samples 
were quantified and expressed as fractions o f the band density o f  non heat-treated 




The results described here show that there were approximately 2,500,000 
copies of syntaxin4, 8,900,000 copies of SNAP23, 1,900,000 copies of VAMP2 and
1,000,000 copies of Muncl8c per adipocyte (Figure 4.3, Table 4.2). The relative 
expression levels of these proteins was in rough agreement with those previously 
measured in 3T3-L1 adipocytes (Hickson et a l , 2000), although absolute levels were 
around five-fold higher in the rat adipocytes.
The distribution of these proteins was detected by western blotting of 
subcellular fractions of basal and insulin treated adipocytes (Figure 4.5, Figure 4.6, 
Table 4.3). 95% of SNAP23 was located in the plasma membrane. Approximately 
77% of syntaxin4 was found in the plasma membrane, 15% in the basal HDM 
fraction, and the remainder in the LDM. There was a shift of around 4% of the total 
syntaxin4 to the HDM fraction followong insulin treatment. The distribution agrees 
roughly with that seen in 3T3-L1 adipocytes and rat adipocytes by other groups (Rea 
et a l , 1998; St Denis et al., 1999), although some groups have detected insulin- 
stimulated movement of syntaxin4 from the LDM to the plasma membrane in 3T3-L1 
adipocytes (Volchuk et al., 1996; Jagadish et al., 1997; Tellam et al., 1997).
There was a redistribution of 0.4% of the total cellular SNAP23 to the LDM 
following insulin treatment, in contrast with previous studies in both 3T3-L1 
adipocytes and rat adipocytes that found no change in distribution following insulin 
treatment (Chen et a l , 1997; Wang et a l , 1997; Wong et a l , 1997; Rea et a l , 1998;
St Denis et a l , 1999). Although consistent enough to be statistically significant, the 
measured insulin effect was much smaller than the variation in LDM SNAP23 content 
from experiment to experiment. This may have been because the bands on the western 
blots were of very low intensity compared to those on adjacent lanes. Furthermore, it
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was unclear which of the other fractions accounted for the increase in LDM SNAP23. 
More detailed examination of the LDM in isolation and in direct comparison to each 
of the other fractions may be required to clarify this point.
VAMP2 was predominantly located in the LDM in the basal condition. On 
insulin stimulation there was a shift in distribution, predominantly from the LDM to 
the plasma membrane, which resulted in a 2.2-fold increase in VAMP2 at the plasma 
membrane. This is also consistent with previously published results (Cain et a l , 1992; 
Laurie etal., 1993).
Muncl8c was predominantly found in the plasma membrane, with the 
remainder distributed between the intracellular membrane and cytosolic fractions. 
There was no difference in Muncl8c distribution between basal and insulin-treated 
cells in these experiments. There are reports of Muncl8c trafficking to the plasma 
membrane following insulin stimulation of 3T3-L1 adipocytes, though this has not 
been confirmed in other reports (Tellam et a l , 1997; Thurmond et a l , 1998; Nelson et 
a l , 2002).
In previous reports of work in 3T3-L1 adipocytes, increasing SNAP23 levels 
increased insulin stimulated trafficking of GLUT4 to the plasma membrane as well as 
glucose uptake, suggesting that SNAP23 availability limits insertion of GLUT4 into 
the plasma membrane (Foster et al, 1999). This finding implied that SNAP23 
availability must be tightly regulated, as it was also present in excess compared to 
syntaxin4 in 3T3-L1 adipocytes, and had a similar distribution in those cells to that 
seen in rat adipocytes (Rea et al, 1998; Hickson et a l, 2000). A proportion of 
SNAP23 was associated with a Triton-insoluble cytoskeletal fraction in 3T3-L1 
adipocytes, and colocalised with vimentin in fibroblasts and HeLa cells (Foster et a l, 
1999). SNAP23 also interacted with kinesin in a yeast two-hybrid assay and in vitro
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(Diefenbach et al., 2002). These cytoskeletal interactions may regulate availability of 
SNAP23 for SNARE complex formation.
Synaptic SNAREs assemble spontaneously in vitro into complexes that are 
resistant to SDS at temperatures up to 80°C. This assembly was prevented by 
cleavage of SNAP25 with BoNT E, in a manner which parallels BoNT E inhibition of 
calcium-evoked exocytosis (Hayashi et al., 1994; Baneijee et al., 1996). BoNT E 
inhibition of exocytosis was relieved by addition of a SNAP25 peptide that was 
incorporated into SDS-resistant complexes (Chen et al., 1999), suggesting that these 
complexes may precede exocytosis. SDS-resistant complexes isolated from secretory 
cells migrate as a series of bands of different sizes when analysed by SDS-PAGE 
(Hayashi et al., 1994; Otto et al., 1997; Chen et al., 1999). These may represent 
oligomers of ternary complexes, or different folding states of individual complexes 
(Tokumaru et al., 2001; Lawrence and Dolly, 2002). Previous attempts have failed to 
detect SDS-resistant SNARE complexes between adipocyte SNAREs in 3T3-L1 cells 
(Foster et al., 1998), although the recombinant proteins do form an SDS-resistant 
complex in vitro (Rea et al., 1998).
SDS-resistant complexes were detected indirectly in plasma membranes of rat 
adipocytes by comparing the detection of SNARE monomers on western blots of heat 
and non-heat treated samples (Figure 4.7). The intensities of all three SNARE 
monomer bands increased with heat treatment, implying the existence of SDS- 
resistant states with altered mobility on SDS-PAGE. A number of additional minor 
bands were also detected on the gels. Of these, the band at -94 kDa was common to 
blots with antibodies against all three SNAREs (Figure 4.6A). This band also 
decreased in intensity in the heat-treated samples, although the decrease was greater 
in blots against SNAP23 and syntaxin4 compared VAMP2.
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Using the estimates of numbers of each SNARE in the plasma membrane, the 
increase in number of SNAP23 monomers following heat treatment was estimated as 
being in excess of twenty times the increase in number of syntaxin4 monomers. This 
lopsided distribution suggests that the SDS-resistant states of syntaxin4 and SNAP23 
are not simply multiple heterodimers of the two proteins. SNAP23 must therefore be 
associated with proteins other than syntaxin4 in the SDS-resistant complexes. A 
proportion of the SDS-resistant states of SNAP23 may therefore represent protein that 
is unavailable for binding to other SNAREs, supporting the limited availability model.
The amount of SNARE monomers released following heat treatment did not 
differ between basal and insulin-treated cells (Figure 4.7). No changes were detected 
in the amount of SDS-resistant SNARE complexes during neurotransmitter release in 
nerve terminals or granule release in chromaffin cells either (Mehta et a l , 1996; 
Leveque et a l , 2000; Lawrence and Dolly, 2002), so it is not certain that changes 
would be detected following insulin treatment. It is thought that this is because 
SNAREs go through a variety of folded states and complexes prior to membrane 
fusion, and those states that occur immediately prior to fusion may be short lived and 
relatively rare in a snapshot view of the population.
Previously reported results have indicated that participation of plasma 
membrane syntaxin4 in SNARE complexes may also be regulated. Only half the 
syntaxin4 precipitated from rat adipocyte plasma membranes was in a complex with 
SNAP23 (St Denis et a l , 1999). This is interesting because in the experiments 
described above, there are half as many copies of Muncl8c on the plasma membrane 
as there are of syntaxin4. It is therefore possible that Muncl8c is associated 
exclusively with one half of the syntaxin4 population. Muncl8c co- 
immunoprecipitated with SNAP23 and syntaxin4 in platelets, and with syntaxin4 but
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not with SNAP23 in 3T3-L1 adipocytes (Tamori et al., 1998; Schraw et a l 2003). 
Muncl8c also inhibits the complex between syntaxin4 and SNAP23 when all three 
proteins are expressed together in COS cells (Araki et al., 1997). The quantitative data 
shown here support a model where syntaxin4/Muncl8c complexes and 
syntaxin4/SNAP23 complexes are mutually exclusive and each account for half of the 
syntaxin4 in the plasma membrane.
Insulin stimulated GLUT4 exocytosis was inhibited and GLUT4 vesicles 
accumulated adjacent to the plasma membrane when the syntaxin4-Muncl8c 
interaction was disrupted by a blocking peptide (Thurmond et al., 2000). One 
interpretation of this result is that the Muncl8c/syntaxin4 interaction is required for 
the fusion reaction. An alternative explanation which may better fit with the data on 
Muncl8c inhibiting SNARE complex formation is that Muncl8c bound to non- 
SNAP23 bound syntaxin4 molecules in the basal state, and prevents them combining 
with VAMP2. Blocking Muncl8c binding to syntaxin4 may allow syntaxin4 to bind 
VAMP2 on GLUT4 vesicles in the absence of SNAP23, thereby competing with 
ternary syntaxin4/SNAP23/VAMP2 complex formation. Recent reports from in vitro 
assays and SNAP25 knockout work have suggested that syntaxin 1 /VAMP complexes 
may support slow constitutive exocytosis but not fast calcium-evoked exocytosis 
(Woodbury and Rognlien, 2000; Washboume et al., 2002; Bowen et al., 2004). 
Therefore increasing syntaxin4/VAMP2 complexes at the expense of 
syntaxin4/SNAP23/VAMP2 complexes by disrupting the Muncl8c-syntaxin4 
complex with a blocking peptide may reduce the overall rate of fusion of GLUT4 
vesicles with the plasma membrane (Thurmond et al., 2000). The relationship 
between the amount of available SNAP23 and Muncl8c may therefore be a crucial
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determinant of the insulin response, and suggests that regulation of insulin-stimulated 
GLUT4 translocation may occur at this level.
The number of VAMP2 molecules on the plasma membrane in the insulin- 
stimulated state was also found to be approximately half the total number of syntaxin4 
molecules (Table 4.3). This is the same as the number of syntaxin4/SNAP23 
complexes (St Denis et al., 1999), consistent with VAMP2 from GLUT4 vesicles 
being recruited to syntaxin4/SNAP23 complexes on insulin stimulation. The 
Syntaxin4/SNAP23 complex as a whole is therefore likely to be rate-limiting for 
GLUT4 docking with the plasma membrane.
As well as regulation of SNARE complex formation, another function that has 
been attributed to Muncl8 proteins is in the trafficking of syntaxins through the cell 
(Rowe et al, 1999; Rowe et a l , 2001). Syntaxin4 trafficking to the plasma membrane 
was disrupted when syntaxin4 was overexpressed in a number of cell types. 
Trafficking was restored when Muncl8c was co-expressed in the same cells (Takuma 
et al, 2002). These results suggest that Muncl8c participates in the trafficking of 
syntaxin4 by preventing undesirable interactions with other proteins. In rat adipocytes 
however, syntaxin4 was present in large excess over Muncl8c in the intracellular 
membrane fractions (Table 4.3). This suggests that Muncl8c does not play a major 
role in preventing premature interactions with syntaxin4 in these membranes.
In summary, syntaxin4, SNAP23, VAMP2 and Muncl8c were quantified in 
rat adipocytes and in intracellular fractions. The proteins were expressed at 
approximately five times the levels previously seen in 3T3-L1 adipocytes, though 
expression levels of the proteins relative to each other were similar in both cell types. 
Syntaxin4, SNAP23 and Muncl8c were predominantly localised to the plasma 
membrane. A small proportion of syntaxin4 and SNAP23 were redistributed to the
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HDM and LDM respectively following treatment of adipocytes with insulin. VAMP2 
was predominantly intracellular, and its presence on the plasma membrane increased 
2.2-fold in response to insulin. The relative proportions of these proteins suggest that 
SNAP23 availability is tightly regulated and that Muncl8c does not play a major role 
in syntaxin4 trafficking. There was also a large excess of SNAP23 over syntaxin4 and 
VAMP2 in SDS-resistant complexes isolated from adipocyte plasma membranes. 
Insulin treatment had no effect on the number of these proteins segregated into SDS- 
resistant complexes. The stoichiometry of these complexes suggested that they were 
not directly linked to membrane fusion.
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Chapter 5 - Expression, purification and reconstitution of bacterially-expressed 
adipocyte SNAREs into liposomes for in vitro fusion experiments
5.1. Introduction
The fusion of GLUT4 vesicles with the plasma membrane of adipocytes is an 
important step in exposing GLUT4 to the exterior of the cell, thus enabling it to 
transport its hexose substrate into and out of the cell (Sections 1.3. and 1.7.). There is 
evidence that insulin as well as stimulating translocation of GLUT4 vesicles to the 
plasma membrane, also directly promotes docking of vesicles at the plasma 
membrane (Timmers et al., 1996; Inoue et al., 1999). This upregulation of docking by 
insulin occurs both on the plasma membrane and on GLUT4 vesicles. Membrane 
fusion itself is also a target of regulation by insulin. Insulin treatment affects 
intracellular pH (Yang et a l , 2002), interactions of SNAREs with proteins such as 
Muncl8c and synip (Tellam et al, 1997; Min et al., 1999), and calcium ion 
concentration (Whitehead et al., 2001), all of which affect membrane fusion. Insulin 
treatment of cells increased the ability of syntaxin4 to bind GLUT4 vesicles (Olson et 
al., 1997), and also increased the ability of VAMP2 on GLUT4 vesicles to form 
complexes with plasma membrane SNAREs (Timmers et al., 1996).
Syntaxin4, SNAP23 and VAMP2 have been shown to bind pairwise in vitro 
with affinities similar to those of the neuronal homologs (Foster et al., 1998). They 
also form a ternary complex in vitro (Rea et a l, 1998; Widberg et al, 2003) and are 
present together in 20S SNARE complexes from adipose cells (St Denis et al, 1999).
It is known that trans-SNARE complex assembly functions upstream of 
membrane fusion (Section 1.7.2.), but whether the complex itself catalyses the fusion
136
Figure 5.1. Reconstitution of v-s n a r e
membrane fusion with liposomes and 
recombinant SNAREs. Recombinant 
VAMP2 is reconstituted into liposomes 
containing a mixture o f fluorescent and 
quenching lipid head groups. The t- 
SNARE complex o f syntaxinl and 
SNAP25 is reconstituted into non- 
fluorescent liposomes. When mixed, 
liposomes containing complementary 
SNAREs dock and fuse. Subsequent 
fusion of the liposomes causes an 
increase in fluorescence as a result o f 
dilution o f the quenching lipid from the 
v-SNARE liposomes (Weber et al.,
1998).
reaction is still a matter o f debate (Szule and Coorssen, 2003). In vitro assays show 
that SNARE proteins are able to catalyse fusion between artificial lipid bilayers, and 
that this reaction retains many of the properties that characterise in vivo membrane 
fusion (Weber et al., 1998). Figure 5.1 shows an assay that has been used to 
demonstrate liposome fusion by SNAREs. Aside from lipid mixing, similar liposome- 
based assays have used content mixing to demonstrate full fusion between liposomes 
(Nickel et al., 1999). Although SNARE proteins are promiscuous, in that they are able 
to form complexes in vitro with SNAREs that they do not encounter in vivo 
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vivo trafficking events are able to catalyse fusion between liposomes (Parlati et al., 
2002). This suggests that the function of SNAREs in fusion is separate from their 
ability to form complexes.
Although this assay shows that SNARE proteins are able to facilitate lipid 
mixing in vitro, it does not necessarily mean that they carry out the same function in 
vivo. Structural studies of VAMP show that a number of residues in the carboxy- 
terminal part of the SNARE motif are buried in the membrane (Kweon et al., 2002). 
This makes VAMP unable to bind soluble syntaxin or SNAP25. Furthermore, no lipid 
mixing was observed between VAMP-containing liposomes and liposomes containing 
syntaxin and SNAP25 isolated from bovine brain, and VAMP from synaptic vesicles 
was unable to form complexes with soluble syntaxin and SNAP25 (Hu et al., 2002). 
Some argue that the fusion observed between v- and t-SNARE liposomes in the assay 
by the Rothman group may be an artefact caused by the high ratio of VAMP:lipid 
molecules (-1:20) in the liposomes. This is around 30 times the density in synaptic 
vesicles (Walch-Solimena et al., 1995a). The VAMP may not be able to interact fully 
with the membrane in these conditions. However, SNARE density was nearer 
physiologically relevant levels in the liposome based assays performed with yeast 
SNAREs, and in studies that observed fusion between cells that were made to express 
VAMP and syntaxin/SNAP25 on their outer surfaces (McNew et al., 2000a; Parlati et 
al., 2002; Hu et al., 2003).
Despite these doubts, this liposome-based assay has provided the basis for 
studies on structural requirements of SNAREs and regulation of fusion (Parlati et al., 
2000; Weber et al., 2000; McNew et al., 2000b; Melia et al., 2002), the role of 
calcium and synaptotagmin in membrane fusion (Hu et al., 2002; Mahal et al., 2002;
138
Tucker et al., 2004; Jeremic et al., 2004) and the role of Seel in stimulating fusion 
(Scott et al., 2004).
This chapter describes the adaptation of the liposome-based assay of SNARJE- 
mediated fusion shown in Figure 5.1 to the GLUT4 vesicle-plasma membrane system 
using recombinant syntaxin4, SNAP23, and VAMP2. The aim of developing this 
assay is to demonstrate whether these SNAREs are capable of catalyzing fusion 
between artificial liposomes. If this is so, it will be used as a model in studies of the 
regulation of fusion of GLUT4 vesicles with the plasma membrane. This means that 
there will be a defined starting point for experiments examining the effects of altering 
parameters such as mutations of the SNAREs, pH, metal ion concentration or the 
effects of addition of recombinant proteins or cellular components such as cytosol or 
peripheral membrane proteins on membrane fusion. This information can then be 
related to data obtained on the fusion apparatus from insulin-responsive cells to 
increase our understanding of the regulation of GLUT4 vesicle fusion with the plasma 
membrane by insulin.
5.2. Results
5.2.1. Reconstitution of recombinant t-SNAREs into liposomes
5.2.1.1. Expression and purification of syntaxin4
A number of approaches to expressing, purifying and reconstituting t-SNAREs 
into liposomes were examined. The first step towards enabling bacterial expression of 
syntaxin4 was to clone the coding sequence of syntaxin4. Two independent clones 
coding for full length syntaxin4 were obtained by RT-PCR from rat adipocyte mRNA 
as described in Section 2.4.1.1. The coding sequence of both syntaxin4 clones was
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identical to that of rat syntaxin4 (NM 031125) except for the substitution of the bases 
gc for eg at bases 647 and 648. This corresponds to the substitution of a serine for a 
threonine at residue 216 in the translated protein.
The syntaxin4 coding sequence was ligated into pET28a to produce pET28a- 
stx4 (Section 2.4.1.2.). The fusion protein expressed from this plasmid should 
resemble endogenous syntaxin4 on the cytosolic domain, but would contain the his- 
tag on the lumenal domain as shown in Table 5.1. The cytosolic domain is thought to 
be important in the protein-protein interactions that precede membrane fusion. The 
lumenal affinity tag should therefore not affect the function of the molecule in fusion 
assays.
Total syntaxin4-his expression from pET28a-transformed E. coli is described 
in Section 2.5.1. and was estimated at 0.7 mg per 1 of culture. Of this total, an 
estimated 0.45 mg per 1 of culture was soluble protein (Figure 5.2A). The soluble 
syntaxin4-his bound to Ni-NTA as predicted, but only partially eluted in buffer 
containing 250 mM imidazole (Figure 5.2B). The protein eluted on a pH step gradient 
at pH 6, consistent with a monomeric his-tag interaction with the nickel ions on the 
resin (Figure 5.2C). The total recovery of syntaxin4-his was estimated at 0.23 mg per 
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Table 5.1. Bacterial expression of adipocyte SNARE proteins. Schematic of the 
plasmids and recombinant SNARE proteins that were expressed for reconstitution 
studies described in this chapter. TM indicates the position of the transmembrane 
domain and arrowheads show the position of thrombin cleavage sites.
A final concentration 1-2 mg/ml of syntaxin was used when reconstituting the 
protein into liposomes in previously published studies (Weber et al., 1998). This was 
approximately 40 times the concentration of syntaxin4 purified from E. coli 
containing pET28a-stx4. Massive scaling up of the expression and purification steps 
would be required in order to achieve this final concentration with this syntaxin4 
expression system.
In an attempt to increase the yield and concentration of recovered syntaxin4, a 
vector was constructed with the aim of expressing of the protein as a fusion with the 
Staphylococcus aureus Nuclease A protein (NucA). As well as facilitating high 
expression levels in E. coli, NucA fusion proteins have the advantage of having a 
calcium-dependent endonuclease activity. This allows digestion of genomic DNA to 
reduce viscosity of bacterial lysates under mild conditions, minimising possible 
denaturation of the recombinant protein. NucA fusion proteins tend to be sequestered 
into inclusion bodies, which reduces the potential toxic effects of hydrophobic 
domains on the host cells, potentially increasing expression levels (Laage and 
Langosch, 2001).
The syntaxin4 coding sequence was cloned into pSNiR3, which was then 
modified to reduce the glycine spacer at the N-terminus of syntaxin4 and to remove 
the HA tag that is coded for by the plasmid (Section 2.4.1.3.). The resulting plasmid, 
pDRSNl-stx4 coded for syntaxin4 with a thrombin-cleavable NucA moiety at its
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Figure 5.2. Syntaxin4-his expression in Rosetta (DE3)pLysS. A. Total lysates from 
cells that were either uninduced (U) or induced (I) with 1 mM IPTG were separated 
by SDS-PAGE and stained with coomassie blue. B. Total lysates from uninduced 
cells (UT), induced cells (IT), proteins soluble in 25 mM  phosphate buffer pH 8, 1 M 
NaCl, 4% TritonX-100 (S), and the insoluble pellet (P) were analysed by SDS-PAGE 
and blotted with anti-syntaxin4 rabbit serum. C. Coomassie stained gel showing 
syntaxin4-his eluted from Ni-NTA with 250 mM  imidazole (IM) or a pH gradient o f 
50 mM  phosphate and phosphate-citrate buffers containing 300 mM  KC1 and 1% n- 
octylglucoside. The arrowheads indicate the expected position o f syntaxin4-his.
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amino terminus (Table 5.1). Cells transform ed with this plasm id expressed an 
estim ated 18 mg o f  N ucA -syntaxin4 per 1 o f  culture when induced as described in 
Section 2.5.2. All o f  this protein was soluble in a high salt detergent buffer designed 
to solubilise inclusion bodies (Figure 5.3A). In a typical experiment, NucA-syntaxin4 
m ade up an estim ated 70%  o f  the total protein in the washed and solubilised inclusion 
body fraction (Figure 5.3B). The concentration o f NucA-syntaxin4 in the final 
solubilised inclusion body fraction was typically 3.6 mg/ml. This was equivalent to 
2.4 mg/m l o f  syntaxin4.
kDa T S IB kDa
Figure 5.3. Solubilisation of NucA-syntaxin4. A. Coomassie stained gel showing 
total lysates o f  cells expressing N ucA -syntaxin4 (T), proteins soluble in 50 mM 
phosphate buffer pH 8 (S), and inclusion bodies solubilised in IB buffer (25 mM 
phosphate buffer pH 8, 1.5 M  NaCl, 1% n-octylglucoside) (IB). B. Inclusion bodies 
washed three times in 50 m M  sodium  phosphate buffer pH 7.5, 1 mM  EDTA, 1% n- 
octylglucoside and solubilised in IB buffer. N ucA syntaxin4 migrated at the 
theoretical m olecular w eight o f  55 kDa.
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Figure 5.4. Purification of NucA-syntaxin4. A. Inclusion bodies were solubilised 
and bound to N i-NTA agarose. The following samples were run on SDS-PAGE and 
stained with coomassie blue: an aliquot o f  the agarose beads boiled in sample buffer 
(B), flow through from beads washed with IB buffer (F), successive fractions eluted 
w ith 500 mM  imidazole in IB buffer (1-7). B. An inclusion body preparation was 
bound to Ni-NTA agarose, washed, then digested with thrombin. Lanes show proteins 
eluted from beads boiled in SDS-sample buffer. C. Proteins in the supernatant 
following digestion w ith thrombin. Proteins were washed o ff  with increasing KC1 
concentrations in 25 m M  phosphate buffer pH 7, 250 mM  NaCl, 1% n-octylglucoside.
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Solubilised inclusion bodies were bound to Ni-NTA agarose in an attempt to 
purify the protein further. However the protein did not elute from the agarose in 
buffer containing 500 mM imidazole (Figure 5.4A). Thrombin digestion showed that 
the syntaxin4 moiety adhered to Ni-NTA agarose even when the NucA moiety that 
contained the His-tag had been cleaved away (Figure 5.4.B). Syntaxin4 eluted from 
the Ni-NTA agarose at low concentrations in a buffer containing large amounts of 
KC1 (Figure 5.4C). In a typical experiment, 1 mg of syntaxin4 was recovered from 
each 1 of culture by this method.
In the interest of maximising yield and concentration of syntaxin4, the washed 
and solubilised inclusion body fraction was used in subsequent reconstitution 
experiments.
5.2.1.2. Expression and purification of SNAP23
SNAP23 was expresed as a fusion with glutathione-S-transferase (GST). GST 
is useful as a fusion protein because it aids high level expression in bacteria, increases 
the solubility of fusion proteins, and can be purified on immobilized glutathione 
(Smith and Johnson, 1988). The plasmid pGEX-SNAP23 was designed to express 
SNAP23 with an amino terminal thrombin-cleavable GST tag (Table 5.1). Cells 
transformed with this plasmid expressed around 12 mg of soluble GST-SNAP23 per 1 
of culture (Section 2.5.3.). This could be purified on glutathione-sepharose and 
recovered in a total volume of 4 ml (Figure 5.5). This was equivalent to 5 mg of 
SNAP23 per 1 of cultured cells.
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kDa
Figure 5.5. Purified GST-SNAP23. Lysates from cells expressing GST-SNAP23 
were bound to glutathione sepharose, washed in 50 mM  Tris buffer pH 8 containing 
500 mM  NaCl, 10 mM  DTT. Bound proteins were eluted in 50 m M  borate buffer pH 
9, 500 mM  NaCl, 10 mM  DTT, 20 mM  glutathione. Eluted proteins were analysed by 
SDS-PAGE and coomassie staining. GST-SNAP23 ran at the predicted m olecular 
w eight o f  50 kDa.
5.2.1.3 Reconstitution of syntaxin4 into liposomes
Liposomes were prepared by dissolving lipids in a detergent solution 
containing NucA-syntaxin4, followed by rapid dilution o f  the detergent below it 
critical m icellar concentration (CM C), as described in Section 2.13.1. Liposomes 
were harvested by density gradient centrifugation. Following centrifugation, 
liposomes were visible as a closely spaced doublet o f  faint white bands above the 
30% Optiprep layer. They were recovered by careful pipetting o f  the different layers, 
which were then analysed by SDS-PAGE. The NucA-syntaxin4 concentrated in the 
two white bands on the gradient. No bands other than NucA-syntaxin4 were 
detectable on the gel, indicating that the lipids had effectively partitioned the NucA-
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syntaxin4 from the other proteins in the inclusion bodies (Figure 5.6A). The NucA- 
syntaxin4 containing layers were pooled, m aking a total o f 550 pi o f  NucA-syntaxin4 
at a concentration o f 3 mg/ml, equivalent to 2 mg/ml o f syntaxin4. This accounted for 
>90%  o f  the syntaxin4 that was initially m ixed with the lipids. Thrombin digestion 
revealed that 75% o f NucA- syntaxin4 reconstituted with the cytosolic domain o f  
syntaxin facing outward, in the ‘correct’ orientation for the fusion experiments 
(Figure 5.6B).
kDa 1 2 3 4 5 kDa U 1 2A.
Figure 5.6. NucA-syntaxin4 reconstituted into liposomes. A. Liposomes were 
separated from unreconstituted proteins by flotation on a Optiprep step gradient. 
Samples were taken from various points on the gradient and analysed by SDS-PAGE 
and coomassie staining. Samples are labeled 1 to 5, with 1 being the bottom  layer and 
5 being the top o f  the gradient. B. 200 pi o f  NucA -syntaxin4 containing liposomes 
were digested with thrombin. Undigested liposom es (U) were run on SDS-PAGE 
alongside those incubated with 1 or 2 units o f throm bin for 2 hours at room 






5.2.1.4. Reconstitution of t-SNARES into liposomes
In order to form liposomes containing a t-SNARE complex, a second 
preparation was made, substituting a 2 mg/ml solution of GST-SNAP23 for detergent- 
free buffer at the stage where the lipid solution was diluted to form liposomes 
(Section 2.13.1).
The resulting liposomes were concentrated by gradient centrifugation and 
contained both NucA-syntaxin4 and GST-SNAP23 (Figure 5.7B). The molar ratio of 
SNAP23:syntaxin4 on the liposomes was estimated at approximately 1:5 by 
comparison of intensity of staining by coomassie blue. This preparation is not likely 
to be useful for reconstitution of fusion, as syntaxin4 is likely to compete with the 
syntaxin4/SNAP23 complex for binding to VAMP2. The interaction between 
SNAP23 and the cytosolic domain of syntaxin4 has an experimentally determined 
dissociation constant of 0.76 pM (Foster et al., 1998). According to this figure more 
than 90% of syntaxin would be expected to be in a complex with SNAP23 in this 
experiment. Complexes were therefore not formed efficiently by this method.
5.2.1.5. Formation of t-SNARE complex on glutathione-sepharose
A second approach to forming the t-SNARE complex involved incubating 4 
mg of GST-SNAP23 that had been pre-bound to 0.5 ml glutathione-sepharose with 
3.6 mg of NucA-syntaxin4 inclusion body preparation containing detergent in 2 ml of 
IB buffer (Section 2.13.2.). The proteins were eluted with buffer containing 
glutathione. A small proportion of NucA-syntaxin4 co-eluted with GST-SNAP23. A 
sample of the glutathione sepharose was also boiled in SDS sample buffer following 
elution and analysed by SDS-PAGE. This showed that most of the NucA-syntaxin4 
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Figure 5.7. t-SNARE complex assembly. A. NucA-syntaxin4 (NucA stx) was 
incubated with immobilized GST-SNAP23 (GST SNAP) on glutathione-sepharose. 
Bound proteins were eluted with glutathione (eluate). Proteins rem aining on the beads 
were eluted by boiling in SDS sample buffer (boiled). B. GST-SNAP23 (GST SNAP) 
was incubated overnight at 4°C with syntaxin4 following reconstitution into 
liposomes. Following dialysis, liposomes were isolated by flotation on an Optiprep 
step gradient. Samples were taken from the top and bottom  o f  the gradient and 
separated by SDS-PAGE and stained with coomassie blue.
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5.2.1.6. Co-expression of adipocyte t-SNAREs in bacteria
Due to the low recovery of t-SNARE complexes using the approaches 
described above, the strategy was changed to one where the adipocyte t-SNAREs 
were co-expressed in bacteria. GST-SNAP23 was co-expressed with untagged 
syntaxin4 or NucA-syntaxin4 from the plasmids pDRSNl-tSNAREs and pDRSNl- 
tSNAREs(NucA), described in Section 2.4.1.4. These plasmids were derived from 
pGEX-SNAP23, and code for bacterial expression of GST-SNAP23 and syntaxin4 or 
NucA-syntaxin4 under the control of a single tac promoter (Table 5.1).
Inclusion body preparations were made from bacterial cultures transformed 
with either plasmid as described in Section 2.5.4. These were analysed by SDS-PAGE 
and Coomassie staining. A number of protein bands in the solubilised inclusion 
bodies were common to both sets of expressed proteins, implying that they were 
either bacterial proteins, degradation products or truncated products of GST-SNAP23 
(Figure 5.8A). Each plasmid however also produced a unique band at the predicted 
molecular weight of the translated products. Inclusion body preparations from cells 
transformed with pGEX-tSNAREs contained an estimated 10 mg of GST-SNAP23 
and 1.5 mg of syntaxin from 1 1 of culture. Cells transformed with pGEX- 
tSNAREs(NucA) produced around 15 mg of GST-SNAP23 and 10 mg of NucA- 
syntaxin4 in inclusion bodies from 11 of culture.
5.2.1.7. Reconstitution of coexpressed t-SNAREs into liposomes
Solubilised inclusion bodies from cells transformed with pGEX-tSNAREs 
were used to form liposomes by dilution of lipids as described for NucA-syntaxin4 
liposomes. Following flotation on an Optiprep gradient, GST-SNAP23 and syntaxin4 
were detected at the top of the gradient by coomassie staining and western blot,
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coinciding with the visible band o f  lipid on the gradient (Figure 5.8B). Syntaxin4 
concentration in the final liposome fraction was estimated at 0.025 mg/ml. These 






Figure 5.8 Coexpression and reconstitution of recombinant t-SNAREs. A.
Inclusion bodies from Rosetta(DE3)pLysS cells transfected with the indicated 
plasm ids were solubilised in 6 M guanidine hydrochloride, 10 mM DTT, 1% n- 
octylglucoside, run on SDS-PAGE and coomassie stained. B. Solubilised inclusion 
bodies from bacteria coexpressing GST-SNAP23 and syntaxin4 were m ixed with lipid 
followed by rapid dilution, dialysis and flotation in an Optiprep gradient to form 
liposom es as described in the text. Samples o f  the protein m ixture that was initially 
m ixed with the lipids (IB), the bottom o f the gradient (bottom), and the top o f the 
gradient (top) were run on SDS-PAGE and stained with coomassie blue. Arrowheads 
indicate the expected m igration o f  the recom binant proteins.
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5.2.2. Reconstitution of VAMP2 into liposomes
5.2.2.I. Expression of VAMP2 in bacteria
VAMP2 was cloned by PCR from a rat adipocyte cDNA library made by Dr 
Paul Whitley (Whitley et al., 2003), as described in Section 2.4.2.1. Sequence 
analysis showed that the cloned VAMP2 sequence was identical to the rat VAMP2 
mRNA sequence (M24105). This coding sequence was ligated into pET28a to form 
pET28a-VAMP2 (Section 2.4.2.2.). This plasmid was used to express VAMP2 with a 
carboxy-terminal his-tag on the lumenal side of the membrane, ensuring minimal 
interference with interactions of the cytosolic domain.
Protein expressed by E. coli transformed with this plasmid was bound to Ni- 
NTA agarose as described in Section 2.5.5. VAMP2 was not detected in imidazole 
elutions from the resin (Figure 5.9A). The protein eluted from the resin at pH 4.8 on a 
pH gradient (Figure 5.9B), suggesting that the protein was eluting as an homo­
oligomer, consistent with previous reports (Laage and Langosch, 1997). A total of 
-0.5 mg of VAMP2-his was eluted by the pH gradient in a total volume of 20 ml from 
an initial culture volume of 2 1.
In order to increase the yield of VAMP2, the protein was also expressed as a 
NucA fusion from the plasmid pDRSNl-VAMP2 (Table 5.1), that was constructed as 
described in Section 2.4.2.3. E. coli transformed with this plasmid expressed -16 mg 
of NucA-VAMP2 per 1 of culture, all of which was recovered in the inclusion body 
fraction (Figure 5.10A). The protein bound to Ni-NTA and could be recovered by 
elution with imidazole (Section 2.5.6., Figure 5.1 OB). Alternatively, digestion with 
thrombin released VAMP2 into the bead supernatant. Purity of this VAMP2 was 
estimated at > 90% by coomassie staining (Figure 5.10C). Typically, 1 1 of culture 
yielded -6  mg of VAMP2 in a final volume of 1 ml by digestion from Ni-NTA
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Figure 5.9. Expression and purification of VAMP2-his. Lysates from bacteria 
expressing VAM P2-his were incubated with N i-NTA agarose. Bound proteins were 
eluted with A. increasing concentrations o f imidazole, or B. a gradient o f  phosphate 
and phosphate-citrate buffers o f  decreasing pH. Fractions were collected and analysed 
by SDS-PAGE and coomassie staining.
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Figure 5.10. Expression and purification of NucA-VAMP2. A. Total lysates (T) 
from cells expressing VAM P2 were run on SDS-PAGE alongside proteins soluble in 
50 mM  phosphate buffer pH 8 (S) and inclusion bodies solubilised in 25 mM 
phosphate buffer, 1.5 M NaCl, 1% n-octylglucoside (IB). B. Solubilised inclusion 
bodies were bound to Ni-NTA agarose and bound proteins were eluted in IB buffer 
containing increasing concentrations o f  imidazole. C . Supernatant from beads 
following throm bin digestion. Arrowheads indicate expected positions o f  NucA- 
VAM P2 in A and B, and o f  VAM P2 in C.
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Figure 5.11. VAMP2 reconstituted into liposomes. VAM P2 purified by throm bin
digestion o f  NucA-VAM P2 on Ni-NTA agarose was m ixed with dried lipids in
detergent solution. Liposomes were prepared by rapid dilution and isolated by
flotation on an Optiprep step density gradient. Samples were taken from points on the
gradient. Fractions are num bered 1-3 where 1 was the lowest layer in the gradient.
5.2.2.2. Reconstitution of VAMP2 into liposomes
Fluorescent liposomes containing VAM P2 were made by solubilizing the 
fluorescently labeled lipids in the VAM P2 solution followed by rapid dilution o f  the 
detergent below its CM C as described in Section 2.13.4. Liposomes were 
concentrated by centrifugation on a density gradient. All VAM P2 co-m igrated with 
the lipid band near the top o f the gradient (Figure 5.11). The reconstituted protein was 
recovered in a volume o f  250 pi, containing 0.6 mg o f  VAM P2. These liposomes 













Figure 5.12. Fusion between liposomes containing adipocyte t-SNAREs and 
VAMP2. Liposomes containing VAM P2 and a m ixture o f  fluorescent and quenching 
lipids were incubated with liposomes containing syntaxin4 and SNAP23 for 16 h at 
4°C. A second experiment was set up with liposomes lacking the VAMP2. NBD 
fluorescence was m onitored at 37°C for 3 h. Following m easurem ents, TritonX-100 
was added to 0.4% (w/v) and fluorescence was measured again. The lowest reading 
was set as a baseline and fluorescence was expressed as a percentage o f  the value 
following addition o f  TritonX-100. The graph shown is representative o f  results from 
two separate experiments.
5.2.3. Fusion Assays
t-SNARE liposomes were m ixed with either VAM P-containing or protein-free 
fluorescent liposomes and incubated for 16 h at 4°C to allow liposomes to dock 
together. Fusion assays were carried out at 37°C as described in Section 2.13.5. 
Fluorescence was m easured at 535 nm with the excitation filter set to 485 nm over a 
period o f  3 h and plotted on a graph (Figure 5.12). There was a slow initial decrease 
in fluorescence up to about 90 m in in both VAM P2 and protein-free donor liposome
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wells. The fluorescence in VAMP2-containing wells remained above that of protein- 
free wells throughout the duration of the experiment, although from around 100 min 
to the end of the experiment, the rate of increase of the reading from the protein-free 
donor liposome was greater than that from the VAMP liposomes. This was also true 
of a second experiment carried out with the same t-SNARE liposomes and a fresh 
preparation of donor liposomes two days after the first experiment.
5.3. Discussion
This chapter describes the expression of full length syntaxin4, SNAP23 and 
VAMP2 in bacteria for use in an in vitro fusion assay. Bacterial expression of 
SNAP23 and VAMP2 have been described previously (Rea et ol., 1998; Weber et al., 
1998), but bacterial expression and purification of full length syntaxin4 has not been 
demonstrated before. Syntaxin4-his was expressed at comparatively low levels and 
was difficult to purify as it adhered to Ni-NTA agarose even under conditions of high 
imidazole and low pH (Figure 5.2). NucA-syntaxin4 was expressed at much higher 
levels and could be isolated from inclusion bodies and by reconstitution into artificial 
liposomes (Figure 5.3, Figure 5.6). Incubation of NucA-syntaxin4 with GST-SNAP23 
produced smaller amounts of complex than that predicted by the kd of the cytosolic 
domains (Foster et al., 1998). This may be because of interference by the fusion 
proteins, or because of incorrect folding of the polypeptide chains. Alternatively, 
complex assembly may be hindered when syntaxin4 is associated with a lipid bilayer.
When syntaxin4 and GST-SNAP23 were coexpressed in bacteria the proteins 
sequestered into inclusion bodies, which were soluble in solution containing 6 M 
guanidine (Figure 5.8A). Following buffer exchange, approximately equimolar 
amounts of syntaxin4 and SNAP23 were successfully reconstituted into liposomes
158
(Figure 5.8B). A great deal of precipitation of protein was seen following buffer 
exchange, suggesting that the yield of soluble protein might be increased using a more 
sophisticated refolding strategy. Examples of suitable approaches to try include 
solubilisation followed by removal of denaturants and chaotropes such as urea or 
guanidine, solubilisation at high or low pH followed by gradual neutralisation, or 
chaperone-mediated refolding.
VAMP2 was expressed with a carboxy terminal his-tag and as a NucleaseA 
fusion protein. Once again the NucleaseA fusion protein was expressed at higher 
levels than the his-tagged version (Figure 5.9, Figure 5.10). VAMP2 could be purified 
by binding NucA-VAMP2 to Ni-NTA agarose and cleaving the fusion protein with 
thrombin. Purified VAMP2 successfully reconstituted into liposomes (Figure 5.11).
When t-SNARE liposomes where mixed with VAMP liposomes containing 
fluorescent and quenching lipids, there was an initial decrease in fluorescence (Figure 
5.12). This was likely to be a result of the increase in temperature when the 96-well 
plate was transferred from incubation at 4°C to the chamber of the plate reader at 
37°C, as NBD fluorescence is sensitive to temperature changes (Chapman et al.,
1995). The time taken for the temperature to equilibrate might be reduced by not 
preincubating the plates at 4°C. The preincubation step was used to maximise the 
initial signal, by allowing the liposomes to dock, ensuring that fusion commenced 
immediately on the temperature change (Weber et a l, 1998). However, even when the 
chamber in the fluorescent plate reader was pre-warmed, it took more than 30 min 
after the 96-well plate was inserted for the chamber temperature to return to 37°C.
Bearing this limitation in mind, wells containing donor liposomes with 
VAMP2 still showed higher fluorescence readings than protein-free donor liposomes 
as the experiments progressed, even though initial fluorescence was the same.
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However, after-100 min of incubation at 37°C, the rate of increase in fluorescence 
was greater with the protein-free vesicles. Though a specific SNARE-dependent 
effect cannot be discounted, it is possible that the initial increased fluorescence is 
simply an exaggeration of the background rate of increase due to the destabilising 
presence of large amounts of proteins in the donor liposomes. The existence of 
specific SNARE-dependent effects could be established by experiments with VAMP- 
cleaving toxins or by substituting VAMP with other transmembrane proteins.
The kinetics of fusion events mediated by the adipocyte SNAREs are 
unknown. Synaptic vesicle fusion occurs rapidly in vivo, and individual fusion events 
occur on a similar timescale (<100 ms) when VAMP is reconstituted into liposomes 
and t-SNAREs are reconstituted into a planar lipid bilayer (Fix et al., 2004). This 
reaction is slower when both sets of SNAREs are in liposomes (Parlati et al., 1999). 
The geometries of the lipid bilayers involved therefore affect the kinetics of 
reconstituted fusion. The appearance of GLUT4 on the plasma membrane of 
adipocytes follows soon after GLUT4 translocation, and has a ti/2  of several min 
(Satoh et al., 1993). The use of a temperature-sensitive Muncl8c mutant however has 
shown that trafficking of GLUT4 to the plasma membrane and not membrane fusion 
is rate-limiting to the appearance of GLUT4 on the cell surface (Thurmond and 
Pessin, 2000). The rate at which fusion between liposomes containing adipocyte 
SNAREs could occur is therefore unknown. The combination of the liposome 
geometry and the low density of t-SNAREs in the acceptor liposomes used in the 
assay described above may slow fusion to the point where it is overtaken by the 
background increase in fluorescence in these assays.
Previous liposome-based fusion studies have used pre-formed binary t- 
SNARE complexes on one of the liposome populations. However, recent reports have
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questioned the requirement for SNAP25 in this kind of assay. Reconstituted VAMP 
liposomes and synaptic vesicles are able to fuse with planar lipid bilayers containing 
only syntaxinl (Woodbury and Rognlien, 2000; Bowen et al., 2004). Furthermore, 
knockout mice lacking SNAP25 show normal vesicle docking and constitutive fusion, 
although stimulus dependent neurotransmitter release was abolished (Washboume et 
al., 2002). SNAP23 has been shown to function in modulating the calcium sensitivity 
of docking and fusion of secretory granules (Chieregatti et al., 2004), and may 
therefore be involved in regulating fusion rather than directly participating in 
catalyzing fusion as previously thought. It may therefore be possible to reduce the 
assay further to one with VAMP2 donor liposomes and acceptor liposomes containing 
only syntaxin4.
The fusion reconstituted between VAMP liposomes and t-SNAREs in a planar 
bilayer may also be sensitive to divalent ion concentration (Fix et al., 2004), although 
this effect was not duplicated in other similar studies (Bowen et al., 2004); (Tucker et 
al., 2004). In one study, high calcium concentrations were able to induce fusion 
between liposomes in the total absence of SNARE proteins (Jeremic et al., 2004). 
Therefore fusion of the liposomes in the assay described here may require calcium 
ions. This would be consistent with the reported requirement for calcium at a late 
docking stage or fusion of GLUT4 vesicles with the plasma membrane in 3T3-L1 
adipocytes (Whitehead et al., 2001).
In summary, syntaxin4, SNAP23 and VAMP2 were expressed in bacteria and 
reconstituted into liposomes. Fusion assays based on these reconstituted proteins were 
not conclusive and may have been limited by the concentration of syntaxin4-SNAP23 
complexes in acceptor liposomes, among other factors. Nevertheless, the work
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described here provides material on which future studies on membrane fusion 
mediated by adipocyte SNAREs can be based.
Chapter 6 -  Conclusions
This thesis set out to investigate the events at the plasma membrane that 
follow insulin stimulation of adipocytes and the roles played by SNAREs and other 
proteins involved in membrane fusion.
The experiments on activation of the p38 MAP kinase pathway in Chapter 3 
showed a relatively small stimulation of p38 MAP kinase phosphorylation at the 
regulatory site by insulin (35% above basal levels), and no insulin effect at all on 
phosphorylation of the downstream molecule CREB. This contrasts with the more 
than two-fold activation of p38 MAP kinase seen in 3T3-L1 adipocytes and cultured 
muscle cells (Konrad et ah, 2001), and the complete lack of activation of p38 MAP 
kinase by insulin seen in human adipocytes (Carlson et ah, 2003). The marginal 
insulin stimulated increase in p38 MAP kinase activation seen in the rat adipocyte 
experiments may not be consistent with the large effect that it is reported to have on 
GLUT4 transporter activity.
The experiments with the p38 MAP kinase inhibitor SB203580 showed that 
insulin stimulated glucose uptake and labelling of cell surface GLUT4 were inhibited 
to similar degrees. This initially suggested that SB203580 was inhibiting GLUT4 
exocytosis, consistent with the reported effects of the inhibitor on the Akt pathway. 
However, only a small activation of Akt is required for the full insulin effect on 
GLUT4 exocytosis (Whitehead et ah, 2001), meaning that it is unlikely that this small 
effect of SB203580 on Akt activation would noticeably affect GLUT4 exocytosis. 
Furthermore it has been shown that treatment with 10 pM SB203580 does not affect 
insulin stimulated GLUT4 exocytosis (Somwar et ah, 2002). Subsequent experiments 
have shown that SB203580 acts as a competitive inhibitor of glucose transport on the
163
intracellular surface of GLUT4 (Ribe et al., 2005). Furthermore, a recent report 
demonstrated that treatment with SB203580 reduced affinity labelling of cell surface 
GLUT4 independently of insulin stimulated GLUT4 exocytosis (Bazuine et al.,
2005). These later experiments suggest that SB203580 binds to the intracellular face 
of GLUT4, displacing the hexose substrate from the intracellular binding site, and 
also prevents binding of the hexose moiety of the affinity label to the extracellular 
binding site on GLUT4. The discrepancy between GLUT4 labelling and exocytosis 
might have been detected if the modified GLUT4 exocytosis assay described in 
Section 3.2.2. had been used in the SB203580 experiments instead of the simpler 
affinity labelling assay.
The results of these experiments did not rule out a role for p38 MAP kinase in 
insulin stimulated GLUT4 translocation. They did however imply that SB203580 is 
not a good tool for studying p38 MAP kinase involvement in insulin stimulated 
glucose transport, because it interfered directly with GLUT4 function. The SB203580 
evidence from previous studies cannot now be viewed as supporting the case for p38 
MAP kinase activation of GLUT4 transport activity.
It has previously been shown that wortmannin was able to block insulin 
stimulated glucose uptake at lower concentrations than were needed to block GLUT4 
vesicle translocation and GLUT4 vesicle fusion with the plasma membrane in 3T3-L1 
adipocytes (Hausdorff et al., 1999; Somwar et al., 2001b). The inhibition experiments 
with wortmannin reported in Chapter 3 demonstrate that this was not the case in rat 
adipocytes. Instead they showed that at low wortmannin concentrations, insulin 
stimulated GLUT4 vesicle fusion and glucose uptake were blocked independently of 
GLUT4 vesicle translocation. This implied that there was a high affinity wortmannin 
target downstream of GLUT4 vesicle trafficking to the plasma membrane, but
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upstream of GLUT4 incorporation into the plasma membrane. This is in agreement 
with recently reported studies that have shown that 1) PI 3-kinase inhibition blocks a 
late pre-fusion step in 3T3-L1 adipocytes (Bose et ah, 2004), 2) a late pre-fusion step 
is blocked under conditions that inhibit Akt activity (van Dam et ah, 2005), 3) that the 
function of synip, a protein that regulates the SNARE complex is regulated by Akt 
(Yamada et ah, 2005), 4) and that a PI 3-kinase dependent block at a late pre-fusion 
step is dependent on Muncl8c, also a SNARE complex regulator (Kanda et ah, 2005). 
These reports give the membrane fusion machinery a major role in insulin stimulation 
of glucose uptake.
The quantitation of syntaxin4, SNAP23, VAMP2 and Muncl8c in rat 
adipocytes (Chapter 4) was intended to provide a quantitative context for interpreting 
data on the membrane fusion machinery in these cells. The quantitative data 
suggested two key points. The first was that syntaxin4 outnumbered Munc 18c on 
intracellular membranes by a factor of four. This meant that it was unlikely that 
Munc 18c was the main binding partner supporting syntaxin4 trafficking to the plasma 
membrane, as had been suggested by previous studies (Takuma et ah, 2002). The 
second point was that in the plasma membrane, SNAP23 was present at more than 
four-fold the levels of syntaxin4. This suggests that if the excess SNAP23 is not to 
compete with syntaxin4 by forming ‘unproductive’ SNARE complexes, SNAP23 
availability must be tightly regulated. This was supported by the 20-fold excess of 
SNAP23 over syntaxin4 in SDS-resistant complexes that may represent a segregated 
state of SNAP23 that is unavailable for SNARE binding.
In a study on plasma membrane lawns made from PC 12 cells, syntaxinl was 
concentrated in numerous clusters of approximately 200 nm in size. Docking and 
fusion of secretory vesicles occurred within these clusters. SNAP25 was concentrated
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in a different set of clusters that partially overlapped with the syntaxinl clusters, and 
its distribution was more diffuse than that of syntaxinl. The majority of syntaxinl 
clusters contained SNAP25, but there were many SNAP25 clusters that did not 
contain syntaxinl (Lang et a l, 2001). This distribution may represent segregation of 
the excess SNAP25, as SNAP25 was expressed in 5 to 6-fold excess over syntaxinl in 
these cells (Xiao et al, 2004). It would be instructive to see if this kind of spatial 
segregation occurs in lawns prepared from adipocyte plasma membranes, and whether 
the ‘segregated’ SNAP23 pool colocalises with other proteins, such as the cytoskeletal 
proteins that are reported to bind to SNAP23 (Foster et al, 1999; Diefenbach et al, 
2002).
Unfixed plasma membrane lawns from PC 12 cells also support SNARE 
complex formation and exocytosis of secretory vesicles (Lang et al, 2001; Holroyd et 
al, 2002; Lang et a l, 2002). Similar membrane preparations from adipocytes could 
be used in combination with soluble recombinant VAMP2, purified GLUT4 vesicles, 
or recombinant VAMP2 reconstituted into liposomes to monitor SNARE complex 
formation and localisation of vesicle fusion. The usefulness of such a system could be 
extended by adding signalling molecules such as Akt or inhibitors such as 
wortmannin, for example. This type of assay, has a lot of potential for elucidating the 
regulation of the steps leading to membrane fusion.
This plasma membrane lawn based assay system would be an intermediate 
between observations of membrane fusion events in cells, and the entirely artificial 
fusion assay system that is described in Chapter 5. In the cell-free system, mixing of 
liposomes with reconstituted v- and t-SNAREs should produce a signal indicating that 
lipid mixing, or fusion has taken place. This assay is intended to enable studies of the 
SNAREs in isolation, or in combination with other proteins such as Munc 18c and
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synip. Again the system could be manipulated by adding external factors such as 
calcium ions, signalling proteins, inhibitors or cytosol. This type of ‘minimal 
machinery’ assay has been used to study the function of synaptotagmin in sensitizing 
SNARE-mediated fusion to calcium, the function of NSF/aSNAP and the function of 
Munc 18 in synaptic SNARE-mediated fusion (Weber et al., 2000; Tucker et a l , 2004; 
Scott et al., 2004). The signal in the liposome assays reported in this thesis was very 
close to background. This was likely to be because of the low concentration of t- 
SNAREs in the acceptor liposomes. Although syntaxin4 and SNAP23 could be 
expressed at high levels and isolated individually, difficulties arose when attempting 
to form a t-SNARE complex from co-expressed or individually expressed syntaxin4 
and SNAP23, either in solution or on liposomes. This may have been due to faulty 
refolding of the proteins following isolation. As the proteins could be expressed at 
high levels and isolated, refolding strategies would be the logical next step to 
obtaining functional recombinant proteins.
In conclusion, this thesis has described treatments of intact cells with 
inhibitors of signalling pathways, quantitation of proteins in whole cells and 
subcellular fractions and a reductionist approach using an entirely non-cell based 
assay, with the unifying aim of dissecting the events and interactions that lead from 
insulin signalling to glucose uptake by means of fusion of GLUT4 vesicles with the 
plasma membrane. The results described here add to the evidence linking the PI 3- 
kinase signalling pathway to the regulation of GLUT4 vesicle fusion. Results of 
quantitation experiments indicate that Munc 18c is unlikely to play a major role in 
intracellular syntaxin4 trafficking, and that SNAP23 availability for SNARE complex 
formation in the plasma membrane is likely to be highly regulated. SNAP23
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